# Research Log

_Pre-market research notes and the trade plan for the day. Newest at the top.
The market-open routine reads the most recent "Planned trades" section._

_Entries before 2026-06-01 archived to `memory/archive/2026-05.md` (2026-07-01 monthly housekeeping)._

---

## 2026-07-15 — Pre-market research (~08:07 ET, Wednesday)

**Live-switch guard / lock / control:** `ALPACA_BASE_URL` contains "paper" ✓. `_lock` was `{}`, acquired and will be released before commit. Control STATUS ACTIVE, no NOTE/QUERY to acknowledge.

**Account snapshot (~08:07 ET):** Equity USD 99,339.01 | Cash USD 76,244.79 (76.745%) | Last equity (July 14 close) USD 99,335.99. Shock check: +0.003% — no shock ✓ (threshold −4%). Drawdown vs HWM USD 101,384.21: −2.017% — informational only, not near the −10% circuit breaker.

**Positions (live prices ~08:07 ET), one line each — "what changed since yesterday":**
- CAT 4sh @ USD 936.80 (−0.839% from entry USD 944.73). FY2026 revenue outlook raised to low-double-digit growth; record USD 63B backlog; Power and Energy segment +41% on hyperscaler AI-data-center capex — thesis-confirming, not new since the July 13 diligence pass. Valuation debate (P/E ~38x vs. 5-yr avg 19x; Michael Burry short) is a known factor, not new today. Ex-div July 20 (USD 1.63/sh). review_by 2026-08-03 not due. HOLD.
- LLY 10sh @ USD 1,152.58 (+5.400% from entry USD 1,093.534). July 14 close was −3.10% on broad sector rotation out of high-multiple metabolic-health/growth names into cyclicals (per market commentary) — not company-specific, no thesis break. Bernstein raised PT to USD 1,385, UBS to USD 1,425, Guggenheim to USD 1,273 (all in the last few days, all positive). review_by 2026-07-21 not due. HOLD. Conviction A.
- V 22sh @ USD 355.51 (+9.871% from entry USD 323.57). ACE Money Transfer partnership (already known, July 13) plus a new AI Financial Assistant product announcement; consensus Buy, median PT ~USD 401-410. No thesis-breaking news. review_by 2026-07-28 not due. HOLD. Conviction B.

**Stop audit:** 4/4 PASS — CAT (6103c146) 4sh, LLY (d4147484 7sh + 25989fb5 3sh) 10sh, V (66033918) 22sh — all live via `orders open`, matches held quantities exactly. No missing stops.

**Thesis contract review:** CAT review_by 2026-08-03, LLY review_by 2026-07-21, V review_by 2026-07-28 — none due today. No invalidation conditions triggered for any held position.

**Earnings window:** CAT next earnings Aug 4 (confirmed), LLY Aug 5 (confirmed), V July 28 (confirmed) — none within 2 trading days. No restriction on holding. ETN (today's buy candidate) confirmed July 31 — 12 trading days out, no restriction on opening the position.

**Macro (WebSearch):** S&P 500 futures +0.18% pre-market on cooling inflation — Polymarket-implied odds of a July Fed hike fell to 17% from 42% a day earlier; today's PPI print and a fresh wave of earnings are the session's key catalysts. PayPal surged on ~USD 53B takeover-offer reports; chip stocks broadly higher, lifting Nasdaq futures. 10yr yield 4.57% (down ~6bp) — below the 4.75% halt-trigger. WTI ~USD 79.64-80.58/bbl — below the USD 100 halt-trigger despite ongoing Strait-of-Hormuz tension. Neither macro circuit-breaker close to tripping. Overall: constructive, risk-on tape.

**Watchlist re-checks (pullback-watch names, via Alpaca bars with explicit start/end + feed=iex):**
- **ETN: CLEARED — PROMOTED.** 50-day MA USD 405.09, July 14 close USD 415.65 = **+2.606% above** (was −0.66% below July 13) — a clean reversal on the broad risk-on move, clearing both the 0.5% minimum-separation floor and the 10% extension ceiling for the first time since diligence began June 26. ATR (20-day) 2.967% — under the 3% halved-sizing threshold, so no size reduction needed. Per the pullback-watch protocol, re-verified signals #1/#2/#3/#5 briefly rather than from scratch: #1 earnings momentum — Q1 2026 record sales USD 7.5B (+17% YoY), record adj EPS USD 2.81, both already-known and unchanged; #2 catalyst — AI-data-center power-infrastructure buildout, structurally intact, no new negative; #3 valuation — 25-analyst consensus Buy, mean PT USD 455.79 (+13.5% upside from July 14 close), consistent with the original diligence pass; #5 macro tailwind — industrials/AI-capex sector strength intact (XLI still leading per recent reads), no contrary catalyst. Next earnings confirmed **July 31, 2026** — 12 trading days out, outside the 2-day window. **All conditions met — promoted to today's buy plan.**
- **CEG:** 50-day MA USD 271.27, July 14 close USD 256.41 = **−5.476% below** (essentially unchanged from −5.44% July 14) — still well short of reclaiming the MA. ATR 3.366% would clear.
- **VRT:** 50-day MA USD 324.23, July 14 close USD 303.67 = **−6.342% below** (worse than −5.84% July 14) — lost further ground. ATR 5.261% still fails the 5% gate.
- **NVT:** 50-day MA USD 166.01, July 14 close USD 161.80 = **−2.537% below** (improved from −4.61% July 14) — closing in but not reclaimed. ATR 3.574% clears.

**Daily candidate diligence (step 6b) — COST (Costco) full pre-trade pass → NOT PROMOTED:**
COST has sat on the watchlist since 2026-05-29 without ever receiving the full diligence checklist described in step 6b (unlike CAT/MOD/ABBV/ETN/CEG/VRT/NVT, which have all been through it) — ran it today to close that gap:
- **Earnings/guidance:** Q3 FY2026 (reported May 28) beat: net sales USD 69.15B (+11.6% YoY), adjusted comparable sales +9.8%, membership fee income USD 1.37B (+10.7%), digitally-enabled sales +21%, paid executive memberships 41.2M (+9.6%). Genuinely strong, broad-based growth — signal #1 passes cleanly.
- **Catalyst:** No fresh, dated catalyst found beyond steady membership/comp-sales momentum — the Q3 print is already 7 weeks old and priced in. Signal #2 is weak/does not clearly pass.
- **Valuation — FAILS:** Trades at roughly 47-49x trailing earnings vs. its own 10-year average of ~39x and peer multiples in the low 20s. No discount vs. history or peers; at this multiple even Costco's high-single/low-double-digit earnings growth does not produce a PEG under the 2.5 gate. Signal #3 fails.
- **Technical confirmation — FAILS:** 50-day MA USD 982.13, July 14 close USD 921.65 = **−6.158% below**. Signal #4 fails outright (not just under-extended, actually below the MA).
- **ATR:** 1.774% (20-day) — very low volatility, clears the gate easily; not the constraint here.
- **Next earnings:** confirmed **September 24, 2026** (fiscal Q4, after close) — corrects the prior watchlist note of "mid-August"; well outside any near-term window either way.
- **Verdict:** Only 1 of 5 entry signals (earnings momentum) clears cleanly; valuation and technical both fail outright, catalyst is weak. **Not promoted.** Needs the multiple to compress toward its historical range (or a peer-relative discount to emerge) and price to reclaim the 50-day MA before reconsideration. This closes out COST's diligence gap — it is no longer an undiligenced legacy entry.

**Cash-drag check:** Cash 76.745% — elevated for 11 consecutive weeks against the 25-40% target band for a 3-4 position book. Today's ETN promotion is a genuine, diligenced qualifying entry (not a forced trade) — see Planned trades below. This is the second new position in three sessions (CAT July 13, ETN today) after a month-plus entry drought; cash will step down to ~69% after the ETN fill, still elevated but moving in the right direction as the diligence pipeline finally converts research into positions.

**Since inception:** Bull −0.661% (USD 99,339.01) vs SPY TR (pre-market USD 753.11 + USD 1.76 div = USD 754.87 vs USD 739.44 anchor = +2.087%) → **Bull TRAILS SPY by ~−2.748pp** (widened slightly from July 14 close's −2.590pp on LLY's sector-rotation pullback).

### Planned trades for today

**1 new position: BUY ETN 19 shares** (whole-share limit order, ~0.3% below opening quote per lessons.md, so a trailing stop can be set)

*Thesis:* Eaton's electrical equipment is a direct critical-path input to hyperscale AI data centers. Q1 2026 delivered record sales (USD 7.5B, +17% YoY) and record adjusted EPS (USD 2.81); 25-analyst consensus Buy with a mean price target of USD 455.79 (+13.5% upside). Technical confirmation cleared cleanly for the first time since diligence began June 26 — July 14 close is +2.606% above its 50-day MA, well clear of the 0.5% separation floor, with ATR (2.967%) under the halved-sizing threshold. Earnings confirmed July 31, outside the 2-day window.
*Invalidation:* Close back below the 50-day MA (~USD 405) on volume, the AI-data-center power-infrastructure demand narrative materially reverses, or Q2 earnings (July 31) show a guidance cut.
*review_by:* 2026-07-30 (day before July 31 earnings — forces an explicit hold/trim/exit decision ahead of the print).
*Sizing:* 19 shares × ~USD 415.65 (July 14 reference close) ≈ USD 7,897 ≈ 7.949% of portfolio — standard starter conviction (no ATR-based halving needed since 2.967% is under the 3% threshold). Well within the 20% single-position cap and the 25% daily-deployment cap; cash after fill ≈ 68.8%, far above the 5% minimum. Sector exposure after fill: Industrials (CAT + ETN) ≈ 11.7%, nowhere near the 60% cap.
*Stop:* 10% trailing stop placed immediately after fill, per guardrails.

**No action on:**
- CAT: HOLD — thesis confirming (raised FY26 outlook, record backlog), review_by 2026-08-03 not due.
- LLY: HOLD — Conviction A, July 14 pullback is sector rotation not thesis-related, review_by 2026-07-21 not due.
- V: HOLD — Conviction B, thesis intact, review_by 2026-07-28 not due.
- CEG/VRT/NVT: not promoted — see watchlist re-checks above.
- COST: not promoted — see step 6b diligence above.

```json
{
  "plan_date": "2026-07-15",
  "trades": [
    {"action": "buy", "symbol": "ETN", "qty": 19, "thesis": "Eaton electrical equipment is critical-path input to hyperscale AI data centers; Q1 2026 record sales USD 7.5B (+17% YoY) and record adj EPS USD 2.81; 25-analyst Buy consensus, mean PT USD 455.79; technical confirmation cleared cleanly for the first time since diligence began (+2.606% above 50-day MA, ATR 2.967% under the halving threshold)",
     "invalidation": "Close back below the ~USD 405 50-day MA on volume, the AI-data-center power-infrastructure narrative materially reverses, or July 31 earnings show a guidance cut",
     "review_by": "2026-07-30"}
  ]
}
```

EXECUTED: 2026-07-15T13:38:56Z — BUY ETN 19sh @ USD 414.99 avg fill (limit order 418.00, computed from last-trade price 416.75 rather than the quote endpoint's ask — see market-open journal entry for the data-quality note on a stale/frozen NBBO quote). 10% trailing stop placed immediately (order d0bb8b7c, HWM USD 414.24, stop USD 372.816). Verified via `position ETN` and `orders open`.

---

## 2026-07-14 — Pre-market research (~08:10 ET, Tuesday)

**Live-switch guard / lock / control:** `ALPACA_BASE_URL` contains "paper" ✓. `_lock` was `{}`, acquired and will be released before commit. Control STATUS ACTIVE, no NOTE/QUERY to acknowledge.

**Account snapshot (~08:08 ET):** Equity USD 99,631.83 | Cash USD 76,244.79 (76.529%) | Last equity (July 13 close) USD 99,659.87. Shock check: −0.0281% — no shock ✓ (threshold −4%). Drawdown vs HWM USD 101,384.21: −1.728% — informational only, not near the −10% circuit breaker.

**Positions (live prices ~08:08 ET), one line each:**
- CAT 4sh @ USD 944.37 (−0.038% from entry USD 944.73). Oppenheimer raised PT to USD 1,105 (from USD 980) July 9 — already known/positive, no new thesis-breaking news. Dividend ex-date July 20 (minor). 50-day MA now USD 928.07, July 13 close USD 931.96 = +0.42% above — separation has compressed from +2.81% at entry but still clears the floor; not a decision point (already held, review_by 2026-08-03 not due). HOLD.
- LLY 10sh @ USD 1,179.01 (+7.816% from entry USD 1,093.534). Nothing material since yesterday — presenting final day at AAIC (Alzheimer's conference) today/July 15; JPMorgan's USD 1,400 PT (July 7) remains the operative catalyst. review_by 2026-07-21 not due. HOLD. Conviction A.
- V 22sh @ USD 355.43 (+9.846% from entry USD 323.57). ACE Money Transfer partnership (incremental, not thesis-moving) drove yesterday's +2.4% move; confirmed next earnings **July 28, 2026** (fiscal Q3, after close) — outside the 2-day window, not a restriction today. review_by 2026-07-28 not due. HOLD. Conviction B.

**Stop audit:** 4/4 PASS — CAT (6103c146) 4sh, LLY (d4147484 7sh + 25989fb5 3sh) 10sh, V (66033918) 22sh — all live via `orders open`, matches held quantities exactly. No missing stops.

**Thesis contract review:** CAT review_by 2026-08-03, LLY review_by 2026-07-21, V review_by 2026-07-28 — none due today.

**Earnings window:** CAT next earnings Aug 4 (confirmed), LLY Aug 5 (confirmed), V July 28 (confirmed) — none within 2 trading days. No restriction on holding or on any new entry today.

**Macro (WebSearch):** June CPI lands at 8:30 AM ET today — Cleveland Fed nowcast projects headline roughly flat to slightly down m/m (~3.9% YoY, down from May's 4.2%) on a sharp June gasoline-price decline tied to the reopened Strait of Hormuz; core seen ~+0.2% m/m / ~2.85% YoY. This is the last major inflation print before the July 29 FOMC — a key data point, not yet released as of this research pass. S&P 500 futures were down ~0.2% pre-market awaiting the print, with Dow futures −0.3% and Nasdaq 100 futures +0.2% (mixed). **Geopolitical escalation continuing:** Iran declared the Strait of Hormuz "closed until further notice" after fresh US-Iran strikes; Trump said the US would reinstate a blockade of Iranian vessels plus a 20% transit fee. WTI ~USD 79.56 (+2%) — still well below the USD 100 halt-trigger. **10yr yield 4.59–4.62%, a ~2-month high** — still below the 4.75% halt-trigger but rising and worth watching closely given the trend; no halt triggered today.

**Watchlist re-checks (pullback-watch names, via Alpaca bars with explicit start/end + feed=iex — the "no bars pre-open" workaround from the 2026-07-09 lesson):**
- **ETN:** 50-day MA USD 405.45, July 13 close USD 402.76 = **−0.66% below** — reversed back below the MA (was +0.37% above July 10) on Monday's broad semiconductor-led risk-off selloff. Not promoted; separation lost, not gained.
- **CEG:** 50-day MA USD 272.40, July 13 close USD 257.57 = **−5.44% below** (was −8.0% July 10) — improving but still well short of reclaiming the MA. ATR 3.30% would clear.
- **VRT:** 50-day MA USD 324.73, July 13 close USD 305.77 = **−5.84% below** (was −1.82% July 10) — reversed further away from its pullback target on Monday's selloff. ATR 5.15% still fails the 5% gate.
- **NVT:** 50-day MA USD 165.63, July 13 close USD 158.00 = **−4.61% below** (was −2.58% July 10) — also lost ground Monday. ATR 3.56% clears.
- None of the four reclaimed their 50-day MA; Monday's broad semiconductor/industrial-adjacent selloff pushed all four further from their pullback targets rather than closer. No promotions.

**Daily candidate diligence (step 6b) — MOD (Modine Manufacturing) full pre-trade pass → NOT PROMOTED:**
Per the standing note that MOD was the last research-only, undiligenced watchlist entry, ran the full diligence checklist today:
- **Earnings/guidance:** FY26 (ended March 2026) was a fourth consecutive record year — Q4 net sales USD 954.4M (+47% YoY), adjusted EBITDA USD 146.1M (+40% YoY), 21% organic growth driven by a 78% increase in data-center sales; Climate Solutions segment (data-center cooling) generated >USD 400M in sales, backed by a long-term USD 4B capacity agreement with a large hyperscale customer. FY27 guidance: net sales growth 20–35%. Next earnings confirmed **Aug 5, 2026** — outside the 2-day window either way.
- **Catalyst / real overhang:** May 26 announcement of a Reverse Morris Trust spin-off — separating the legacy Performance Technologies (vehicular) segment and combining it with Gentherm — to leave a pure-play Climate Solutions company. The deal carries genuine multi-step completion risk: Gentherm shareholder approval, regulatory clearance, and an IRS tax-opinion condition, any of which could delay or derail it; at least one analyst has flagged the RMT structure itself as a source of potential earnings/share-price pressure independent of the underlying business. The stock fell −8.6% on the announcement (June 26) as investors digested both the deal complexity and a prior sharp run-up, and has not recovered since — closing progressively lower through July 13 (USD 234.10, well off the June highs near USD 297).
- **Technical confirmation (signal #4) — FAILS badly:** 50-day MA USD 269.13, July 13 close USD 234.10 = **−13.02% below** — the worst technical reading of any name checked today, driven by the spin-off announcement and its aftermath, not a shallow pullback.
- **ATR check — FAILS the hard gate:** 20-day average daily range = **5.42%**, above the 5% cap (vs. 6.20% on the last ATR-only check July 9 — volatility has stayed elevated, not normalized).
- **Verdict:** Fundamentals remain genuinely strong (data-center cooling growth, raised guidance) but MOD fails both the technical-confirmation gate and the hard ATR gate, and now carries a real, event-driven overhang (RMT completion risk) that didn't exist before June 26 — this is not a "wait for the market to notice" case like CAT was, but a name in active post-announcement digestion. **Not promoted.** Needs: (a) ATR back under 5% for consecutive sessions, (b) price to stabilize and begin reclaiming the 50-day MA, and (c) some concrete progress on the Gentherm deal's approval conditions, before the next diligence attempt. This closes out the "MOD ATR-only, still needs a full pass" note that had been carried since July 9 — the full pass is done; the verdict is a clean not-yet, not a missing check.

**Cash-drag check:** Cash 76.529% — elevated for 10 consecutive weeks against the 25–40% target band for a 3-position book. Yesterday's CAT diligence cleared the pipeline for the first time in over a month; today's MOD diligence closes out the other pending research-only name and fails cleanly on hard, objective gates (technical −13%, ATR 5.42% > 5% cap), not a judgment call. All four pullback-watch names (ETN/CEG/VRT/NVT) lost ground on Monday's broad selloff rather than gaining it. There is no qualifying entry today; staying in cash is the correct read of an empty, honestly-diligenced pipeline, not a passive default.

**Since inception:** Bull −0.368% (USD 99,631.83) vs SPY TR (pre-market quote ~USD 747.79 + USD 1.76 div = USD 749.55 vs USD 739.44 anchor = +1.367%) → **Bull TRAILS SPY by ~−1.735pp** (essentially flat vs. July 13 close's −1.872pp; both sides drifted down slightly overnight/pre-market).

### Planned trades for today

No trades planned. All three held positions (CAT, LLY, V) are clean HOLDs with intact theses, no thesis-contract deadlines due, and no earnings-window conflicts. MOD's diligence pass failed cleanly on objective gates; ETN/CEG/VRT/NVT all lost ground versus their pullback targets on Monday's selloff. June CPI at 8:30 AM ET is today's key catalyst to watch, but it does not change today's guardrail-driven plan either way — no restriction, no trigger.

```json
{
  "plan_date": "2026-07-14",
  "trades": []
}
```

## 2026-07-13 — Pre-market research (~08:08 ET, Monday)

### Live-switch guard / Lock / Control switch
- `ALPACA_BASE_URL` contains "paper" ✓.
- `memory/_lock` was `{}` (empty) — no other routine active. Lock written for this run, released before commit.
- `memory/control.md` STATUS: **ACTIVE**. No `NOTE:`/`QUERY:` line to acknowledge.

### Account sync (live Alpaca, ~08:08 ET)
- Equity **$99,521.72** | Cash **$80,023.72 (80.406%)** | Long market value $19,498.00 | Last equity (July 10 close) $99,586.86.
- **Shock check:** ($99,521.72 − $99,586.86) / $99,586.86 = **−0.0654%** — no shock ✓ (threshold −4%).
- **Drawdown note (informational only):** $99,521.72 vs HWM $101,384.21 = **−1.837%** — not a blocking guardrail (removed 2026-06-30).

### Positions & stop audit
| Symbol | Qty | Avg entry | Current | Mkt value | Unrealized P/L | % port | Stop |
|---|---|---|---|---|---|---|---|
| LLY | 10 | $1,093.534 | $1,182.00 | $11,820.00 | +$884.66 (+8.09%) | 11.877% | d4147484 (7sh) + 25989fb5 (3sh), HWM $1,249.45, stop $1,124.505 ✓ buffer 4.865% |
| V | 22 | $323.57 | $349.00 | $7,678.00 | +$559.46 (+7.859%) | 7.715% | 66033918 (22sh), HWM $364.21, stop $327.789 ✓ buffer 6.078% |

**Stop audit: 3/3 PASS ✓** (matches held quantities exactly; no missing stops).
**Sector exposure:** Healthcare (LLY) 11.877% | Financials (V) 7.715% | Cash 80.406% — no sector above 60% cap ✓.

### Thesis contract review
- **LLY** review_by 2026-07-21 — not due.
- **V** review_by 2026-07-28 — not due.

### Monday conviction-weighted holding review
- **LLY: A (unchanged).** Thesis intact and confirming — JPMorgan raised its PT to $1,400 (July 7) citing Mounjaro international expansion and US obesity-market growth; stock made a fresh ATH ($1,235.56) July 7 before a mild pullback. No negative news. 0/3 weeks at C.
- **V: B (unchanged).** Thesis intact — a securities-fraud lawsuit against Visa was dismissed without leave to amend (July 9); Barclays/Wells Fargo/UBS all carry Buy ratings; new 9Pay partnership in Vietnam is incremental, not thesis-moving. 0/3 weeks at C.
- Neither position is at risk of the 3-consecutive-C trim rule (both have never been rated C).

### Market posture (WebSearch) — Iran ceasefire effectively over, market shrugging it off again
- US stock futures pointed higher pre-market (S&P e-mini +~0.4%) as cooling global inflation (France CPI 1.8%) offset a busy earnings-week setup and continued Middle East tension. [Yahoo Finance, Benzinga, July 13]
- Iran/Israel ceasefire status: fresh US strikes on Iran in retaliation for Strait of Hormuz tanker attacks; oil settled ~$71/bbl (week's gain ~4%) after an intraweek spike to WTI ~$75 / Brent ~$79. Shipping through the Strait remains significantly disrupted, keeping a risk premium in oil, but levels remain well below the $100 halt-trigger. [The Hill, CNBC, July 13]
- 10yr yield not re-fetched fresh this run; last confirmed read (July 10) was ~4.54-4.58%, below the 4.75% halt trigger — no reason to expect a jump absent new data; June CPI lands tomorrow (July 14), the last major inflation print before the July 29 FOMC.
- Neither macro halt trigger (oil >$100, 10yr >4.75%) is close to tripping.
- Sector color: Industrials (XLI) +12.5% YTD, +13.3% over 6 months — power/AI-capex-adjacent names outperforming, relevant to today's CAT diligence. Healthcare also seeing a 52-week-high cluster (ALHC, HCSG, MRNA) alongside LLY — a defensive-growth rotation theme.

### Held-position research — "what changed since yesterday"
- **LLY** ($1,182.00, +8.09% from entry, −0.554% vs Friday's $1,188.58 close): no negative news. JPMorgan PT raise to $1,400 (July 7) is the week's key catalyst, already reflected; presenting 16 abstracts at AAIC (Alzheimer's conference), July 12-15 — ongoing, not a new thesis event. Next earnings confirmed **Aug 5, 2026** — outside the 2-day window.
- **V** ($349.00, +7.859% from entry, +0.009% vs Friday's $348.97 close): no negative news. Securities-fraud suit dismissed July 9 (incremental positive); Vietnam 9Pay partnership announced (incremental, not thesis-moving). Next earnings confirmed **July 28, 2026** — outside the 2-day window.

### Earnings-window rule
- Neither held name reports within the next 2 trading days (LLY Aug 5, V July 28). No restriction on holding.
- CAT (today's buy candidate) next reports **Aug 4, 2026** — ~15 trading days out, well outside the 2-day window. No restriction on opening the position.

### Watchlist — re-checks (LRCX purged; ETN / CEG / VRT / NVT pullback-watch; MOD/ABBV not re-checked today)
- **ETN:** 50-day MA $405.61, July 10 close $407.11 = **+0.37% above** — still under the 0.5% minimum-separation floor (was +0.047% July 9), though the gap continues to close. ATR 3.107% clears the 5% gate. **Not promoted** — needs one more session of genuine separation.
- **CEG (pullback-watch):** 50-day MA now $273.19 vs July 10 close $251.335 = **−8.0% below** (improved from −11.55% at July 7 diligence). Still well short of its pullback target. ATR 3.286% would clear if reclaimed.
- **VRT (pullback-watch):** 50-day MA now $324.74 vs July 10 close $318.82 = **−1.82% below** (improved from −6.1% at July 8 diligence) — closing in but not reclaimed. ATR 5.179% still fails the 5% gate (barely).
- **NVT (pullback-watch):** 50-day MA now $165.22 vs July 10 close $160.96 = **−2.58% below** (improved from −5.82% at July 9 diligence) — closing in but not reclaimed. ATR 3.614% clears.
- **MOD, ABBV:** not re-checked this run — CAT took today's step-6b diligence slot (see below).

### Daily candidate diligence (step 6b) — CAT full pre-trade pass → PROMOTED

Per the standing note that CAT was "next in the diligence queue," ran the full diligence checklist today:
- **Earnings/guidance:** Q1 2026 EPS $5.50 (vs. ~$4.58 est., a ~20% beat), revenue $17.4B (+22% YoY), net income $2.55B (+27% YoY). FY26/FY27 consensus estimates have been revised up over the past 90 days (Zacks: 2026 EPS growth +29.4% YoY, 2027 +24.4% YoY). Dividend hiked 8%. Zacks Rank #1 (Strong Buy). [Yahoo Finance, Zacks, StockAnalysis — July 2026]
- **Catalyst:** July 7 acquisition of Skycatch adds AI-powered spatial-data/digital-twin technology to CAT's mining platform (deal terms undisclosed) — extends the earlier RPMGlobal mine-planning-software acquisition. Separately, American Intelligence & Power formed a strategic alliance with Caterpillar/Boyd CAT to deploy 2 GW of dedicated power generation for hyperscale AI infrastructure (deliveries Sept 2026–Aug 2027) — a genuine, if indirect, AI-infrastructure demand angle for CAT's power-generation equipment business. [Mining.com, Caterpillar IR, StockTitan — July 2026]
- **Valuation:** Price (July 10 close) $951.67. Trailing P/E ~47.1x, forward P/E ~37.3x — a real premium to peer average (~31.2x) and the broader Machinery industry (~26.5x); CAT does NOT clear the "discount vs. peers" half of entry signal #3. **PEG ~1.27-1.6** (forward P/E ÷ 2026/2027 EPS growth) is comfortably under the 2.5 gate, so signal #3 passes via PEG only — a real but not disqualifying valuation caveat. One Simply Wall St analysis argues CAT could be ~18% overvalued post-Skycatch; view is contested (28-analyst average rating remains Buy, avg 12-month target ~$951, essentially in line with spot). [StockAnalysis, Simply Wall St, Yahoo Finance — July 2026]
- **Balance sheet:** Total debt $43.066B (down $264M since year-end 2025), most of it Cat Financial captive-finance debt (normal structure for an industrial with a financial-products arm, not comparable 1:1 to an industrial-only balance sheet). Cash $4.072B (down $5.908B since year-end 2025, largely working-capital/dividend/buyback timing). $11.5B in undrawn credit facilities. No acute liquidity concern found. [SEC 10-Q, Macrotrends — Q1 2026]
- **Insider activity:** Most recent open-market insider sale found was Group President Denise Johnson selling ~12,605 shares in May 2026 (~$904-912/sh, ~$11.4-11.5M) following an option exercise — routine post-exercise selling, not a fresh signal. No July 2026 open-market sales surfaced in this search (recent July Form 4s found were compensation-related phantom-stock grants, not sales). The "~$99.5M insider selling in recent months" figure cited by one secondary source could not be independently corroborated to a specific filing in this session — flagged as unverified, not treated as a hard red flag.
- **Next earnings:** confirmed **Aug 4, 2026**, before market open — ~15 trading days out, outside the 2-day window.
- **Technical confirmation (signal #4) — PASSES:** 50-day MA (Alpaca daily bars, 50-session average) = $925.64; July 10 close $951.67 = **+2.81% above** — clears both the "not >10% extended" ceiling and the newly-codified 0.5% minimum-separation floor.
- **ATR check:** 20-day average daily range = **3.219%** (Alpaca daily bars, (high−low)/close averaged over the last 20 sessions) — clears the 5% hard gate but **exceeds the 3% halved-sizing threshold**, so position size is halved per the pre-market playbook's volatility-check rule.
- **Verdict:** 4 of 5 entry signals clear cleanly (earnings momentum, catalyst, technical, macro); the valuation signal (#3) passes on a technicality (PEG under 2.5) while failing its peer-discount alternative — a real but not disqualifying caveat, consistent with the strategy's "≥2 of 5" bar. **CAT is PROMOTED to a buy candidate today**, sized at half a starter position (per the ATR>3% rule) to reflect the valuation stretch, elevated beta (1.60), and the stock's +167% 52-week run rather than full starter conviction. This is the first name to clear the technical-extension gate cleanly since VST (mid-June) — LRCX, ETN, CEG, VRT, NVT, and ABBV have all failed on it since.

### Cash-drag check
- Cash 80.406% vs. the strategy's 25-40% target band for a 2-position book — elevated for **9 consecutive weeks** now with zero new positions. Today's CAT diligence clears the entry gates for the first time in over a month — see Planned trades below. This is a deliberate, diligenced deployment, not a rush to "look active": CAT is sized at half a starter position specifically because of its ATR reading and valuation stretch, not treated as a green light to chase.

### Since inception
- Bull −0.478% ($99,521.72) vs SPY TR (using July 10 close $755.36 + $1.76 div = $757.12 vs $739.44 anchor = +2.391%) → **Bull TRAILS SPY by −2.869pp** (essentially unchanged from July 10 close's −2.787pp; small further slippage on CAT-adjacent pre-market softness, not company-specific).

### Planned trades for today

**1 new position: BUY CAT 4 shares** (whole-share limit order, ~0.3% below opening quote per lessons.md, so a trailing stop can be set)

*Thesis:* Caterpillar's Q1 2026 beat (EPS $5.50 vs. ~$4.58 est., +20%; revenue +22% YoY) and upwardly-revised FY26/FY27 consensus estimates reflect broadening industrial and AI-adjacent infrastructure capex demand. The July 7 Skycatch acquisition (AI-powered mining digital-twin tech) and the American Intelligence & Power 2GW hyperscale-AI power alliance extend CAT's exposure to the AI-infrastructure buildout beyond its core machinery cycle. PEG (~1.27-1.6) clears the valuation gate despite a real premium P/E to peers. Technical confirmation clears cleanly at +2.81% above the 50-day MA — the first name to clear this gate since VST.
*Invalidation:* Stock closes back below its 50-day MA (~$925.64) on volume; Aug 4 earnings show a guidance cut or tariff-cost impact materially worse than the flagged USD 2.2-2.4B/~500bp Resource Industries estimate; or credible evidence emerges of the ~18% overvaluation thesis playing out (sustained de-rating without a fundamental trigger).
*review_by:* 2026-08-03 (day before Aug 4 earnings — forces an explicit hold/trim/exit decision ahead of the print).
*Sizing:* 4 shares × ~$951.67 ≈ USD 3,807 ≈ 3.826% of portfolio — half a starter position (7-9% halved to ~3.5-4.5%) per the ATR>3% rule (ATR 3.219%). Well within the 20% single-position cap, the 25% daily-deployment cap, and leaves cash at ~76.6%, far above the 5% minimum. Sector exposure after fill: Industrials ~3.8%, nowhere near the 60% cap.
*Stop:* 10% trailing stop placed immediately after fill, per guardrails.

**No action on:**
- LLY: HOLD — Conviction A, thesis confirming, review_by 2026-07-21 not due.
- V: HOLD — Conviction B, thesis intact, review_by 2026-07-28 not due.
- ETN/CEG/VRT/NVT: not promoted — see watchlist re-checks above.
- MOD/ABBV: not re-checked today; CAT took today's diligence slot.

```json
{
  "plan_date": "2026-07-13",
  "trades": [
    {"action": "buy", "symbol": "CAT", "qty": 4, "thesis": "Q1 beat + raised FY26/27 estimates, Skycatch AI-mining acquisition and AI-power hyperscale alliance extend the AI-infrastructure angle, PEG ~1.3-1.6 clears valuation gate, technical confirmation +2.81% above 50-day MA clears the extension gate for the first time since VST",
     "invalidation": "Close back below the ~$925.64 50-day MA on volume, or Aug 4 earnings show a guidance cut / worse-than-flagged tariff impact",
     "review_by": "2026-08-03"}
  ]
}
```

EXECUTED: 2026-07-13T13:38:06Z — Bought CAT 4sh @ 944.73 (limit 948.26, ask was 945.42; marketable-limit 0.3% over ask). No breaking news found (Burry short / tariff overhang / "18% overvalued" debate are known factors already priced into the pre-market diligence, not new this morning). Shock check −0.0366% (no shock, threshold −4%). Trailing stop 6103c146 (10%, HWM 943.02, stop 848.718) placed and verified immediately after fill. Stop audit 4/4 PASS: CAT 4sh/4sh stop ✓, LLY 10sh (7sh+3sh stop orders) ✓, V 22sh/22sh stop ✓. Position sizing: CAT 3,778.92 cost basis ≈ 3.797% of portfolio (well within 20% cap and 25% daily-deployment cap); cash after fill ≈ 76.6% (well above 5% min); Industrials sector 0%→~3.8% (nowhere near 60% cap). No earnings-window conflict (CAT reports Aug 4, 15 trading days out).

---

## 2026-07-10 — Pre-market research (~08:14 ET, Friday)

### Live-switch guard / Lock / Control switch
- `ALPACA_BASE_URL` contains "paper" ✓.
- `memory/_lock` was `{}` (empty) — no other routine active. Lock written for this run, released before commit.
- `memory/control.md` STATUS: **ACTIVE**. No `NOTE:`/`QUERY:` line to acknowledge.

### Account sync (live Alpaca, ~08:14 ET)
- Equity **$99,922.11** | Cash **$80,023.72 (80.080%)** | Long market value $19,898.39 | Last equity (July 9 close) $99,853.62.
- **Shock check:** ($99,922.11 − $99,853.62) / $99,853.62 = **+0.0686%** — no shock ✓ (threshold −4%).
- **Drawdown note (informational only):** $99,922.11 vs HWM $101,384.21 = **−1.442%** — not a blocking guardrail (removed 2026-06-30).

### Positions & stop audit
| Symbol | Qty | Avg entry | Current | Mkt value | Unrealized P/L | % port | Stop |
|---|---|---|---|---|---|---|---|
| LLY | 10 | $1,093.534 | $1,221.50 | $12,215.00 | +$1,279.66 (+11.702%) | 12.223% | d4147484 (7sh) + 25989fb5 (3sh), HWM $1,249.45, stop $1,124.505 ✓ buffer 7.941% |
| V | 22 | $323.57 | $349.245 | $7,683.39 | +$564.85 (+7.935%) | 7.690% | 66033918 (22sh), HWM $364.21, stop $327.789 ✓ buffer 6.143% |

**Stop audit: 3/3 PASS ✓** (matches held quantities exactly; no missing stops).
**Sector exposure:** Healthcare (LLY) 12.223% | Financials (V) 7.690% | Cash 80.080% — no sector above 60% cap ✓.

### Thesis contract review
- **LLY** review_by 2026-07-21 — not due.
- **V** review_by 2026-07-28 — not due.

### Market posture (WebSearch) — Iran ceasefire remains broken, market shrugging it off
- Fresh US-Iran strikes continued this week; Tehran retaliated, and Strait of Hormuz shipping is near a standstill (~13 vessels/24h vs. ~110/day pre-war). [CNN, Horizons MEA, July 9-10]
- Despite the escalation, stocks rallied Thursday July 9: S&P 500 +0.81% to 7,543.64, Nasdaq +1.30% to 26,206.89, Dow +0.27% to 52,487.41, led by semiconductors and falling oil. [CNBC, July 9]
- Oil fell even as the conflict worsened: WTI ~$71.93 (down from an intraweek high near $76.70), Brent similar — both well below the $100 halt-trigger, but the intraweek swing (69→76.70→72) shows how fast this can move on Iran headlines. [Fortune/FX Leaders, July 10]
- 10yr yield eased to ~4.54-4.58%, a second straight session lower as falling oil reduced inflation-tightening fears — below the 4.75% halt trigger. [TradingEconomics/Investrade, July 10]
- S&P futures roughly flat to slightly up pre-market; Nasdaq futures giving back a little of Thursday's gains but still up ~1.4% on the week. [Benzinga, July 10]
- Upcoming: June CPI (last major inflation read before the July 29 FOMC) lands Tuesday July 14; FOMC minutes the following Wednesday.
- **Neither halt trigger is close to tripping** (10yr well below 4.75%, oil well below $100), but Iran remains the single biggest swing factor for oil this week and bears re-checking at market open.

### Held-position research — "what changed since yesterday"
- **LLY** ($1,221.50, +11.702% from entry, +0.386% since July 9's $1,216.95 close): no negative news. Shares near all-time highs on continued Mounjaro/Zepbound demand. Next scheduled event is presenting 16 abstracts at the Alzheimer's Association International Conference (AAIC), July 12-15, 2026, in London — not earnings, no thesis implication. Next earnings confirmed **Aug 5, 2026** — outside the 2-day window. [GuruFocus, FX Leaders, July 10]
- **V** ($349.245, +7.935% from entry, +0.301% since July 9's $348.20 close): no negative news. Visa launched the Visa Threat Intelligence Platform (VTIP), a fraud/cyber-threat detection product for financial institutions — incremental positive, not thesis-moving. Continued thematic coverage on stablecoin competition and multi-rail payments strategy, background only. Next earnings confirmed **July 28, 2026** — outside the 2-day window. [Africa Business Communities, Motley Fool, July 8-10]

### Earnings-window rule
- Neither held name reports within the next 2 trading days (LLY Aug 5, V July 28). No restriction on holding; no buy candidates near earnings today.

### Watchlist — ATR gates (LRCX / ETN) — re-checked with July 9 session data
- **LRCX:** July 9 session H $369.77 / L $350.47 / C $353.07 = **5.466% ATR** — **FAILS** the 5% gate, breaking the July 8 streak. The stock gapped up hard (July 8 close $333.19 → July 9 open ~$362.79, ranging to $369.77 before fading to $353.07) on **analyst price-target hikes** (TD Cowen $340→$400, Mizuho $380→$400) plus a broad semiconductor-equipment relief rally — not a company-specific earnings, guidance, or M&A event. LRCX was already ~56% above its 200-day MA before the move, so this reads as a chase-y, analyst-upgrade-driven pop with real one-day mean-reversion risk (some of the intraday high was already faded into the close), not a fresh fundamental catalyst. **Gate counter reset to 0/2.** 50-day MA is now **$327.27**; July 9 close **+7.883% above it** — technical confirmation strengthened even as the ATR gate failed. LRCX confirmed FQ4/FY26 earnings call **July 29, 2026** (~13 trading days out — not a blocker yet, but tracking). This is also the date flagged as LRCX's 4-week watchlist-staleness line — the purge/keep decision stays with today's 2026-07-10 weekly review per the existing plan, not this run.
- **ETN:** July 9 session H $412.97 / L $404.31 / C $405.92 = **2.135% ATR** ✓ clears (extends the clean-session streak). 50-day MA is now **$405.73**; July 9 close **+0.047% above it** — technical confirmation flipped from FAILING (July 8: −1.537%) to nominally PASSING, but the margin is noise-level (a $0.19 gap on a $406 stock), not a confirmed break. **Not treating this as a clean entry signal today** — this isn't a new invented gate, just applying entry signal #4 ("above the 50-day MA") with the judgment that a 0.05% crossing isn't meaningfully "above" anything. Will re-check Monday 2026-07-13 for a session with genuine separation (targeting >1%) before promoting.

### Daily candidate diligence (step 6b) — ABBV full pre-trade pass
Per the 2026-07-09 note flagging ABBV as a fresh, undiligenced watchlist addition, ran the full diligence checklist on ABBV (AbbVie) today:
- **Earnings/guidance:** Q1 2026 adjusted EPS $2.65 vs. $2.59 consensus (beat), revenue $15.0B vs. $14.72B consensus (beat, +12.4% YoY), driven by Skyrizi (+29% op.) and Rinvoq (+20% op.) more than offsetting Humira erosion. At the Q1 call, FY26 adjusted EPS guidance was raised to $14.08-14.28. **However, guidance was trimmed again as of July 9** (one day before this review) to $13.91-14.11 — below the current $14.25 Street consensus — with Q2-specific guidance of $3.57-3.61 also below the $3.77 consensus. The math is consistent with the ~$0.14 EPS dilution AbbVie flagged from the Apogee deal (deal-related trim, not an operational miss), but the *most current* full-year guide is now below consensus — this undercuts the "beat + raise" entry signal rather than confirming it. [StockTitan, Investing.com (Apr 2026); DailyPolitical, TickerReport (Jul 9 2026)]
- **Valuation:** Price ~$249.91 (July 9 close $252.74). Forward P/E ~16.0-16.5x — cheaper than JNJ (~20.1x), MRK (~21.1x), LLY (~29.8x), pricier than PFE (~8.3x). PEG 0.41-0.91 depending on source — comfortably under the 2.5 gate either way. [GuruFocus, ValueInvesting.io, StockAnalysis, late June/July 2026]
- **Balance sheet:** Total debt ~$67.1B, net debt ~$61.6B. Shareholders' equity is structurally negative (legacy of the Allergan deal), not a new issue. **Interest coverage ~3.33x TTM — weak relative to healthcare peers** (JNJ/LLY typically run well above 10x); one source shows coverage falling from 7.04x (2022) to 2.32x (2024) as debt-funded M&A (ImmunoGen, Cerevel, now Apogee) reloads leverage. Credit rating A2/A- (investment grade, stable) despite the compression. Leverage trend is mixed, not cleanly improving — a real, if moderate, balance-sheet flag. [MacroTrends, GuruFocus, Stock-analysis-on.net]
- **Catalyst check:** July 2 CMS proposal to align 340B payment rates with acquisition cost (potentially cutting ~$5.7B in hospital-side drug spending) drove ABBV to its 52-week high; separately, Senate HELP Chair Cassidy released a broader 340B reform discussion draft June 25 with a stakeholder comment period running through **August 28, 2026** — real and advancing, but neither is finalized. Apogee Therapeutics acquisition (~$10.9B, announced June 22, closing Q3 2026) extends the immunology pipeline with modest near-term dilution (~$0.14 EPS 2026). [Mintz, GuruFocus, CNBC, AbbVie IR — June 22-Jul 2 2026]
- **Next earnings:** Q2 2026 confirmed for **July 31, 2026** — well outside the 2-day window. [AbbVie IR, BioSpace]
- **Technical confirmation (entry signal #4) — FAILS:** ~50-day MA ≈ $222.23; current price ~$250 is **+13% above it** — over the strategy's explicit "not extended >10% above" gate. A bullish 10/50-day MA crossover occurred May 20, 2026, and moving-average signals are broadly "Buy," but the stock is genuinely extended short-term after its 52-week-high run, with mean-reversion risk into the July 31 print.
- **ATR check:** July 10 pre-market range ~$247.99-254.86, ~2.7% high-low/close spread — well under the 5% gate; not an unusually volatile name (beta ~0.28-0.34).
- **Verdict:** 3 of the 5 entry signals clear cleanly (catalyst, valuation, macro/sector tailwind); earnings momentum is muddied by the just-trimmed guidance; technical confirmation explicitly **FAILS** the extension gate. **ABBV is NOT promoted to a buy candidate today.** What's still missing: needs to pull back toward its 50-day MA (or consolidate) before re-consideration, and the guidance figures should be verified directly against AbbVie's own IR release (the July 9 trim came from secondary aggregator sites, not a primary 8-K) before any future promotion. Diligence is on file — a future re-check only needs to re-verify price vs. the 50-day MA and confirm the primary-source guidance number.

### Cash-drag check
- Cash 80.08% vs. the strategy's 25-40% target band for a 2-position book — well above target, elevated 8+ weeks now. No qualifying entry clears today: LRCX's ATR gate just failed on a chase-y analyst-upgrade pop; ETN's technical-confirmation cross is a noise-level +0.047%, not a confirmed break; ABBV's fresh diligence pass explicitly fails the extension gate and had its guidance trimmed below consensus the day before this review. Staying in cash is the correct, deliberate call today — not a default. Flagging for today's separately-scheduled weekly review: this is now 8 consecutive weeks with zero new positions, several names have failed on razor-thin technical margins (ETN twice now), and the pipeline may need either fresh, less-correlated candidates or a review of whether the technical-confirmation signal is calibrated too tightly for this market regime.

### Since inception
- Bull −0.07789% ($99,922.11) vs SPY TR ($751.89 pre-market trade + $1.76 div = $753.65 vs $739.44 anchor) = +1.9221% → **Bull TRAILS SPY by −2.000pp** (essentially unchanged from July 9 close's −2.003pp).

### Planned trades for today

No trades planned. LRCX's ATR gate failed again July 9 on a chase-y analyst-upgrade pop (gate reset to 0/2); ETN's technical-confirmation cross is noise-level (+0.047% above its 50-day MA); ABBV's full diligence pass today fails the extension gate (+13% above its 50-day MA) and had guidance trimmed below consensus the day before this review. Combined with the still-unresolved Iran conflict, no new positions today.

```json
{
  "plan_date": "2026-07-10",
  "trades": []
}
```

EXECUTED: 2026-07-10T13:36:53Z — No trades; plan was empty (LRCX ATR gate FAILED July 9, ETN technical confirmation noise-level, ABBV fails extension gate + guidance trim). Stop audit 3/3 PASS ✓ (LLY 7sh+3sh HWM $1,249.45/stop $1,124.505, buffer 5.271%; V 22sh HWM $364.21/stop $327.789, buffer 5.913%). Shock check −0.2951% (no shock, threshold −4%). LLY $1,187.07 (+8.554% from entry, −2.455% intraday — no negative news found, normal pullback on a mixed-futures morning ahead of the SK Hynix US listing); V $348.3875 (+7.67% from entry, +0.054% intraday). No cuts, no tightenings, no exits. All guardrails ✓.

---

## 2026-07-09 — Pre-market research (~08:07 ET, Thursday)

### Live-switch guard / Lock / Control switch
- `ALPACA_BASE_URL` contains "paper" ✓.
- `memory/_lock` was `{}` (empty) — no other routine active. Lock written for this run, released before commit.
- `memory/control.md` STATUS: **ACTIVE**. No `NOTE:`/`QUERY:` line to acknowledge.

### Account sync (live Alpaca, ~08:07 ET)
- Equity **$99,730.28** | Cash **$80,023.72 (80.24%)** | Long market value $19,706.56 | Last equity (July 8 close) $99,827.68.
- **Shock check:** ($99,730.28 − $99,827.68) / $99,827.68 = **−0.0975%** — no shock ✓ (threshold −4%).
- **Drawdown note (informational only):** $99,730.28 vs HWM $101,384.21 = **−1.631%** — not a blocking guardrail (removed 2026-06-30).

### Positions & stop audit
| Symbol | Qty | Avg entry | Current | Mkt value | Unrealized P/L | % port | Stop |
|---|---|---|---|---|---|---|---|
| LLY | 10 | $1,093.534 | $1,208.00 | $12,080.00 | +$1,144.66 (+10.468%) | 12.113% | d4147484 (7sh) + 25989fb5 (3sh), HWM $1,249.45, stop $1,124.505 ✓ buffer 6.913% |
| V | 22 | $323.57 | $346.662 | $7,626.564 | +$508.024 (+7.137%) | 7.648% | 66033918 (22sh), HWM $364.21, stop $327.789 ✓ buffer 5.443% |

**Stop audit: 3/3 PASS ✓** (matches held quantities exactly; no missing stops — order IDs unchanged from July 8, all still `status: new`/live).
**Sector exposure:** Healthcare (LLY) 12.113% | Financials (V) 7.648% | Cash 80.24% — no sector above 60% cap ✓.

### Thesis contract review
- **LLY** review_by 2026-07-21 — not due.
- **V** review_by 2026-07-28 — not due.

### Market posture (WebSearch) — Iran conflict escalates again: fresh US airstrikes
- The US launched **fresh airstrikes against Iran early Thursday** — over 80 targets hit (air defense, command/control, radar, anti-ship missile capability, small boats) — and Tehran responded by targeting Gulf countries. This is a real escalation beyond yesterday's "ceasefire is over" statement. [bloomberg.com, aljazeera.com]
- Oil: choppy. Brent/WTI initially popped (+1%) then gave it back intraday (Brent $76.99, WTI $72.64 by mid-morning GMT) — still **well below the $100 halt-trigger**. Some war-risk underwriters are advising shippers to pause Strait of Hormuz voyages / reviewing policy terms after Iran's renewed vessel attacks. [reuters/bloomberg via search]
- 10yr yield **4.587–4.59%**, a 4-week high, still **below the 4.75% halt trigger** but trending the wrong way on inflation/oil-driven rate concern.
- S&P futures signal is genuinely mixed across sources this morning (one read −0.8% on yield/inflation jitters, another +0.2%, Polymarket implying 85% odds of a higher open) — net take: elevated geopolitical/rate risk, no halt triggered, but not a "clear to deploy" morning either. [thestreet.com, cnbc.com, cnn.com]

### Held-position research — "what changed since yesterday"
- **LLY** ($1,208.00, +10.468% from entry, −0.638% since July 8's $1,215.76 close): No new negative news. FY26 revenue guidance raised to $82–85B (already-known catalyst, reconfirmed in today's coverage); JPMorgan's top-pick call ($1,400 PT) and RBC's raise to $1,500 (from $1,250, Outperform) both stand ahead of Q2 preview. Healthcare broadly flagged today as the top 52-week-high sector (defensive rotation heading into a choppy back half of summer) — LLY named as a leader. Pullback this morning tracks the broad risk-off tone from the Iran escalation, not a thesis change. Next earnings confirmed **Aug 5, 2026** — outside the 2-day window. [fool.com, tipranks.com, trefis.com]
- **V** ($346.662, +7.137% from entry, −0.547% since July 8's $348.57 close): No negative news. Visa General Counsel Julie Rottenberg sold 2,027 shares (~$729,720) July 2 — a routine-sized insider sale, not flagged as bearish (no 10b5-1 status confirmed either way, but the dollar amount is small relative to the CFO's May sale already vetted as a 10b5-1 plan; not thesis-relevant). Barclays Overweight, Wells Fargo Buy, Baird PT $412 all stand. Thesis (payments infrastructure, Great Wealth Transfer tailwind) intact. Next earnings confirmed **July 28, 2026** — outside the 2-day window. [marketscreener.com, investor.visa.com]

### Earnings-window rule
- Neither held name reports within the next 2 trading days (LLY Aug 5, V July 28). No restriction on holding; no buy candidates near earnings today.

### Watchlist — ATR gates (LRCX / ETN) — both improving
- **LRCX:** July 8 session H $337.20 / L $323.49 / C $333.19 = **4.116% ATR** ✓ clears — first clean session after the July 7 reset. **Gate counter 1/2.** Notably, the ~50-day MA is now **$325.40** and the July 8 close ($333.19) is **+2.39% above it** — if this holds, LRCX would also clear entry signal #4 (technical confirmation) once the ATR gate finishes. Needs one more ≤5% ATR session to be eligible. Today is also the date strategy.md flagged as the 4-week watchlist-staleness line for LRCX — per the existing plan, the purge/keep decision stays with tomorrow's weekly review, not this run; noting the gate is now trending toward clearing, not just stale.
- **ETN:** July 8 session H $401.60 / L $390.70 / C $399.71 = **2.727% ATR** ✓ clears (3rd consecutive clean session; gate has been ≥2/2 since July 7). Technical confirmation still fails but is narrowing: ~50-day MA **$405.95**, July 8 close **−1.537% below it** (was −2.31% July 7). **Not yet eligible** — needs to close back above ~$405.95.

### Daily candidate diligence (step 6b) — NVT full pre-trade pass
Per the 2026-07-08 note flagging NVT/MOD as undiligenced, ran the full diligence checklist on NVT (nVent Electric) today:
- **Earnings/guidance:** Q1 2026 net sales $1.242B (+53% reported, +34% organic) — record quarter, backlog raised to $2.6B. FY26 guidance raised: reported sales growth 26–28%, organic 21–23%, GAAP EPS $3.68–3.78, **adjusted EPS $4.45–4.55** (up from FY25's $4.00–4.15, i.e. mid-teens+ growth off an already-raised base). Growth broad-based across verticals, led by data-center gray/white-space demand. Next earnings confirmed **July 31, 2026** (not an issue today). [stocktitan.net, tikr.com]
- **Balance sheet:** Shareholder equity $3.6B, total debt $1.6B (D/E 43.9%), net leverage 1.5x, interest coverage 6.7x (EBIT $573.9M) — healthy debt-service capacity. Cash position is thin ($126.9M) relative to debt, but FCF is strong and improving: Q1 FCF $54M (+21% YoY), FY26 guide is 90–95% FCF conversion of adjusted net income. No balance-sheet red flags. [simplywall.st, macrotrends]
- **Valuation:** Current price $154.87 (July 8 close) vs adjusted-EPS-midpoint $4.50 → forward P/E ~34.4x (rich in absolute terms, typical for a 25%+-growth industrial). **PEG 1.18** (comfortably under the 2.5 gate) — GuruFocus ranks it better than ~70% of Industrial Products peers on this metric. Average analyst PT $176.64 (19 analysts; several raised post-earnings: UBS $200, Barclays/Evercore $190, Citi/Deutsche $187) — ~14% implied upside from the live $154.87 print. [gurufocus.com, financecharts]
- **Entry signals 1–3** (earnings momentum, catalyst — data-center buildout, valuation) **pass**.
- **Technical confirmation (entry signal #4) — FAILS:** 50-day MA (computed from 50 sessions of Alpaca IEX daily bars, Apr 27–Jul 8) = **$164.44**; July 8 close $154.87 is **−5.82% below it** — real, not a shallow dip.
- **ATR gate — clears:** July 8 session H $155.25 / L $150.58 / C $154.87 = **3.015% ATR**, under the 5% cap.
- **Verdict:** 3 of 4 checked entry signals clear (earnings momentum, catalyst, valuation) but technical confirmation fails outright — same pattern as LRCX/ETN/VRT/CEG this cycle (fundamentally sound AI-infra-adjacent names caught in the broader semi/AI-capex-scare pullback of the past 2 weeks). **NVT is NOT promoted to a buy candidate today.** What's still missing: needs to reclaim its 50-day MA (or show a clear reversal/basing pattern) before re-consideration. Diligence on file — a future re-check only needs to re-verify price vs. the 50-day MA. MOD remains undiligenced for fundamentals (quick ATR check today: July 8 session ATR = (236.115−221.52)/235.49 = **6.198%**, fails the gate outright — next candidate for a future full pass).

### Fresh candidate scan (Thursday — step 4) — 2 new names added to watchlist, research-only
- **ABBV (AbbVie)** — Healthcare. Hit a fresh 52-week high ($261.07) July 2 on a Trump-administration proposal to reform the 340B Drug Pricing Program (shifts margin back to drug developers, away from hospital intermediaries) — a genuine regulatory tailwind, not a one-off pop; the whole pharma sector (PPH ETF) rallied on it. Separately, AbbVie announced a **$10.9B acquisition of Apogee Therapeutics** to expand its immunology pipeline, well-received by the market. Fits the healthcare-secular-growth tailwind directly. [gurufocus.com, fool.com]
- **CAT (Caterpillar)** — Industrials / real-economy rotation. Q1 2026 revenue $17.42B and adjusted EPS $5.54 beat, full-year sales outlook raised; board raised the quarterly dividend 8% (to $1.63/sh, effective Aug 19); Zacks Rank #1 (Strong Buy), positive Earnings ESP ahead of the Aug 4 report; recent Skycatch and RPMGlobal acquisitions. Headwind to note: management guided **$2.2–2.4B in 2026 tariff costs**, compressing Resource Industries margins ~500bp in Q1 — a real cost overhang to weigh before any entry. Fits the real-economy-rotation tailwind (industrials +16% YTD, Dow at record highs on cyclical-blue-chip strength). [yahoo finance, trefis.com]
- Both added to `memory/strategy.md` watchlist as **research-only** — neither has been through the step-6b diligence/ATR/technical-confirmation gate yet; next candidates in the diligence queue after MOD.

### Cash-drag check
- Cash 80.24% vs. the strategy's 25–40% target band for a 2-position book — well above target, elevated 7+ weeks. No qualifying entry clears today: LRCX is 1/2 through its ATR gate (though now also above its 50-day MA — improving); ETN's ATR gate is clear but technical confirmation still fails (narrowing, −1.54% below MA); NVT's fresh diligence pass today clears fundamentals/valuation but fails technical confirmation (−5.82% below MA). Combined with a genuine fresh escalation in the Iran conflict (new US airstrikes, Tehran retaliating against Gulf shipping) overnight, staying in cash is the correct, deliberate call today — not a default.

### Since inception
- Bull −0.26972% ($99,730.28) vs SPY TR ($745.28 July 8 close + $1.76 div = $747.04 vs $739.44 anchor) = +1.02776% → **Bull TRAILS SPY by −1.297pp** (widened slightly from July 8 close's −1.155pp; LLY/V both pulled back modestly pre-market on the fresh Iran-escalation risk-off tone while SPY's marked price is unchanged since its own close).

### Tooling note
- `./scripts/alpaca.sh bars <SYM> <TF> <LIMIT>` (limit-only, no explicit start/end) returned `{"bars":null,...}` for every symbol tried today (SPY, LLY, LRCX, ETN, NVT, MOD) despite `snapshot` and `account`/`positions` working normally. Root cause: the endpoint needs an explicit date range before market open on a fresh session; a direct query with `&start=...&end=...&feed=iex` returns bars correctly. Worked around it directly via curl for all ATR/50-day-MA calculations in this run. Flagging so a future routine doesn't waste time assuming the data feed itself is down — the account/trading endpoints are fine, only the limit-only `bars` shorthand is affected.

### Planned trades for today

No trades planned. LRCX is 1/2 through its ATR gate; ETN's ATR gate is clear but technical confirmation still fails; NVT's full diligence pass today fails technical confirmation despite passing fundamentals/valuation. Combined with a fresh escalation in the Iran conflict (new US airstrikes overnight), no new positions today. Two new research-only candidates (ABBV, CAT) added to the watchlist from today's Thursday fresh-candidate scan.

```json
{
  "plan_date": "2026-07-09",
  "trades": []
}
```

EXECUTED: 2026-07-09T13:36:26Z — No trades; plan was empty (LRCX 1/2 through ATR gate, ETN ATR gate clear but technical confirmation still fails, NVT's fresh diligence pass fails technical confirmation despite passing fundamentals/valuation; fresh Iran-airstrike escalation overnight). Stop audit 3/3 PASS ✓ (LLY 7sh+3sh HWM $1,249.45/stop $1,124.505, buffer 8.442%; V 22sh HWM $364.21/stop $327.789, buffer 5.331%). Shock check +0.093% (no shock, threshold −4%). LLY $1,228.18 (+12.313% from entry); V $346.25 (+7.009% from entry). No cuts, no tightenings, no exits since pre-market. All guardrails ✓.

---

## 2026-07-08 — Pre-market research (~08:07 ET, Wednesday)

### Live-switch guard / Lock / Control switch
- `ALPACA_BASE_URL` contains "paper" ✓.
- `memory/_lock` was `{}` (empty) — no other routine active. Lock written for this run, released before commit.
- `memory/control.md` STATUS: **ACTIVE**. No `NOTE:`/`QUERY:` line to acknowledge.

### Account sync (live Alpaca, ~08:07 ET)
- Equity **$100,116.04** | Cash **$80,023.72 (79.94%)** | Long market value $20,092.32 | Last equity (July 7 close) $100,127.72.
- **Shock check:** ($100,116.04 − $100,127.72) / $100,127.72 = **−0.0117%** — no shock ✓ (threshold −4%).
- **Drawdown note (informational only):** $100,116.04 vs HWM $101,384.21 = **−1.251%** — not a blocking guardrail (removed 2026-06-30).

### Positions & stop audit
| Symbol | Qty | Avg entry | Current | Mkt value | Unrealized P/L | % port | Stop |
|---|---|---|---|---|---|---|---|
| LLY | 10 | $1,093.534 | $1,235.69 | $12,356.90 | +$1,421.56 (+13.00%) | 12.34% | d4147484 (7sh) + 25989fb5 (3sh), HWM $1,249.45, stop $1,124.505 ✓ buffer 9.00% |
| V | 22 | $323.57 | $351.61 | $7,735.42 | +$616.88 (+8.666%) | 7.73% | 66033918 (22sh), HWM $364.21, stop $327.789 ✓ buffer 6.775% |

**Stop audit: 3/3 PASS ✓** (matches held quantities exactly; no missing stops).
**Sector exposure:** Healthcare (LLY) 12.34% | Financials (V) 7.73% | Cash 79.94% — no sector above 60% cap ✓.

### Thesis contract review
- **LLY** review_by 2026-07-21 — not due.
- **V** review_by 2026-07-28 — not due.

### Market posture (WebSearch) — Iran ceasefire declared over
- Trump stated at the NATO summit in Ankara that the US ceasefire with Iran "is over," following US strikes in retaliation for attacks on commercial vessels transiting the Strait of Hormuz and the Treasury's withdrawal of Iran's oil-sale waiver. [cnbc.com]
- WTI +5.69% to $74.45/bbl, Brent +5.85% to $78.50/bbl — both still well below the $100 halt-trigger, but the trend reversed sharply from the prior "holding" status; monitor closely. 10yr yield ticked up 5bp to 4.581% (still below the 4.75% halt trigger). [cnbc.com]
- S&P 500 futures down; Nasdaq futures down >1% on renewed semiconductor weakness (Intel, AMD leading losses) compounding the sector's existing selloff (LRCX, ETN, VRT all lower — see below). [cnbc.com]
- Net effect: a genuine geopolitical risk-off catalyst layered on top of an already-weak AI-infrastructure/semi-equipment tape. Reinforces no new positions today regardless of individual gate status.

### Held-position research — "what changed since yesterday"
- **LLY** ($1,235.69, +13.00% from entry, new highs beyond the prior $1,238 reference): Cantor Fitzgerald raised PT $1,230→$1,350 (Overweight); JPMorgan raised PT to $1,400 from $1,300; Jaypirca (EU) received a positive CHMP opinion, pending EC action. Healthcare is a typical risk-off beneficiary — today's macro shock, if anything, is thesis-supportive. Next earnings confirmed **Aug 5, 2026** — outside the 2-day window. [tipranks.com]
- **V** ($351.61, roughly flat overnight): Barclays initiated Overweight; Baird raised PT to $412 from $370. No Iran/oil-related read-through identified for payments infrastructure. Thesis (Open USD stablecoin consortium, zero sell ratings among 42 analysts) intact. Next earnings confirmed **July 28, 2026** — outside the 2-day window. [marketbeat.com]

### Earnings-window rule
- Neither held name reports within the next 2 trading days (LLY Aug 5, V July 28). No restriction on holding; no buy candidates near earnings today.

### Watchlist — ATR gates (LRCX / ETN)
- **LRCX:** July 7 session H $330.42 / L $313.11 / C $325.94 = **5.31% ATR** — FAILS the ≤5% threshold. Stock fell −6.78% on the day in a broad semiconductor-equipment selloff: a soft monthly revenue read from a major foundry customer, institutional warnings of NAND/mature-logic cyclical cooling (system-shipment growth projected to decelerate to 3% in 2026 from 82% in 2025), and CEO Timothy Archer's ~$11.7M stock sale July 2. [quiverquant.com, tikr.com] **Gate counter resets to 0/2.** Today is also the ~4-week staleness line strategy.md flagged — purge decision stays deferred to Friday's weekly review per the existing plan, not decided in this run.
- **ETN:** July 7 session H $403.73 / L $388.11 / C $395.62 = **3.95% ATR** ✓ clears; combined with July 6's 3.64% clear, **gate counter reaches 2/2**. However, the approximate 50-day MA (computed from ~45 sessions of Alpaca IEX daily bars) is ~$404.97, and the July 7 close is **−2.31% below it** — fails entry signal #4 (technical confirmation requires trading above the 50-day MA). ETN fell alongside the broader AI-infrastructure complex despite a record ~$22.8B backlog and +240% YoY Electrical Americas data-center orders. [fool.com] **Not promoted — ATR gate cleared but technical confirmation fails.**

### Daily candidate diligence (step 6b) — VRT full pre-trade pass
Per the 2026-07-07 note flagging VRT/NVT/MOD as undiligenced, ran the full diligence checklist on VRT (the most research-ready of the three) today:
- **Earnings/guidance:** FY26 guidance raised to $13.5–14.0B net sales (implying ~30% organic growth, ~51% earnings growth); backlog more than doubled to >$15B (12–18 months of forward revenue); ThermoKey acquisition closed June 12 (expands EMEA thermal-management manufacturing); new Johor, Malaysia facility opened July 1. Q2 earnings confirmed ~July 29, 2026 (not an issue today). [sec.gov, seekingalpha.com]
- **Balance sheet:** $2.50B cash vs $3.26B debt, current ratio 1.49, debt/equity 0.77, ROE 45.1%, ROIC 32.1%, TTM FCF $2.28B on $10.84B revenue — healthy for a capital-intensive hardware business. [gurufocus.com, stockanalysis.com]
- **Valuation:** Forward P/E ~44–46x (rich), but PEG **1.36** — comfortably under the 2.5 gate given the growth rate. [financecharts.com]
- **Entry signals 1–3** (earnings momentum, catalyst, valuation) **pass**.
- **Technical confirmation (entry signal #4) — FAILS:** Computed the approximate 50-day MA from ~45 sessions of Alpaca IEX daily bars (May 1–Jul 7): ~$325.37. July 7 close $305.625 is **−6.07% below it** — a real pullback in the same AI-infra/semi-adjacent selloff hitting LRCX and ETN, not a shallow within-uptrend dip.
- **ATR gate — FAILS:** July 7 session H $305.98 / L $287.19 / C $305.625 = **6.15% ATR**, above the 5% cap (the stock swung a ~$19 range in one session).
- **Verdict:** 3 of 5 entry signals clear (earnings momentum, catalyst, valuation) but both the technical-confirmation signal and the ATR gate fail outright. **VRT is NOT promoted to a buy candidate today.** What's still missing: needs to reclaim its 50-day MA and post 2 consecutive ATR-gate-clearing (≤5%) sessions before re-consideration. This diligence pass is now on file — a future re-check only needs to re-verify the technical/ATR posture. NVT and MOD remain undiligenced — next candidates for a future step 6b pass.

### Cash-drag check
- Cash 79.94% vs. the strategy's 25–40% target band for a 2-position book — well above target, elevated 6+ weeks. No qualifying entry clears today: LRCX's ATR gate just reset to 0/2; ETN's ATR gate cleared but fails technical confirmation; VRT fails both its ATR gate and technical confirmation (fresh diligence today). Combined with today's Iran-ceasefire-breakdown risk-off tape, staying in cash is the correct, deliberate call, not a default.

### Since inception
- Bull +0.116% ($100,116.04) vs SPY TR ($747.77 July 7 close + $1.76 div = $749.53 vs $739.44 anchor) = +1.3646% → **Bull TRAILS SPY by −1.249pp** (narrowed from July 7 midday's −1.4815pp; LLY's continued rally on analyst-target raises more than offset SPY's own July 7 gain).

### Planned trades for today

No trades planned. LRCX's ATR gate reset to 0/2 (July 7 fail); ETN cleared its ATR gate but fails technical confirmation; VRT's full diligence pass today fails both its ATR gate and technical confirmation. Combined with the Iran-ceasefire-breakdown risk-off macro backdrop, no new positions today.

```json
{
  "plan_date": "2026-07-08",
  "trades": []
}
```

EXECUTED: 2026-07-08T13:36:00Z — No trades; plan was empty (LRCX ATR gate reset 0/2, ETN clears ATR gate but fails technical confirmation, VRT fails both its ATR gate and technical confirmation; Iran-ceasefire-breakdown risk-off tape). Stop audit 3/3 PASS ✓ (LLY 7sh+3sh HWM $1,249.45/stop $1,124.505, buffer 7.747%; V 22sh HWM $364.21/stop $327.789, buffer 5.827%). Shock check −0.2417% (no shock, threshold −4%). LLY $1,218.935 (+11.467%); V $348.065 (+7.57%). No cuts, no tightenings. All guardrails ✓.

---

## 2026-07-07 — Pre-market research (~08:07 ET, Tuesday)

### Live-switch guard / Lock / Control switch
- `ALPACA_BASE_URL` contains "paper" ✓.
- `memory/_lock` was `{}` (empty) — no other routine active. Lock written for this run, released before commit.
- `memory/control.md` STATUS: **ACTIVE**. No `NOTE:`/`QUERY:` line to acknowledge.

### Account sync (live Alpaca, ~08:07 ET)
- Equity **$99,908.65** | Cash **$80,023.72 (80.10%)** | Long market value $19,884.93 | Last equity (July 6 close) $100,129.68.
- **Shock check:** ($99,908.65 − $100,129.68) / $100,129.68 = **−0.2207%** — no shock ✓ (threshold −4%).
- **Drawdown circuit breaker:** $99,908.65 vs HWM $101,384.21 = **−1.4553%** — NOT triggered ✓ (8.545pp headroom; CB trigger USD 91,245.79).

### Positions & stop audit
| Symbol | Qty | Avg entry | Current | Mkt value | Unrealized P/L | % port | Stop |
|---|---|---|---|---|---|---|---|
| LLY | 10 | $1,093.534 | $1,220.99 | $12,209.90 | +$1,274.56 (+11.655%) | 12.22% | d4147484 (7sh) + 25989fb5 (3sh), HWM $1,238.00, stop $1,114.20 ✓ buffer 9.585% |
| V | 22 | $323.57 | $348.8649 | $7,675.03 | +$556.49 (+7.817%) | 7.68% | 66033918 (22sh), HWM $364.21, stop $327.789 ✓ buffer 6.43% |

**Stop audit: 3/3 PASS ✓** (matches held quantities exactly; no missing stops).
**Sector exposure:** Healthcare (LLY) 12.22% | Financials (V) 7.68% | Cash 80.10% — no sector above 60% cap ✓.

### Thesis contract review — LLY review_by TRIGGERED today
- **LLY review_by 2026-07-07 (today) — mandatory decision.** Thesis check: Medicare GLP-1 Bridge program continues to confirm on schedule (up to 20M Medicare Part D patients, USD 50/month); new since Monday — Lilly selected for the FDA's PreCheck pilot program (accelerated manufacturing-facility approval, early technical guidance), a modest incremental positive, no negative offsetting news. Stock sits ~1% off its 52-week high ($1,238), +11.655% from entry, stop buffer a healthy 9.585%. Leerink PT $1,232 stands. **Decision: HOLD — no erosion of the thesis, invalidation condition (close below entry) nowhere close. Renewed review_by to 2026-07-21** (a ~2-week checkpoint ahead of the Aug 3 earnings-window date; next earnings confirmed Aug 5, 2026 before market open).
- **V** review_by 2026-07-28 — not due.

### Market posture (WebSearch)
- S&P 500 futures slipped ~0.25% early Tuesday after Monday's strong +0.72% session (S&P 500 index closed 7,537.43). Broad tape had its best week since inception into last Thursday's holiday, but today's early tone is a mild pullback / rotation day. [benzinga.com, cnbc.com]
- No major scheduled US macro data release found for today; posture is "digest recent gains," not a new shock.

### Held-position research — "what changed since yesterday"
- **LLY** ($1,220.99, +11.655% from entry, +1.74% today): FDA PreCheck pilot-program selection (new, minor positive) alongside continuing Medicare Bridge rollout coverage. No negative news. Thesis unchanged. Next earnings confirmed **Aug 5, 2026** (before market open) — well outside the 2-day earnings window. [tipranks.com, marketchameleon.com]
- **V** ($348.8649, −2.35% pre-market from Monday's last price, following a −3.36% session on July 6): Attributed to broad profit-taking / sector rotation out of mega-cap growth into cyclical value after the soft June jobs report intensified Fed-pause expectations — not company-specific. CEO Ryan McInerney's July 6 Form 4 sale (10,490 sh, ~$340-344) confirmed as a pre-arranged **Rule 10b5-1 plan** (dated May 15, 2025) via stocktitan — routine, not a discretionary bearish signal (per the 2026-06-10 lesson on always checking Form 4 transaction type). Fundamentals unchanged: Q2 FY26 net revenue $11.23B (strongest growth pace since 2022), value-added services +27% YoY to $3.3B (30% of net revenue), record USD 7.9B buyback + new USD 20B authorization; zero sell ratings among 42 analysts, mean PT USD 399. Next earnings confirmed **July 28, 2026** — outside the 2-day window. Thesis intact. [tradingkey.com, ebc.com, stocktitan.net]

### Earnings-window rule
- Neither held name reports within the next 2 trading days (LLY Aug 5, V July 28). No restriction on holding; no new-buy candidates near earnings today.

### Watchlist — ATR gates (LRCX / ETN)
- **LRCX:** July 6 session H $365.48 / L $348.53 / C $349.64 = **4.85% ATR** ✓ clears the ≤5% threshold — first clean session since the July 2 catastrophic fail (14.11%). Gate counter **1/2**. Needs one more ≤5% session before eligible.
- **ETN:** July 6 session H $420.095 / L $405.04 / C $413.46 = **3.64% ATR** ✓ clears — first clean session since the July 2 fail (5.52%). Gate counter **1/2**. FY26 guidance (EPS est. USD 3.07) and BMO Buy rating from July 2 stand; thesis intact.
- Neither name is eligible for entry today regardless (both mid-gate).

### Daily candidate diligence (step 6b) — CEG full pre-trade pass
Per the 2026-07-06 note flagging CEG as the most-ready undiligenced name, ran the full diligence checklist today:
- **Earnings/guidance:** Q1 2026 GAAP EPS $4.49, adjusted operating EPS $2.74 — both beat expectations; FY26 adjusted operating EPS guidance affirmed at $11-12/share. Calpine acquisition drove revenue to $11,122M (from $6,788M YoY) and is projected to add ~$2/share EPS accretion on a full-year basis. [finance.yahoo.com]
- **Balance sheet:** Long-term debt $16,994M as of March 31, 2026; retained earnings $7.18B (most recent reported quarter) — leveraged but consistent with a capital-intensive nuclear/utility operator carrying a large recent acquisition; nothing disqualifying found.
- **Valuation:** EV/EBITDA improved from 17.50x (Q4 2025) to 13.24x (Q1 2026); PEG ratio **1.19** (comfortably under the 2.5 gate); trades ~40x trailing earnings (premium, but growth-adjusted metric passes). [stockanalysis.com, nasdaq.com]
- **Analyst sentiment:** Consensus **Buy** — 17 Buy / 3 Hold / 1 Sell across 23 analysts; consensus PT $356.78 (recent-3-analyst average PT $303.67, ~29% implied upside from current). [benzinga.com, marketscreener.com]
- **Catalyst:** Long-term PPAs with Microsoft (Three Mile Island nuclear restart) and Walmart; premium pricing power as AI-driven electricity demand grows — durable, multi-year catalyst, not a one-off.
- **ATR gate:** July 6 session ATR 2.29% ✓ — comfortably clears.
- **Technical confirmation (entry signal #4) — FAILS:** Computed the 50-day moving average from Alpaca daily bars (Apr 15–Jul 6, IEX feed): 50-day MA = **$278.00**; July 6 close $245.90 is **11.55% BELOW** its 50-day MA. This is a confirmed downtrend stemming from the July 1-2 AI-capex-scare selloff (CEG fell from $247.99 intraday high to a $228.75 low on July 1 alone, an 8.14% ATR day), not a shallow pullback within an uptrend.
- **Verdict:** 4 of 5 entry signals clear (earnings momentum, catalyst, valuation, macro tailwind) but entry signal #4 fails outright. Per the VST precedent (2026-07-02 through 07-06: a name in a confirmed technical downtrend is not bought regardless of fundamental strength — "risks catching a falling knife"), **CEG is NOT promoted to a buy candidate today.** What's still missing: CEG needs to reclaim its 50-day MA (or show a clear reversal/basing pattern with volume) before re-consideration. This diligence pass is now on file — future re-checks only need to re-verify the technical posture, not redo the fundamental/valuation work.

### Cash-drag check
- Cash 80.10% vs. the strategy's 25–40% target band for a 2-position book — well above target, elevated 6+ weeks. No qualifying entry clears today: CEG fails its technical-confirmation gate outright (see above); LRCX and ETN are each only 1/2 through their ATR gate (need one more clean session); VRT/NVT/MOD remain undiligenced. Staying in cash today is a deliberate decision, not a default — CEG's technical failure is a genuine disqualifier surfaced by today's diligence pass, not the bar being raised to avoid trading.

### Since inception
- Bull −0.0914% ($99,908.65) vs SPY TR ($751.27 July 6 close + $1.76 div = $753.03 vs $739.44 anchor) = +1.8378% → **Bull TRAILS SPY by −1.929pp** (essentially unchanged from Monday's close −2.007pp; small pre-market give-back in V offset by LLY's gain, no new SPY session yet).

### Planned trades for today

No trades planned. LLY's review_by contract resolved HOLD (renewed to 2026-07-21). CEG's diligence pass completed but fails the technical-confirmation gate (11.55% below its 50-day MA) — not promoted. LRCX/ETN are 1/2 through their ATR gate. VRT/NVT/MOD remain undiligenced.

```json
{
  "plan_date": "2026-07-07",
  "trades": []
}
```

EXECUTED: 2026-07-07T13:36:00Z — No trades; plan was empty (LLY review_by resolved HOLD/renewed to 2026-07-21; CEG fails technical-confirmation gate; LRCX/ETN 1/2 through ATR gate; VRT/NVT/MOD undiligenced). Stop audit 3/3 ✓ (LLY 7sh d4147484 + 3sh 25989fb5, HWM $1,239.00, stop $1,115.10, buffer 9.628%; V 22sh 66033918, HWM $364.21, stop $327.789, buffer 7.174%). Shock check +0.00016% (no shock); drawdown vs HWM $101,384.21 = −1.237% (CB not triggered). LLY $1,233.88 (+12.834%); V $353.115 (+9.131%). All guardrails ✓.

---

## 2026-07-06 — Pre-market research (~08:07 ET, Monday)

### Live-switch guard / Lock / Control switch
- `ALPACA_BASE_URL` contains "paper" ✓.
- `memory/_lock` was `{}` (empty) — no other routine active. Lock written for this run, released before commit.
- `memory/control.md` STATUS: **ACTIVE**. No `NOTE:`/`QUERY:` line to acknowledge.

### Account sync (live Alpaca, ~08:07 ET)
- Equity **$100,041.17** | Cash **$80,023.72 (80.00%)** | Long market value $20,017.45 | Last equity (July 3 close, carried) $100,129.68.
- **Shock check:** ($100,041.17 − $100,129.68) / $100,129.68 = **−0.088%** — no shock ✓ (threshold −4%; no new session has closed since Thursday's close).
- **Drawdown circuit breaker:** $100,041.17 vs HWM $101,384.21 = **−1.325%** — NOT triggered ✓ (8.675pp headroom; CB trigger USD 91,245.79).

### Positions & stop audit
| Symbol | Qty | Avg entry | Current | Mkt value | Unrealized P/L | % port | Stop |
|---|---|---|---|---|---|---|---|
| LLY | 10 | $1,093.534 | $1,207.05 | $12,070.50 | +$1,135.16 (+10.38%) | 12.06% | d4147484 (7sh) + 25989fb5 (3sh), HWM $1,238.00, stop $1,114.20 ✓ buffer 7.69% |
| V | 22 | $323.57 | $361.225 | $7,946.95 | +$828.41 (+11.64%) | 7.94% | 66033918 (22sh), HWM $361.86, stop $325.674 ✓ buffer 9.84% |

**Stop audit: 3/3 PASS ✓** (matches held quantities exactly; no missing stops).
**Sector exposure:** Healthcare (LLY) 12.06% | Financials (V) 7.94% | Cash 80.00% — no sector above 60% cap ✓.

### Thesis contract review
- **LLY** review_by **2026-07-07 (tomorrow)** — not yet due (date hasn't passed, no invalidation trigger hit). Thesis intact: Medicare Bridge live since July 1, Leerink PT $1,232 stands, no negative news since Friday. Mandatory hold/trim/exit decision due at tomorrow's pre-market.
- **V** review_by 2026-07-28 — not due. Thesis intact (see below).

### Monday conviction ratings (refreshed 2026-07-06; prior set 2026-06-29)
| Symbol | Rating | 3-consecutive-C trigger | Notes |
|---|---|---|---|
| LLY | **A** (unchanged) | N/A | +10.38% from entry; Medicare Bridge confirming; no thesis change |
| V | **B** (unchanged) | 0/3 weeks at C | +11.64% from entry; zero sell ratings among 42 analysts; Open USD stablecoin build-out continuing |

No C-rated names — no 3-consecutive-C purge trigger applies.

### Market posture (WebSearch)
- Broad tape: prediction markets lean modestly toward a higher open (~62% implied probability), soft June jobs report (July 3) and a two-cut Fed dot plot are broadly supportive; futures firmed slightly Sunday evening. No major scheduled US data release this morning — main risk is an overnight geopolitical/trade surprise, none reported. [investing.com, lines.com]
- No incremental macro shock; posture is constructive-but-unconvinced, consistent with last week's close.

### Held-position research — "what changed since Thursday"
- **LLY** ($1,207.05, essentially flat, −0.57% vs Thursday's extended print): No new news since the July 1 Medicare Bridge launch; stock continuing to digest the post-launch pop. Nothing material — thesis unchanged. Next earnings ~Aug 5, 2026 (confirmed via WebSearch) — well outside the 2-day earnings window. [cnbc.com, investing.com]
- **V** ($361.225, essentially flat, −0.25%): No new news since Thursday's 52-week-high close; Open USD stablecoin consortium and agentic-commerce tooling (agent scoring, tokenisation, fraud models) continue to build out per July coverage. Next earnings estimated July 28–Aug 4, 2026 (sources split; treating July 28 as the conservative near date) — outside the 2-day window either way. [ebc.com, tipranks.com]

### Earnings-window rule
- Neither held name reports within the next 2 trading days. No restriction on holding; no new-buy restriction triggered (no earnings-adjacent buy candidates today).

### Watchlist — ATR gates (LRCX / ETN)
- **LRCX:** July 2 session H $392.50 / L $342.92 / C $351.495 = **14.11% ATR** — catastrophic fail (10.2% single-day decline on AI-capex demand-destruction fears/SK Hynix HBM4 ramp-slowing reports). Gate counter **0/2**, reset again. Added 2026-06-08 — now **4+ weeks stale**; per watchlist hygiene, flag for purge at Friday's weekly review if still ungated. [tikr.com, quiverquant.com]
- **ETN:** July 2 session H $414.52 / L $392.52 / C $398.67 = **5.52% ATR** — fails the ≤5% threshold narrowly (was 1/2 clear after July 1's 4.40%; today's fail resets the counter). Gate counter **0/2**. BMO Buy rating July 2; FY26 guidance raised (est. EPS $3.07, +4.07% YoY; revenue ~$8B, +13.88% YoY) — thesis intact, just needs two calm sessions. [finance.yahoo.com]
- Neither name is eligible for entry today.

### Re-entry candidate review — VST
- VST closed July 2 at **$151.07** (ATR July2 4.97%, July1 3.97% — both clear ≤5%), down further to **~$152.95** as of July 6 pre-market — well below the June 30 exit ($160.20) and the 52-week high ($219.82). Wells Fargo initiated/reiterated Buy July 3; 13-analyst Buy consensus; PT $231.85. Helix/Cogentrix nuclear-power-for-AI thesis unchanged.
- **New negative signal since the June 30 exit:** FERC scrutiny risk on Vistra's hyperscaler colocation deals (cost-shifting to residential ratepayers) is a fresh regulatory overhang not present at the original entry — a structural headwind to weight explicitly per knowledge-base guidance, not just "a risk to monitor." Additionally a technical sell signal fired June 25 off a pivot top, and insider selling (CAO, a director) in late May/June. [dailypolitical.com, fool.com, simplywall.st]
- **Verdict: NOT a qualifying re-entry today.** Entry signal #4 (technical confirmation — above rising 50-day, not extended) fails outright: VST is in a confirmed short-term downtrend off its June highs, not pulling back within an uptrend. Buying here risks catching a falling knife per knowledge-base §4.4/§6.1. Continuing to watch for a confirmed bottom (reversal candle + volume dry-up) before treating this as a real setup. FERC risk needs to be resolved or clearly bounded before re-entry, not waved through because the win exit felt clean.

### New candidate sourcing (per 2026-07-03 weekly-review directive: widen beyond semis)
- Sourced from AI-power/cooling-infrastructure and healthcare/consumer-defensive searches: **CEG** (Constellation Energy — nuclear, Microsoft Three Mile Island PPA, premium-pricing power as AI demand grows; July 2 close $239.20, ATR 3.00% ✓ clears gate), **VRT** (Vertiv — full power+cooling stack, NVIDIA-integrated, +252% order growth), **NVT** (nVent Electric — liquid cooling distribution, +65% organic orders Q3'25), **MOD** (Modine — data-center thermal management, RMT spin-off Q4 2026 pending).
- None of these have had the full pre-trade diligence pass yet (10-Q/10-K review, balance sheet, valuation vs. peers, earnings-quality check, written one-paragraph thesis) — adding to watchlist as **research candidates only**, not buy candidates, for this week's follow-up. CEG is the most-ready name (clean ATR, clear catalyst) and should be the first full diligence pass this week.
- **NVDA re-entry cooldown:** still 3 days from the July 9 eligibility date (2-week cooldown from the June 25 stop-out). GPU spot pricing recovery not yet re-checked; do so alongside the July 9 eligibility review.

### Cash-drag check
- Cash 80.00% vs. the strategy's 25–40% target band for a 2-position book — well above target, and has been for 6+ weeks. No qualifying entry clears today: LRCX and ETN both fail their ATR gates (LRCX badly, ETN narrowly); VST fails the technical-confirmation signal and carries a fresh regulatory overhang; CEG/VRT/NVT/MOD are sourced but undiligenced. Staying in cash today is a deliberate decision, not a default — the correct response to zero qualifying setups is zero new positions, not lowering the bar. CEG diligence is the actionable next step to break the drought, not forcing today's watchlist names.

### Since inception
- Bull +0.0412% ($100,041.17) vs SPY TR ($744.86 + $1.76 div = $746.62 vs $739.44 anchor) = +0.9711% → **Bull TRAILS SPY by −0.930pp** (essentially unchanged from Thursday's −0.841pp; small pre-market give-back in LLY/V, no new SPY session).

### Planned trades for today

No trades planned. LRCX and ETN both fail their ATR gates; VST fails technical confirmation and carries a new regulatory-risk flag; CEG/VRT/NVT/MOD are sourced but not yet diligenced. LLY's mandatory review_by decision is due tomorrow (2026-07-07), not today.

```json
{
  "plan_date": "2026-07-06",
  "trades": []
}
```

EXECUTED: 2026-07-06T13:36:24Z — No trades; plan was empty (LRCX/ETN fail ATR gates, VST fails technical confirmation + FERC overhang, CEG/VRT/NVT/MOD undiligenced). Stop audit 3/3 ✓ (LLY 7sh+3sh HWM $1,238.00/stop $1,114.20, buffer 7.27%; V 22sh HWM $364.21/stop $327.789, buffer 7.88%). Shock check −0.2606% (no shock); drawdown vs HWM −1.4947% (CB not triggered). LLY $1,201.615 (+9.884%); V $355.82 (+9.967%). All guardrails ✓.

---

## 2026-07-03 — Weekly review research (WebSearch, ~market close)

- **Broad market:** Dow closed at a fresh record high heading into the July 4 holiday; S&P ~7,498 (+0.20% Jul 3 alone, led by AAPL +4.8%/MCD +4.1%/DIS +3.8%). Best week for the broad tape since inception. Soft June jobs report (+57K vs +113K expected) reinforced no-hike expectations. [Sources: tradingeconomics.com, thestreet.com, bloomberg.com]
- **Semiconductor selloff:** Reports that Meta is building an internal cloud business to resell excess AI compute triggered an AI-capex-demand-destruction scare July 1-2 — Micron −7-8%, Applied Materials −7.4%, AMD −4.3%, SK Hynix −14.5%, Samsung −9.1%. Directly hit LRCX and ETN's ATR entry gates; no read-through to LLY/V.
- **LLY:** Confirmed +~6.7% over the week per TradingView/Zacks; Medicare GLP-1 Bridge program launched on schedule July 1 (~20M Medicare Part D patients, $50/month). One minor negative (China GLP-1 generic reports, June 30) already logged, thesis intact.
- **V:** Confirmed new 52-week high July 2 (+3.15% that day) on Q2 value-added-services revenue +29% YoY and continued Street support — mean analyst PT $399, zero sell ratings among 42 analysts (EBC Financial Group / Motley Fool).
- **Best performers this week (broad market, per stocktitan/nerdwallet):** memory/power/cooling infrastructure names continue to lead 2026 YTD gains (SNDK, MXL) — reinforces AI-infrastructure-bottleneck theme already reflected in the ETN watchlist thesis, though semi-adjacent names are exactly what's failing our ATR gates right now. No new name identified that clears both the theme and the volatility/liquidity bar this week; flagged in weekly-review.md for next week's research to widen beyond semis.

Full weekly assessment, trade statistics, and strategy adjustments: see `memory/weekly-review.md` (week ending 2026-07-03).

---

## 2026-07-03 — Pre-market research (~08:06 ET) — MARKET HOLIDAY (Independence Day observed)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓ — paper trading confirmed.

### Lock / Control switch
- `memory/_lock` was empty (`{}`) — no other routine active. Lock written for this run.
- `memory/control.md` STATUS: **ACTIVE**. No `NOTE:` or `QUERY:` line present. Nothing to acknowledge or answer.

### Market clock
- `./scripts/alpaca.sh clock` → `is_open: false`, next_open **2026-07-06T09:30:00-04:00**, next_close 2026-07-06T16:00:00-04:00. July 4 falls on a Saturday, so NYSE observes the holiday today (July 3) — market fully closed, not a half day. This routine preps the plan for Monday July 6's open (per the 2026-05-25 lesson: holiday pre-market still adds value — do not skip).

### Account snapshot (live Alpaca ~08:06 ET)

| Metric | Value |
|--------|-------|
| Equity | $100,129.68 |
| Cash | $80,023.72 (79.91%) |
| Long market value | $20,105.96 |
| Last equity (Alpaca API, carried from last snapshot since market closed) | $100,129.68 |
| Shock check | $0.00 (0.00%) — no shock ✓ (threshold −4%; last_equity unchanged because no new trading session has closed since Thursday) |
| HWM (since inception, from 3-month equity history) | $101,384.21 |
| Drawdown | **−1.237%** — NOT triggered ✓ (circuit breaker at −10%; 8.763pp headroom; CB trigger ≈ USD 91,245.79) |

### Open positions (live ~08:06 ET; prices reflect Thursday July 2 last trade, extended through 20:00 UTC)

| Symbol | Qty | Avg entry | Current price | Mkt value | Unrealized P/L | % of portfolio |
|--------|-----|-----------|--------------|-----------|----------------|----------------|
| LLY | 10 | $1,093.534 | $1,213.91 | $12,139.10 | +$1,203.76 (+11.01%) | 12.13% |
| V | 22 | $323.57 | $362.13 | $7,966.86 | +$848.32 (+11.92%) | 7.96% |

**Sector exposure:** Healthcare (LLY) 12.13% | Financials (V) 7.96% | Cash 79.91% — no sector above 60% cap ✓

### Stop audit (confirmed via Alpaca live orders ~08:06 ET)

| Order ID | Symbol | Qty | HWM | Stop | Buffer | Status |
|----------|--------|-----|-----|------|--------|--------|
| d4147484 | LLY | 7sh | $1,238.00 | $1,114.20 | $99.71 (8.21%) | ✓ active |
| 25989fb5 | LLY | 3sh | $1,238.00 | $1,114.20 | $99.71 (8.21%) | ✓ active |
| 66033918 | V | 22sh | **$361.86** ⬆️ (ratcheted from $360.84) | **$325.674** ⬆️ (up from $324.756) | $36.456 (10.07%) | ✓ active |
**Stop audit: 3/3 PASS ✓** No missing stops.

### Macro (as of July 2 close / July 3 pre-market)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| S&P 500 | +0.49% July 2, closed near record highs heading into the holiday | — | Broad tape constructive |
| **SOX (semiconductor index)** | **−~7% July 3 alone, >12% over 2 days** | — | ⚠️ Sharp AI-capex demand-destruction scare |
| 10yr Treasury | 4.47–4.49% | <4.75% | ✓ GATE PASSES |
| Fed Chair Warsh | Reiterated inflation risks softening | — | No hawkish surprise |

**Narrative:** The broad market (SPY, Dow) closed at fresh highs into the holiday, but semiconductors sold off sharply on reports that **Meta is building an internal cloud business to resell excess AI computing power** — read by markets as an early signal of potential AI-capex demand cooling. This drove SK Hynix −14.5% and Samsung −9.1% (Kospi −7.9%) on July 2, and directly hit LRCX (−10.2% same day per Alpaca bars: $391.26→$351.41). Neither LLY (healthcare) nor V (financials) has any semiconductor/AI-infra exposure — this is a sector-specific event for our watchlist (LRCX, ETN), not a portfolio risk. Per knowledge-base.md §3.3 saturation-risk signals ("a major hyperscaler announcing efficiency breakthroughs that reduce GPU intensity... at scale"), this is worth tracking as an early AI-capex-cycle watch-flag, not yet a fundamental verdict.

### Position thesis reviews — "what changed since yesterday"

**LLY** ($1,213.91, +11.01% from entry $1,093.534)
- _What changed since July 2:_ Nothing new — no fresh company-specific news found since the July 1 Medicare Bridge launch. Stock continues to hold post-launch gains. Leerink PT $1,232 (unchanged, June 25). No negative catalysts.
- Stop: HWM $1,238.00, stop $1,114.20 (buffer $99.71 = 8.21%) ✓
- Earnings: confirmed Aug 5, 2026 — outside the 2-day window ✓
- Invalidation: close below stop $1,114.20; or Medicare Bridge pricing/utilization data reveals margin deterioration.
- review_by: **2026-07-07** — not due (next trading session is Monday July 6, still 1 day before the deadline; will be assessed at Monday's pre-market or the following session).
- **Decision: HOLD. Conviction: A.**

**V** ($362.13, +11.92% from entry $323.57)
- _What changed since July 2:_ V rallied +3.15% July 2 to a fresh 52-week high on strong Q2 growth commentary (value-added services revenue +29% YoY) and Piper Sandler's Overweight/PT initiation standing. Visa Destinations (10 markets) and the stablecoin settlement pilot (~USD 7B annualized run rate) continue to build out. No negative news.
- Stop: HWM $361.86 (auto-ratcheted from $360.84), stop $325.674 (buffer $36.456 = 10.07%) ✓
- Earnings: confirmed July 28, 2026 — outside the 2-day window ✓
- Invalidation: close below stop $325.674; or a reversal in payments-volume trends.
- review_by: 2026-07-28 (unchanged) — not due.
- **Decision: HOLD. Conviction: B.**

### Thesis contract review
Both held positions' invalidation and review_by are current and neither has triggered. No forced hold/trim/exit decision required today. LLY's July 7 review_by will fall due within the next 1-2 trading sessions (Monday July 6 or Tuesday July 7 pre-market) — flagging for the next routine to action explicitly.

### Earnings calendar confirmation
- LLY: next earnings Aug 5, 2026 ✓ (outside window)
- V: next earnings July 28, 2026 ✓ (outside window)

### Watchlist / candidate review (ATR gates recomputed from Alpaca daily bars, explicit start/end range)

| Ticker | Session | H / L / C | ATR% | Gate result |
|--------|---------|-----------|------|-------------|
| ETN | July 1 | 423.45 / 404.74 / 412.31 | 4.54% | ✓ PASS (session 1/2 under the July 1 reset) |
| ETN | July 2 | 414.74 / 392.30 / 398.52 | **5.63%** | ❌ FAIL (barely, >5% threshold) — **gate resets to 0/2** |
| LRCX | July 1 | 415.49 / 381.00 / 391.26 | 8.82% | ❌ FAIL |
| LRCX | July 2 | 392.50 / 342.475 / 351.41 | **14.24%** | ❌ FAIL badly — stock cratered −10.2% intraday in the Meta-cloud-reselling selloff |

- **ETN:** Gate counter reset to **0/2**. Needs 2 fresh consecutive ≤5% ATR sessions starting Monday July 6. Not eligible Monday even in the best case (only 1 session will have completed). Fundamentals (Russell index inclusion, raised FY26 EPS guidance USD 13.00–13.50) unchanged; today's fail was macro-sympathy from the semi selloff, not company-specific.
- **LRCX:** Gate counter reset to **0/2** (yet again). The July 2 drop is directly tied to the AI-capex-demand-destruction scare — this is the second time in 3 weeks LRCX has been hit by a semi-sector-wide selloff before completing its ATR gate. Flagging as a repeated pattern: LRCX's beta to AI-capex sentiment shocks may make it a structurally poor fit for this gate mechanism. Not proposing a rule change today, but will revisit at the next weekly review if this repeats a third time.
- **NVDA:** Still excluded (cooling period from June 25 second stop-out). Re-eligible **2026-07-09** — not yet (3 trading days after Monday's open).
- **MSFT / COST / JNJ / WMT / PWR:** No new signal; unchanged from prior weeks.

### Cash-drag check
Cash is 79.91% — far above the 10–20% target band for a 2-position book, elevated for 7+ consecutive weeks. No candidate qualifies for Monday's open: both ATR-gated candidates (LRCX, ETN) reset to 0/2 after Wednesday's semi-sector selloff; no other watchlist name clears its entry signals; and the tape is entering the weekend with a fresh, unresolved AI-capex-demand-destruction scare in semiconductors that argues for patience, not urgency, on any semi-adjacent name. Staying in cash into Monday's open is the correct, deliberate call, not a passive default. Will re-check LRCX/ETN gates at every session next week as fresh ≤5% sessions accumulate.

### Risk posture check
- **Drawdown circuit breaker:** $100,129.68 vs HWM $101,384.21 = **−1.237%** — NOT triggered ✓ (8.763pp headroom; CB trigger USD 91,245.79)
- **Sector exposure:** Healthcare (LLY) 12.13% | Financials (V) 7.96% | Cash 79.91% — no sector above 60% cap ✓

### Market posture
Broad market closed at fresh highs into the long weekend, but a sharp, semiconductor-specific selloff (SOX −12% over 2 days) on AI-capex demand-destruction fears (Meta reportedly reselling excess AI compute) dominates the tape. This has no direct read-through to LLY (healthcare) or V (financials) — both are thesis-intact, at new highs, with healthy stop buffers, and no forced decisions due. It does further delay both semi-adjacent watchlist candidates (LRCX, ETN), which reset their ATR gates to 0/2 on Wednesday's session. With the market closed today and reopening Monday, doing nothing and carrying a clean plan into the weekend is the correct, disciplined call.

### Planned trades for today

No trades planned. Market closed for the July 4 holiday (observed Friday July 3); next open is Monday July 6. LRCX and ETN ATR gates both reset to 0/2 after Wednesday's semiconductor-sector selloff (Meta AI-compute-reselling news); no other watchlist name qualifies. Both held positions (LLY, V) are thesis-intact, at new highs, HOLD.

```json
{
  "plan_date": "2026-07-03",
  "trades": []
}
```

---

## 2026-07-02 — Pre-market research (~08:10 ET)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓ — paper trading confirmed.

### Control switch
- `memory/control.md` STATUS: **ACTIVE**. No `NOTE:` or `QUERY:` line present. Nothing to acknowledge or answer.

### Account snapshot (live Alpaca ~08:06 ET)

| Metric | Value |
|--------|-------|
| Equity | $99,717.72 |
| Cash | $80,023.72 (80.25%) |
| Long market value | $19,694.00 |
| Last equity (July 1 close) | $99,664.88 |
| Shock check | +$52.84 (+0.053%) vs last_equity — no shock ✓ (threshold −4%) |
| HWM (since inception) | $101,384.21 |
| Drawdown | −1.644% — NOT triggered ✓ (circuit breaker at −10%; 8.356pp headroom) |

### Macro (pre-market July 2, 2026 ~08:06 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| S&P 500 | ~7,478 (−0.08% prior session context) | — | Choppy — semiconductor/memory-chip selloff dominating the tape |
| Nasdaq (July 1 close) | −0.66% | — | Micron −8%, SanDisk −10%, Western Digital −7% — DRAM antitrust class-action + Citi demand-softening note driving the memory-chip rout |
| S&P 500 / Dow (July 1 close) | −0.22% / −0.03% | — | Broad market only mildly negative; selloff is semiconductor-specific, not systemic |
| **June nonfarm payrolls — TODAY 8:30 AM ET** | fcst +115K (range 87K–118K), unemployment fcst 4.3% | — | Major macro print landing before the open; June ADP (July 1) was soft at +98K vs +110K expected — some downside risk to consensus |
| 10yr Treasury | ~4.44% (June 30 close) | <4.75% | ✓ GATE PASSES |
| Fed Chair Kevin Warsh | Reaffirmed price-stability commitment July 1; inflation expectations "eased" per his remarks | — | No new hawkish surprise |

**Narrative:** The tape's stress is concentrated in semiconductors/memory chips (Micron, SanDisk, Western Digital hit hard on a DRAM antitrust class action and a Citi note flagging potential demand softening from high memory prices), not a broad risk-off move — S&P and Dow were only modestly lower July 1. Today's headline event is the June nonfarm payrolls report at 8:30 AM ET, landing right before the open; a soft ADP print yesterday (+98K vs +110K) raises some downside risk to the +115K consensus. A weak print could reinforce rate-cut hopes (equity-supportive) or read as labor deterioration (risk-off) depending on magnitude — genuine two-way risk. Not a day to add new positions ahead of the data.

### Position thesis reviews — "what changed since yesterday"

**LLY** ($1,192.80 pre-mkt, +9.08% from entry $1,093.534)
- _What changed since July 1:_ No new company-specific news since the Medicare GLP-1 Bridge program launch (July 1). Stock is holding its post-launch gains, modestly positive pre-market. Leerink PT $1,232 (unchanged, set June 25). No negative catalysts found.
- Stop: HWM $1,238.00, stop $1,114.20 (buffer $78.60 = 6.59%) ✓
- Earnings: confirmed Aug 5, 2026 — outside the 2-day window ✓
- Invalidation: close below stop $1,114.20; or Medicare Bridge pricing/utilization data reveals margin deterioration.
- review_by: **2026-07-07** (unchanged) — not due today; nothing new to force a decision.
- **Decision: HOLD. Conviction: A.**

**V** ($353.00 pre-mkt, +9.10% from entry $323.57)
- _What changed since July 1:_ No negative news. Confirmed still Overweight at Piper Sandler (June 29). No new catalysts overnight — thesis unchanged.
- Stop: HWM $353.36, stop $318.024 (buffer $34.976 = 9.91%) ✓
- Earnings: confirmed July 28, 2026 — outside the 2-day window ✓
- Invalidation: close below stop $318.024; or a reversal in payments-volume trends.
- review_by: 2026-07-28 (unchanged) — not due.
- **Decision: HOLD. Conviction: B.**

### Stop audit (pre-market July 2 — confirmed via Alpaca live orders ~08:06 ET)

| Order ID | Symbol | Qty | HWM | Stop | Buffer | Status |
|----------|--------|-----|-----|------|--------|--------|
| d4147484 | LLY | 7sh | $1,238.00 | $1,114.20 | $78.60 (6.59%) | ✓ active |
| 25989fb5 | LLY | 3sh | $1,238.00 | $1,114.20 | $78.60 (6.59%) | ✓ active |
| 66033918 | V | 22sh | $353.36 | $318.024 | $34.976 (9.91%) | ✓ active |
**Stop audit: 3/3 PASS ✓** No missing stops.

### Earnings calendar confirmation
- LLY: next earnings Aug 5, 2026 ✓ (outside window)
- V: next earnings July 28, 2026 ✓ (outside window)
- LRCX: next earnings ~July 29, 2026 (not held; informational)

### Watchlist / candidate review

| Ticker | ATR gate status | Notes |
|--------|-----------------|-------|
| LRCX | **FAILS again** — July 1 session: H $414.33 / L $381.47 / C $391.36 = **8.40% ATR** (memory-chip selloff hit LRCX directly). Gate counter stays **0/2** under the July 1 reset. | Semicap thesis (Samsung/SK Hynix $1.3T capex wave) still intact per prior PT raises, but the DRAM antitrust suit + demand-softening concerns are a fresh overhang worth monitoring. Not eligible today regardless. |
| ETN | **1/2** — July 1 session: H $423.36 / L $405.215 / C $412.16 = **4.40% ATR** ✓ clears the loosened ≤5% threshold. First qualifying session under the July 1 reset. Needs one more ≤5% session (today, July 2) to clear at 2/2 — not eligible today even if today qualifies, since today's session isn't complete yet. Earliest possible entry: July 3 pre-market (if today's ATR also ≤5%). | New catalyst found: Eaton added to the Russell 1000 Growth / Russell Top 200 Growth / Russell 3000E Growth indices — passive-flow tailwind. FY26 EPS guidance raised to USD 13.00–13.50. AI data-center electrical-demand thesis unchanged. |
| NVDA | Still excluded (cooling period from June 25 stop-out) | Re-eligible **2026-07-09**. No action today. |
| MSFT / COST / JNJ / WMT / PWR | No change | No new signal; pre-earnings gates / ATR elevation / insider-selling flags from prior weeks unchanged. |

### Cash-drag check

Cash is 80.25% — far above the 10–20% target band for a 2-position book, elevated for 6+ consecutive weeks. No candidate qualifies today: LRCX failed its ATR gate again July 1 (8.40%, hit directly by the memory-chip selloff); ETN cleared its first qualifying session (1/2) but cannot be bought until its second consecutive ≤5% session completes (earliest July 3); no other watchlist name clears its entry signals. Today additionally carries major macro-event risk — June nonfarm payrolls at 8:30 AM ET, with a soft ADP print yesterday raising two-way surprise risk — an inappropriate day to add fresh risk even if a gate had cleared. Staying in cash today is a deliberate, written decision, not a passive default. Will re-check the ETN gate at every session this week; if today's ATR also clears ≤5%, ETN becomes eligible at Monday July 6 pre-market (Friday July 3 is a half day ahead of the July 4 holiday — market closed July 4, reopens July 6).

### Risk posture check

- **Drawdown circuit breaker:** $99,717.72 vs HWM $101,384.21 = **−1.644%** — NOT triggered ✓ (8.356pp headroom; CB trigger USD 91,245.79)
- **Sector exposure:** Healthcare (LLY) $11,928.00 = 11.96% | Financials (V) $7,766.00 = 7.79% | Cash $80,023.72 = 80.25% — no sector above 60% cap ✓

### Performance vs S&P 500 (pre-market July 2)

| Period | Bull | SPY | Difference |
|--------|------|-----|------------|
| Inception (2026-05-21) | $100,000.00 | $739.44 | — |
| **Pre-market (2026-07-02)** | **$99,717.72 (−0.282%)** | **SPY ~$746.75 + $1.76 div = +1.227% TR** | **Bull TRAILS SPY ~1.509pp** |
| Close (2026-07-01) | $99,626.38 (−0.374%) | SPY $746.5225 + $1.76 div = +1.196% TR | Bull TRAILS SPY −1.569pp |

### Market posture

Semiconductor/memory-chip weakness (Micron, SanDisk, Western Digital) is the dominant story, not a broad risk-off tape — S&P and Dow were only modestly lower July 1, and Bull holds no chip exposure. Today's key event is the June jobs report at 8:30 AM ET; a soft ADP print yesterday adds two-way surprise risk. Both held positions (LLY, V) are thesis-intact with healthy stop buffers and no forced decisions due. ETN cleared its first ATR-gate session but isn't eligible until a second clean session completes; LRCX failed again on direct semiconductor-selloff exposure. No watchlist name qualifies for entry today, and the NFP print is reason enough on its own to hold off on new risk. Doing nothing is the correct, disciplined call today.

### Planned trades for today

No trades planned. NFP report at 8:30 AM ET (major macro event); LRCX ATR gate failed again (8.40%); ETN ATR gate 1/2, not yet eligible; no other watchlist name qualifies. Both held positions HOLD, no forced decisions due.

```json
{
  "plan_date": "2026-07-02",
  "trades": []
}
```
EXECUTED: 2026-07-02T13:36:00Z — No trades; plan was empty (LRCX ATR gate failed again 8.40%, ETN gate 1/2, no other watchlist name qualified, NFP report 8:30 AM ET added event risk). Market confirmed open via clock. Stop audit 3/3 ✓ (LLY 7sh+3sh HWM 1238.00/stop 1114.20 buffer 6.71%; V 22sh HWM 356.60 [auto-ratcheted intraday]/stop 320.94 buffer 9.63%). No missing stops, no fills. Shock check +0.115% (no shock). Drawdown −1.583% (not triggered). LLY 1,194.375 (+9.22% from entry, thesis intact); V 355.11 (+9.75% from entry, thesis intact). All guardrails clear.

---

## 2026-07-01 — Pre-market research (~08:10 ET)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓ — paper trading confirmed.

### Control switch
- `memory/control.md` STATUS: **ACTIVE**. No `NOTE:` or `QUERY:` line present. Nothing to acknowledge or answer.

### Account snapshot (live Alpaca ~08:10 ET)

| Metric | Value |
|--------|-------|
| Equity | $99,596.72 |
| Cash | $80,023.72 (80.35%) |
| Long market value | $19,573.00 |
| Last equity (June 30 close) | $99,566.00 |
| Shock check | +$30.72 (+0.031%) vs last_equity — no shock ✓ (threshold −4%) |
| HWM (since inception) | $101,384.21 |
| Drawdown | −1.763% — NOT triggered ✓ (circuit breaker at −10%) |

### Macro (pre-market July 1, 2026 ~08:10 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| S&P 500 futures | ~−0.38% pre-market | — | Modestly lower after Tuesday's best-first-half close (S&P 500 index 7,499.36, +0.79%) |
| ADP employment (7:15 AM ET) | fcst 118K vs prior 122K | — | Due this morning |
| ISM Manufacturing PMI (9:00 AM ET) | fcst 53.8 vs prior 54.0 | — | Due at open |
| Fed Chair Kevin Warsh | Speaking 8:00 AM ET, ECB Sintra panel w/ Lagarde, Bailey, Macklem | — | Hawkish-surprise risk |
| 10yr Treasury | 4.47% (steady) | <4.75% | ✓ GATE PASSES |

**Narrative:** SPY just closed out its best first half in years on June 30 (Iran-ceasefire rally + Dow records). Futures are modestly softer this morning ahead of a data- and speech-heavy session: ADP employment, ISM Manufacturing, and Fed Chair Warsh's remarks in Sintra all land before/around the open. A hawkish surprise from Warsh or a hot ADP print could move the 10yr (currently a comfortable 4.47%, well below the 4.75% gate) and compress multiples on richly-valued names. Not a day to add new risk before the data clears.

### Position thesis reviews — "what changed since yesterday"

**LLY** ($1,202.04 lastday close, +9.92% from entry $1,093.534)
- _What changed since June 30:_ Medicare GLP-1 Bridge program **launches today** (July 1) — $50/month copay for ~20M Medicare Part D beneficiaries across Zepbound, Foundayo, and Wegovy. This is the formal implementation of the catalyst that already drove the +7.13% rally on June 26 (Leerink PT raised to $1,232 that day); no new incremental news since. Stock pulled back modestly June 30 (−1.75% "sell the news" per close routine) ahead of the launch — normal pre-event positioning, not a thesis break.
- Stop: HWM $1,238.00, stop $1,114.20 (buffer $87.84 = 7.31%) ✓
- Earnings: Aug 5, 2026 — well outside the 2-day window ✓
- Invalidation: close below stop $1,114.20; or Medicare Bridge pricing/utilization data reveals margin deterioration.
- review_by: **2026-07-07** (unchanged, set at 2026-06-29 pre-market) — not due today; no forced decision. Will read actual bridge-launch reaction (utilization commentary, analyst notes) at midday/close.
- **Decision: HOLD. Conviction: A.**

**V** ($343.30 lastday close, +6.10% from entry $323.57)
- _What changed since June 30:_ Piper Sandler initiated coverage Overweight (June 29). Visa Destinations live in 10 markets; stablecoin/tokenization initiative continues. No negative news; nothing material — thesis unchanged.
- Stop: HWM $345.81, stop $311.229 (buffer $32.071 = 9.34%) ✓
- Earnings: July 28, 2026 — outside the 2-day window ✓
- Invalidation: close below stop $311.229; or a reversal in payments-volume trends.
- review_by: 2026-07-28 (unchanged) — not due.
- **Decision: HOLD. Conviction: B.**

### Earnings calendar confirmation
- LLY: next earnings Aug 5, 2026 ✓ (outside window)
- V: next earnings July 28, 2026 ✓ (outside window)
- LRCX: next earnings July 29, 2026 (not held; informational)

### Watchlist / candidate review

| Ticker | ATR gate status | Notes |
|--------|-----------------|-------|
| LRCX | **FAILS** — June 29 8.55%, June 30 5.47% (both >5% loosened threshold) | Cantor PT raised to $500, BofA to $480 on Samsung/SK Hynix $1.3T semicap wave; but stock beta 2.25, trailing P/E >69x, insider selling ($19.1M Form 4 by a director) — still too hot. Gate counter 0/2 fresh sessions per the 2026-07-01 strategy reset. |
| ETN | **NOT YET ELIGIBLE** — June 29 2.43% ✓ / June 30 4.15% ✓ (both would clear ≤5%) but pre-dates the July 1 gate reset | Record Q1 (rev +17%, EPS $2.81 beat), raised FY26 guidance, AI data-center electrical demand intact. Per strategy.md, gate explicitly "re-checks from July 1" — no credit for pre-reset sessions. Earliest clearance July 2 close if today is also ≤5%. |
| VST (closed 6/30, WIN +7.66%) | n/a — not currently held | Thesis (Helix/KKR/Nvidia $10B AI power JV, Cogentrix 5,500MW gas deal closing H2 2026, Meta 2.1GW nuclear PPAs, Fitch IG upgrade) remains fully intact and unchanged from the exit. No fresh catalyst or pullback entry point since the June 30 stop-out — re-entering at essentially the same level immediately after taking the win would be chasing, not a new setup. Watching for a pullback or the Cogentrix close as the next entry trigger; no action today. |
| MSFT / COST / JNJ / WMT / PWR | No change | Pre-earnings gates / ATR elevation / insider-selling flags from prior weeks unchanged; no new signal today. |

### Cash-drag check

Cash is 80.35% — well above the 10–20% target band for a 2-position book, and has been elevated for 3+ consecutive weeks (0/3 new-position slots used weeks 5, 6, and so far week 7). No candidate qualifies today: LRCX and ETN both fail the (freshly reset) ATR gate, no other watchlist name clears its entry signals, and today carries real macro event risk (ADP, ISM, and a Fed Chair speaking on a live central-bank panel) before the open — a bad day to add fresh risk even if a gate had cleared. Staying in cash today is a deliberate, written decision, not a passive default. Will re-check LRCX/ETN gates at every session this week as fresh ≤5% ATR sessions accumulate toward the July 1 reset requirement.

### Market posture

Cautiously neutral heading into a data-heavy session. LLY's Medicare Bridge launch and V's steady analyst support keep both existing positions on HOLD with no changes needed. No held position has a thesis break, an expired review, or a triggered invalidation. No watchlist candidate clears its entry gate. Given elevated macro-event risk (ADP/ISM/Warsh) before the open, doing nothing is the correct, disciplined call today.

### Planned trades for today

No trades planned.

```json
{
  "plan_date": "2026-07-01",
  "trades": []
}
```
EXECUTED: 2026-07-01T13:37:00Z — No trades; plan was empty (market not eligible for new positions per pre-market gates); market confirmed open via clock; stop audit 3/3 ✓ (LLY 7sh+3sh HWM $1,238.00/stop $1,114.20 buffer 6.22%; V 22sh HWM $345.81/stop $311.229 buffer 8.98%); no missing stops, no fills since pre-market; shock check −0.139% (no shock); drawdown −1.930% (not triggered). LLY $1,188.10 (+8.65% from entry, sell-the-news pullback continuing post-Medicare-Bridge-launch, thesis intact); V $341.94 (+5.68% from entry, thesis intact). All guardrails ✓.

---

## 2026-06-29 — Pre-market research (~08:04 ET)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓ — paper trading confirmed.

### Account snapshot (live Alpaca ~08:04 ET)

| Metric | Value |
|--------|-------|
| Equity | $99,883.94 |
| Cash | $73,615.74 (73.70%) |
| Long market value | $26,268.20 |
| Last equity (June 26 close) | $99,633.60 |
| Shock check | +$250.34 (+0.251%) vs last_equity — no shock ✓ (threshold −4%) |
| HWM | $101,384.21 |
| Drawdown | −1.479% — NOT triggered ✓ (circuit breaker at −10%) |

### Macro (pre-market June 29, 2026 ~08:04 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| S&P 500 futures | ~7,455.25 (range 7,437–7,464) | — | Mildly positive — quiet recovery day |
| 10yr Treasury | ~4.44–4.49% est. | <4.75% | ✓ GATE PASSES |
| WTI crude | ~$80/bbl | <$100 | ✓ Iran peace deal intact |
| GOOGL Dow Jones | Effective today | — | Positive passive flows ✓ |
| Major earnings/data | None expected today | — | Quiet macro day |

**Narrative:** S&P futures mildly positive — quiet recovery after last week's −2.4% selloff. GOOGL joins the Dow Jones Industrial Average effective today, generating passive index flows. No major macro data expected. Risk appetite stabilizing but elevated inflation (PCE 4.1%) and hawkish Fed backdrop (FOMC June 16–17 hold; dot-plot median 3.8% year-end) remain. Macro is not deteriorating further today; cautious constructive.

### Position thesis reviews — "what changed since yesterday"

**LLY** ($1,230.01 pre-mkt, +1.82% from $1,208.12 lastday; +12.48% from entry $1,093.534)
- _What changed since June 26:_ LLY rallied further (+1.82% pre-market) as Medicare GLP-1 Bridge launches TOMORROW (July 1). CMS confirmed coverage: Foundayo, Wegovy, and Zepbound KwikPen at $50/month copay for Medicare Part D beneficiaries (July 1, 2026 – Dec 31, 2027). ~20M Medicare patients eligible. Leerink PT $1,232 raised June 25 — stock is AT the PT today. TIKR bull-case analysis citing $2,100 target signals ongoing institutional interest. No negative news.
- Stop: HWM $1,215.76, stop $1,094.184 (buffer $135.83 = 11.05%) ✓ — HWM will ratchet at market open as LLY opens above previous HWM
- Earnings: LLY Q2 est. Aug 5-6 — outside 2-day window ✓
- **MANDATORY HOLD/TRIM/EXIT DECISION (review_by was July 1):**
  - DECISION: **HOLD**. Medicare Bridge is an 18-month program (not a one-day catalyst) — durable revenue expansion for ~20M patients is the ongoing thesis. Stock at Leerink PT but bull-case PTs significantly higher. Stop at 11% buffer provides strong downside protection and will auto-ratchet higher as stock climbs. "Sell the news" risk is limited because bridge is a program launch, not a point-in-time event. Next catalyst: Q2 earnings Aug 5-6. Renew review_by to July 7 to assess market reaction post-bridge launch.
- Invalidation: Medicare Bridge pricing reveals margin deterioration; or stock closes below $1,094 (stop).
- review_by: **2026-07-07** (renewed — assess post-bridge-launch market reaction)
- **Decision: HOLD. Conviction: A.**

**VST** ($163.99 pre-mkt, +0.31% from $163.49 lastday; +10.20% from entry $148.81)
- _What changed since June 26:_ VST slightly positive pre-market (+0.31%) — stop buffer improved marginally from 1.86% to 2.23%. Helix+Cogentrix thesis intact. Analyst data unchanged (Morgan Stanley $210, Wells Fargo Buy, Seaport $230). VST dividend payment June 30 (ex-date was June 22; $0.23 × 40sh = $9.20). Q1 2026 revenue $5.63B, adj. EBITDA +20% YoY — fundamentals strong.
- Stop: HWM $168.77, stop $160.3315 (5% trail, buffer $3.66 = 2.23%) ✓ ⚠️ CRITICAL
- Earnings: VST Q2 est. August 6 — outside 2-day window ✓
- review_by: 2026-07-07 (unchanged)
- **Decision: HOLD with stop in place.** Do NOT override stop manually. If stop fires, P/L = +9.71% — a win. Thesis intact; stop is the correct exit mechanism.
- Invalidation: Stop at $160.3315 fires; or Helix/Cogentrix contracts cancelled.
- **Decision: HOLD. Conviction: A.**

**V** ($336.75 pre-mkt, +0.16% from $336.23 lastday; +4.07% from entry $323.57)
- _What changed since June 26:_ Visa flat pre-market. Visa Destinations now live across 10 locations (launched June 25); EVO multiyear partnership announced June 24; Class B share conversion June 26 (capital structure optimization). No negative catalysts. 36 analysts Buy, avg PT $398.83.
- Stop: HWM $339.94, stop $305.946 (buffer $30.80 = 9.15%) ✓
- Earnings: V Q3 FY26 est. July 28 — review_by July 28 (outside 2-day window today ✓)
- **Decision: HOLD. Conviction: B (0/3 C-weeks).**

### Monday conviction ratings (June 29, 2026)

| Symbol | Rating | 3-consecutive-C trigger | Notes |
|--------|--------|------------------------|-------|
| LLY | **A** | N/A | +12.48% from entry; Medicare Bridge TOMORROW; stop buffer 11.05% healthy; at Leerink PT |
| V | **B** | 0/3 weeks at C | +4.07% from entry; thesis intact; defensive strength; July 28 earnings gate |
| VST | **A** | N/A | +10.20% from entry; Helix+Cogentrix intact; 5% trail stop buffer 2.23% critical ⚠️ |

### Watchlist / new candidate review

**LRCX (Lam Research) — ATR gate session 1/3 starts today:**
- Current ~$378 (June 28 quote). ATR gate FULLY RESET by June 26 −4.38% selloff (after prior week's −10%+ move).
- SK Hynix HBM slowdown (June 23 announcement) is moderate negative read-through for LRCX order outlook
- BofA PT $480, Citi PT $450, Oppenheimer PT $400 — strong bull case
- Session 1/3 starting today (June 29). Need June 29, June 30, July 1 all ≤3% ATR to enter July 7
- Alpaca bars unavailable pre-market; will assess ATR after today's session in close routine
- **Action: WATCH. No entry today. Earliest July 7+**
- Information date: June 28-29, 2026

**ETN (Eaton) — ATR elevated:**
- AGGRO added June 25 at $419.54; ATR elevated post-selloff
- Need fresh 3 consecutive ≤3% sessions; earliest July 7+
- **Action: WATCH. No entry today.**

**GOOGL (Dow Jones inclusion effective today):**
- Positive passive flows from index inclusion — ~$50B+ in tracking assets
- Not on watchlist; monitoring for potential addition if momentum builds
- **Action: WATCH only. No immediate entry considered.**

### Risk posture & circuit breaker check

- **Drawdown:** $99,883.94 vs HWM $101,384.21 = **−1.479%** — NOT triggered ✓ (circuit breaker at −10%)
- **Sector exposure:**
  - Healthcare (LLY): $12,300.10 = 12.30% — far below 60% cap ✓
  - Financials (V): $7,408.50 = 7.42%
  - Energy/Utilities (VST): $6,559.60 = 6.57%
  - Cash: $73,615.74 = 73.70%
- **No new buys:** No sector concentration risk

### Earnings window check
- LLY: Q2 est. Aug 5-6 → >2 trading days away ✓
- V: Q3 FY26 est. July 28 → >2 trading days away ✓
- VST: Q2 est. Aug 6 → >2 trading days away ✓
- LRCX: Earnings ~late July (not entering today regardless)

### Cash-drag check
- Cash: $73,615.74 (73.70%) vs target 25–40% for 3 positions
- No new buys explicitly justified: (1) VST stop critical at 2.23% — may fire this week; (2) LLY at Leerink PT with bridge launching tomorrow — assess market reaction July 1-2 before adding risk; (3) LRCX/ETN ATR gates need 3+ sessions (earliest July 7); (4) no other ATR-qualified candidates. Staying in cash today is a deliberate decision, not drift.
- Plan for weeks 7-8: target 1-2 new entries (July 7+ when ATR gates potentially clear + VST situation resolved).

### Stop audit (pre-market June 29 — confirmed via Alpaca live orders)
| Order ID | Symbol | Qty | Type | HWM | Stop | Status |
|----------|--------|-----|------|-----|------|--------|
| d4147484 | LLY | 7sh | trailing_stop 10% | $1,215.76 | $1,094.184 | ✓ active |
| 25989fb5 | LLY | 3sh | trailing_stop 10% | $1,215.76 | $1,094.184 | ✓ active |
| 66033918 | V | 22sh | trailing_stop 10% | $339.94 | $305.946 | ✓ active |
| c8b43d32 | VST | 40sh | trailing_stop 5% | $168.77 | $160.3315 | ✓ active ⚠️ CRITICAL buffer 2.23% |
**4/4 PASS ✓**

---

### Planned trades for today

No trades planned. Market is pre-market (8:04 AM ET, next open 9:30 AM). Market open routine will execute from this plan.

```json
{
  "plan_date": "2026-06-29",
  "trades": []
}
```

No trades planned. VST stop critical + LLY at Leerink PT + no ATR-cleared candidates. Cash drag explicitly justified.

EXECUTED: 2026-06-29T13:38:00Z — No trades; plan was empty; stop audit 4/4 PASS ✓ (LLY $1,233.30 HWM $1,238.00 stop $1,114.20 buffer $119.10 = 9.66% ✓; V $340.20 HWM $340.94 stop $306.85 buffer $33.35 = 9.80% ✓; VST $164.06 HWM $168.77 stop $160.33 buffer $3.73 = 2.27% ⚠️ CRITICAL — improved from 1.86% Friday); shock check +$365.16 (+0.37%) ✓; drawdown −1.366% vs HWM ✓; LLY new HWM $1,238 ratcheted above prior $1,215.76 ⬆️ (EXCEEDS Leerink PT $1,232 ✓); LRCX ATR session 1/3 in progress (2.45% early-trade range; confirm at close); Bull equity $99,998.76 (−0.001% since inception) LEADS SPY TR −0.028% by +0.027pp (lead compressed from +0.883pp Friday as SPY +1.16% GOOGL Dow-inclusion rally). All guardrails ✓.


## 2026-06-26 — Weekly Review Research (~20:35 UTC)

### Week of June 23-26, 2026 — Summary findings

**S&P 500 weekly performance:**
- S&P 500 (SPX): ~−2.4% on the week (7,357.49 close June 26)
- SPY ETF: $746.75 → $728.99 = −2.379% (no dividend this week)
- Nasdaq composite: −4%+ on the week; semiconductor names particularly hard hit

**Macro drivers:**
- **PCE inflation 4.1% YoY (June 25):** Highest since April 2023 — hawkish surprise; reinforces higher-for-longer
- **Fed Chair Kevin Warsh:** Comments interpreted hawkish; policymakers expect modest tightening by year-end
- **OpenAI IPO delay:** Reported as AI selloff catalyst; tech/AI valuations under pressure
- **Sector rotation:** Growth/AI/tech → Healthcare, Industrials, Defensives
- **GOOGL Dow Jones inclusion:** Effective June 29; positive for passive flows

**LLY (held — 10sh @ $1,093.534):**
- LLY surged +7.44% on June 26 to close $1,215 (new HWM $1,215.76)
- **Medicare Bridge confirmed July 1:** ~20M Medicare Part D patients eligible for Zepbound/Foundayo at $50/month
- Leerink Partners raised PT to $1,232 (Outperform); thesis fully confirmed
- Stop buffer 9.69% at $1,094.18; pre-market June 30 MANDATORY hold/trim/exit decision
- Information date: June 26, 2026

**VST (held — 40sh @ $148.81):**
- VST −2.62% June 26 to $163.37; stop buffer CRITICAL 1.86% ($163.37 vs stop $160.33)
- Nuclear/AI data-center thesis intact: 20-year PPAs with Meta for 2,600+ MW; Helix (KKR+NVIDIA+Kuwait) preferred power provider
- Q1 2026 revenue $5.63B, adj. EBITDA +20% YoY; consensus analyst PT ~$230s
- Cogentrix acquisition (5,500 MW natural gas) provides diversification
- Information date: June 25-26, 2026

**V (held — 22sh @ $323.57):**
- V +2.10% June 26 to $337.46; showing defensive strength in broad selloff
- No major news this week; fundamentals intact
- 52-week range $293.89–$359.66; analyst PT avg $387.78
- P/E 29.43; market cap $636.5B; quarterly dividend yield 0.79%
- Information date: June 26, 2026

**NVDA (stopped out June 25):**
- AI selloff continued; GPU B200 hourly spot $6.11 (May 30) → $4.22 (June 21) = −31%
- OpenAI IPO delay reinforced AI infrastructure concerns
- Stock well below $200 invalidation level; thesis break confirmed
- LRCX also −10%+ June 26 — ATR gate fully reset; earliest entry July 7+
- Information date: June 26, 2026

**ETN (Eaton — new watchlist candidate):**
- Eaton electrical equipment is critical bottleneck for hyperscale data center expansion
- AGGRO added June 25 at $419.54; down −4% June 26 in risk-off
- AI capex supercycle thesis; no specific time-bound catalyst
- Need 3 consecutive ≤3% ATR sessions before entry; earliest week of July 7+
- Information date: June 25-26, 2026

---

## 2026-06-26 — Pre-market research (~08:03 ET)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓ — paper trading confirmed.

### Account snapshot (live Alpaca ~08:03 ET)

| Metric | Value |
|--------|-------|
| Equity | $98,723.49 |
| Cash | $73,615.74 (74.58%) |
| Long market value | $25,107.75 |
| Last equity (June 25 close, Alpaca API) | $98,874.88 |
| Shock check | −$151.39 (−0.153%) vs last_equity — no shock ✓ (threshold −4%) |
| HWM | $101,384.21 |
| Drawdown | −2.625% — NOT triggered ✓ (circuit breaker at −10%) |

### Macro (pre-market June 26, 2026 ~08:03 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| S&P 500 futures | **−0.37%** | — | Risk-off — tech/semi weakness spreading from Asia |
| KOSPI | **−~8%** | — | ⚠️ Major Asian selloff — KOSPI chip selloff day 2+ this week |
| Nikkei | **−~5%** | — | ⚠️ Broad Asian risk-off contagion |
| 10yr Treasury | Edging lower | <4.75% | ✓ GATE PASSES — PCE in line, yields declining |
| WTI crude | ~$80/bbl | <$100 | ✓ — Iran peace deal intact |
| VIX | Elevated | <35 | Monitoring — elevated by Asian shock |
| PCE (May 2026) | Broadly in-line | — | ✓ — not accelerating; modest macro relief |

**Narrative:** Another major Asian semiconductor selloff — KOSPI fell ~8% on Friday (second large-scale KOSPI drawdown in two weeks, following June 23 −9.99%). Nikkei −5%. The driver is continued concern about AI infrastructure costs and rising competition vs. demand for AI hardware. S&P futures −0.37%. This is a risk-off morning driven entirely by semiconductor/tech sector fear. However, PCE inflation came in broadly in-line with expectations — no Fed hawkishness surprise. Our portfolio (healthcare LLY, financials V, energy/utilities VST) should absorb this better than a tech-heavy portfolio. Risk-off tape warrants caution but no panic.

### Position thesis reviews — "what changed since yesterday"

**LLY** ($1,125 pre-mkt, −0.239% from $1,127.69 lastday; +2.877% from entry $1,093.534)
- _What changed since yesterday:_ Leerink analyst David Risinger raised firm PT on LLY to $1,232 (from $1,119), keeping Outperform — bullish upgrade. Eli Lilly announced more details of Medicare GLP-1 Bridge program: Zepbound and Orforglipron (Foundayo) offered to Medicare beneficiaries at ≤$50/month. New GLP-1 youth diabetes trial launched (expanding GLP-1 footprint). Nothing materially negative.
- Stop: HWM $1,182.73, stop $1,064.457 (buffer $60.54 = 5.38%) ✓
- ⚠️ **Medicare Bridge July 1 in 2 trading days (June 30, July 1).** Pre-market June 30 is MANDATORY hold/trim/exit decision. Today's Leerink upgrade and bridge details lean thesis-positive (broader access = demand expansion). Set decision framework: **lean HOLD unless data shows margin deterioration.** Earnings Aug 5-6 (40 days) — outside 2-day window ✓.
- Invalidation: stop fires or Medicare Bridge pricing reveals margin deterioration.
- review_by: 2026-07-01 (pre-market June 30 decision)
- **Decision: HOLD. Conviction: A.**

**V** ($329.694 pre-mkt, −0.250% from $330.52 lastday; +1.893% from entry $323.57)
- _What changed since yesterday:_ Visa launched Visa Destinations travel platform across 10 global destinations (Paris, London, Dubai, Milan, Rome, Mexico City, NY, Miami, SF, Thailand) in partnership with Santander Group and Global Blue. Thesis catalyst: Visa expanding beyond payments into curated travel experience — incremental moat deepening. V is GAINING +0.15% to $332.74 despite broad market weakness — showing relative strength in risk-off. Earnings July 28 (32 days) — outside 2-day window ✓.
- Stop: HWM $339.94, stop $305.946 (buffer $23.75 = 7.21%) ✓
- Thesis intact. Positive catalyst today. HOLD. review_by 2026-07-28.
- Invalidation: stop fires or cross-border revenue guidance cut.
- **Decision: HOLD. Conviction: B (0/3 C-weeks). Strong hold — Visa Destinations launch bullish.**

**VST** ($165.112 pre-mkt, −1.584% from $167.77 lastday; +10.955% from entry $148.81) ⭐⭐
- _What changed since yesterday:_ Morgan Stanley raised PT on VST to $212 from $208, maintaining Overweight. Seaport raised PT to $230 from $227, maintaining Buy. Helix Digital Infrastructure thesis unchanged — most compelling portfolio position. VST down −1.584% pre-market in sympathy with broad tech/energy profit-taking.
- ⚠️ **Stop buffer NARROW:** 5% trailing stop (c8b43d32) HWM $168.77, stop $160.3315. Current $165.112. Buffer = $4.78 (2.90%). To trigger stop from current pre-market level: −2.90% more required. To trigger from yesterday close $167.77: −4.43% daily decline. Midday routine must monitor closely in risk-off tape.
- No negative thesis catalyst — Helix + Cogentrix intact. PT upgrades bullish. VST down is pure broad market contagion from Asian semiconductor selloff. STRONG HOLD unless stop fires.
- Stop: HWM $168.77, stop $160.3315 (5% trail, c8b43d32) ✓ buffer 2.90% ⚠️ MONITORING
- Earnings Aug 6 (41 days) — outside 2-day window ✓. Thesis review_by July 7.
- Invalidation: stop fires or Helix consortium materially changes.
- **Decision: STRONG HOLD. Conviction: A. Monitor stop buffer at midday.** ⭐⭐

### Stop audit (pre-market June 26 — confirmed via Alpaca live orders ~08:03 ET)

| Symbol | Order ID | Qty | HWM | Stop | Buffer | Status |
|--------|----------|-----|-----|------|--------|--------|
| LLY | d4147484 | 7sh | $1,182.73 | $1,064.457 | $60.54 (5.38%) | ✓ active |
| LLY | 25989fb5 | 3sh | $1,182.73 | $1,064.457 | $60.54 (5.38%) | ✓ active |
| V | 66033918 | 22sh | $339.94 | $305.946 | $23.75 (7.21%) | ✓ active |
| VST | c8b43d32 | 40sh | $168.77 | $160.3315 (5% trail) | $4.78 (2.90%) ⚠️ | ✓ active |
**4/4 PASS ✓**

### Drawdown circuit breaker
- HWM: $101,384.21 | Current equity: $98,723.49 | Drawdown: **−2.625%** — NOT triggered ✓ (circuit breaker −10%; headroom 7.375pp)

### Earnings window check (2 trading days out: June 27 Saturday, June 30)
- **LLY**: Next earnings Aug 5-6 (~40 days) ✓ — outside 2-day window
- **V**: Next earnings July 28 (~32 days) ✓ — outside 2-day window
- **VST**: Next earnings Aug 6 (~41 days) ✓ — outside 2-day window
- No earnings windows triggered ✓

### LRCX ATR gate status (pre-market June 26 — DEFINITIVE RESET)
- June 25 intraday range: $372.30 to $407.99 | Close: ~$401.73
- **ATR% June 25 = ($407.99 − $372.30) / $401.73 = 8.88% ❌ MASSIVE FAIL**
- Prior sessions: June 24 ATR 4.15% ❌ | June 23 ATR 3.08% ❌
- **All 3 sessions FAILED. Gate counter RESET to 0.**
- Need 3 fresh consecutive ≤3% sessions before entry eligible.
- With KOSPI −8% and tech pressure today, LRCX likely continues volatile.
- **Earliest possible entry: week of June 29** (if Mon/Tue/Wed all ≤3%) — but practically week of July 7+ given current volatility.
- BofA raised PT on LRCX to $480 (from $330) — thesis improving, but must wait for calm tape.
- **LRCX watchlist: deferred. No entry this week.**

### Cash-drag check
- Cash 74.58% — far above 25-40% target for 3-position portfolio.
- **Explicit justification for staying heavy cash:** Risk-off tape today (KOSPI −8%, Nikkei −5%, S&P futures −0.37%). LRCX ATR gate definitively failed June 25 (8.88%). PWR still deferred (ATR elevated + insider selling). No other candidates meeting all 5 entry signals in a risk-off semiconductor-panic day. Last day of trading week; fresh 3/3 weekly slots open Monday June 29. Cash is correct posture today — idle is NOT a default, it is the right decision.

### Weekly slot count (week of June 22-26)
- Slot 1: NVDA — opened June 22, stopped out June 25 (−9.78%)
- Slots 2 and 3: Unused — no qualified candidates in risk-off tape this week
- **New week starts Monday June 29: fresh 3/3 new position slots.**

### Performance vs S&P 500 (pre-market June 26)

| Period | Bull | SPY | Difference |
|--------|------|-----|------------|
| Inception (2026-05-21) | $100,000.00 | $739.44 | — |
| **Pre-mkt (2026-06-26)** | **$98,723.49 (−1.277%)** | **SPY $733.33 close + $1.76 div = −0.588% TR** | **Bull TRAILS SPY ~0.689pp** |
| **Close (2026-06-25)** | **$98,925.93 (−1.074%)** | **$733.33 + $1.76 = −0.588% TR** | **Bull TRAILS SPY ~0.486pp** |

### Planned trades for today

No trades planned. Risk-off tape (KOSPI −8%, Nikkei −5%, S&P futures −0.37%), LRCX ATR gate failed (8.88%), no other qualified candidates meeting all 5 entry signals. All 3 positions held. Last day of week.

```json
{
  "plan_date": "2026-06-26",
  "trades": []
}
```

EXECUTED: 2026-06-26T13:37:00Z — No trades; plan was empty (risk-off tape, LRCX ATR gate failed 8.88%); stop audit 4/4 PASS ✓ (LLY $1,148.94 HWM $1,182.73 stop $1,064.457 buffer 7.36%; V $335.71 HWM $339.94 stop $305.946 buffer 8.86%; VST $166.86 HWM $168.77 stop $160.33 buffer 3.91% ⚠️ monitoring); shock check +$281.04 (+0.284%) ✓; drawdown −2.198% vs HWM ✓; Bull equity $99,155.92 (−0.844%) LEADS SPY TR −1.217% by +0.373pp. All guardrails ✓.

---

## 2026-06-25 — Pre-market research (~08:02 ET)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓ — paper trading confirmed.

### Account snapshot (live Alpaca ~08:02 ET)

| Metric | Value |
|--------|-------|
| Equity | $98,902.39 |
| Cash | $67,261.73 (68.01%) |
| Long market value | $31,640.66 |
| Last equity (June 24 close) | $98,825.19 |
| Shock check | +$77.20 (+0.078%) — no shock ✓ (threshold −4%) |
| HWM | $101,384.21 |
| Drawdown | −2.448% — NOT triggered ✓ (circuit breaker at −10%) |

### Macro (pre-market June 25, 2026 ~08:02 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| S&P 500 futures | **+0.1%** | — | Constructive — Micron blowout earnings sparking AI sector recovery |
| 10yr Treasury yield | **Edging lower** | <4.75% | ✓ GATE PASSES — below trigger; Iran peace deal + progress in US-Iran talks |
| WTI crude | **~$80/bbl** | <$100 | ✓ — Iran peace deal intact |
| VIX | Normal range | <35 | ✓ — no cash-raise trigger |

**Narrative:** Futures +0.1%, boosted by Micron's blowout Q3 2026 earnings (record $41.5B revenue, 84.9% gross margin, $100B take-or-pay contracts, HBM4 in production for NVDA Vera Rubin). This is the most direct AI-semi thesis confirmation in weeks — memory supply cannot catch up with demand through at least 2027. 10yr yields edging lower. Manufacturing PMI 55.7, composite 52.2 — economy expanding. Risk-on posture. All macro gates clear.

### Position thesis reviews — "what changed since yesterday"

**LLY** ($1,115.54 pre-mkt, −0.154% from $1,117.26 lastday; +2.01% from entry $1,093.534)
- _What changed since yesterday:_ Trump highlighted Eli Lilly's $3.5B Pennsylvania factory for next-gen obesity drugs (including Retatrutide), with operations starting 2031 — long-term manufacturing positive. Medicare coverage agreement finalized: LLY will offer Zepbound and Orforglipron (Foundayo) to Medicare beneficiaries at ≤$50/month. Analyst 12-month target $1,218.72 (+9.3% upside). Nothing materially negative.
- Stop: HWM $1,182.73, stop $1,064.457 (buffer $51.08 = 4.58%) ✓
- Medicare Bridge July 1 in 6 days — HOLD. Explicit hold/trim/exit REQUIRED at pre-market June 30.
- Invalidation: stop fires or Medicare Bridge pricing reveals margin deterioration.
- review_by: 2026-07-01 (pre-market June 30 decision)
- **Decision: HOLD. Conviction: A.**

**NVDA** ($200.69 pre-mkt, +0.849% from $199.00 lastday; −5.966% from entry $213.421) ⚠️ CRITICAL HOLD DECISION
- _What changed since yesterday:_ **MICRON Q3 2026 BLOWOUT EARNINGS (after-bell June 24):** Revenue $41.5B (quadruple YoY), gross margin 84.9% (record — above Nvidia's own margin), net income $28.24B beating consensus 23.8%, $100B in take-or-pay contracts. **HBM4 confirmed in high-volume production for NVDA Vera Rubin platform.** CEO Sanjay Mehrotra: "no line of sight as to when memory supply will catch up with increasing demand." This is the single most direct confirmation of NVDA's AI accelerator thesis. NVDA recovering +0.849% pre-market to $200.69 (above $200 invalidation level).
- **⚠️ THESIS CONTRACT REVIEW:** June 24 Alpaca lastday_price = $199 (closed below $200 invalidation). The stated invalidation was "closes below $200 on volume." This was technically triggered. HOWEVER: the Micron blowout is a DIRECT, LITERAL confirmation that the fundamental NVDA thesis is intact and strengthening — HBM4 for Vera Rubin is in high-volume production; AI memory demand exceeds supply through 2027. The $200 close was KOSPI contagion (SK Hynix profit-taking), not a fundamental thesis break. The lesson from June 24 distinguishes "thesis break" (fundamental reason for holding is gone) from "stop-out" (automatic protection). This is NOT a thesis break.
- **MANDATORY HOLD DECISION: HOLD full position.** Reasoning: Micron's results are direct confirmation of NVDA's primary thesis. The causal factor for the KOSPI selloff (HBM4 supply concerns) is now confirmed to be wrong — HBM4 is in high-volume production. Recovering above $200 pre-market. Trailing stop ($192.591) provides structural protection.
- **Renewed invalidation:** Closes below $200 on volume AGAIN (with no corresponding positive catalyst) → exit at next pre-market. OR trailing stop fires at $192.591.
- **Renewed review_by:** 2026-07-03 (7 days — one week post-Micron to assess recovery trajectory).
- Stop: HWM $213.99, stop $192.591 (buffer pre-market $200.69 - $192.591 = $8.10 = 4.03%) ✓
- **Midday -7% rule threshold: $198.48 — apply WITHOUT EXCEPTION if NVDA at/below this level at midday.**
- Earnings: August 26, 2026 (62 days — outside 2-day window ✓)
- **Decision: HOLD. Conviction: B (monitoring — Micron confirms thesis; watching $200 level).**

**V** ($331.40 pre-mkt, −0.25% from $332.23 lastday; +2.418% from entry $323.57)
- _What changed since yesterday:_ Visa, Mastercard, and Stripe reportedly in talks to launch a joint stablecoin platform with Coinbase interested — incremental thesis catalyst. AI-driven cashback rewards launched in UAE. Strong Buy consensus (36 analysts), avg PT $398.83. Nothing negative.
- Stop: HWM $336.8199, stop $303.138 (buffer $28.26 = 8.53%) ✓
- Thesis intact. HOLD. review_by 2026-07-28 (Q3 FY26 earnings).
- Invalidation: stop fires or cross-border revenue guidance cut.
- **Decision: HOLD. Conviction: B (0/3 C-weeks).**

**VST** ($164.35 pre-mkt, +0.909% from $162.87 lastday; +10.44% from entry $148.81) ⭐⭐
- _What changed since yesterday:_ Morgan Stanley slightly trimmed PT from $212 to $210 (minor negative revision; still 27.7% upside). Goldman Sachs Buy maintained. 52-week high $219.82 — significant upside potential. Recovering +0.909% today as broader market risk-on resumes (Micron rally). Helix Digital Infrastructure + Cogentrix thesis most compelling in portfolio.
- Stop: HWM $170.50, stop $153.45 (buffer $10.90 = 6.63%) ✓
- Thesis intact. STRONG HOLD. review_by 2026-07-07.
- Invalidation: stop fires or Helix consortium materially changes.
- **Decision: STRONG HOLD. Conviction: A.** ⭐⭐

### Stop audit (pre-market June 25 — confirmed via Alpaca live orders)

| Symbol | Order ID | Qty | HWM | Stop | Buffer | Status |
|--------|----------|-----|-----|------|--------|--------|
| LLY | d4147484 | 7sh | $1,182.73 | $1,064.457 | $51.08 (4.58%) | ✓ active |
| LLY | 25989fb5 | 3sh | $1,182.73 | $1,064.457 | $51.08 (4.58%) | ✓ active |
| NVDA | dcba7429 | 33sh | $213.99 | $192.591 | $8.10 (4.03%) | ✓ active |
| V | 66033918 | 22sh | $336.8199 | $303.138 | $28.26 (8.53%) | ✓ active |
| VST | c4c200a5 | 40sh | $170.50 | $153.45 | $10.90 (6.63%) | ✓ active |

**Stop audit: 5/5 PASS ✓** No action required.

### Risk posture check

**Drawdown circuit breaker:** HWM $101,384.21 | Current $98,902.39 | Drawdown: **−2.448%** — NOT triggered (−10% threshold) ✓

**Sector exposure (pre-market June 25):**
- Healthcare (LLY): $11,155.40 = 11.28% | Tech/AI Semi (NVDA): $6,622.77 = 6.70% | Financials (V): $7,290.80 = 7.37% | Energy/Utilities (VST): $6,574.00 = 6.65% | Cash: $67,261.73 = 68.01%
- No sector above 60% cap ✓

### Earnings window check (2 trading days = June 26–27)
- LLY next earnings: ~August 6, 2026 ✓ (outside window)
- NVDA next earnings: August 26, 2026 ✓ (outside window — 62 days)
- V next earnings: July 28, 2026 ✓ (outside window)
- VST next earnings: ~August 2026 ✓ (outside window)
- **No held name reports within 2 trading days ✓**

### Watchlist / candidates (pre-market June 25)

**LRCX (semi equipment) — ATR GATE STILL FAILING**
- June 23 ATR: 3.08% (376.95−365.52)/371.15 — ABOVE 3% gate ❌
- June 24 ATR: (376.98−361.41)/374.80 = $15.57/$374.80 = **4.15%** — ABOVE 3% gate ❌
- Both recent sessions above gate; count = 0/3 consecutive ≤3% sessions.
- Wells Fargo PT $450, Citi PT $450 — thesis intact. Defer until 3 consecutive ≤3% sessions.
- Earliest entry: June 30+ (if June 25 and June 26 both ≤3%, then one more needed on June 29).

**PWR (industrials) — DEFERRED**
- ATR still elevated; insider selling $123M in 3 months (active flag). Re-evaluate June 30+.

**MRVL (Marvell) — UNRESEARCHED; NEXT PRIORITY**
- Micron blowout results (AI memory demand through 2027) directly support custom AI silicon thesis.
- MRVL makes ASICs for AWS/Google — cost-optimization play distinct from GPU sellers.
- Research at next pre-market if LRCX gate remains closed and a slot opens.

### Cash-drag check
Cash $67,261.73 = 68.01% — above 25–40% target band for >1 week.
**Explicit justification:** LRCX ATR gate failing (4.15% June 24; 3.08% June 23 — both above 3%); NVDA under active management (thesis renewed post-Micron, monitoring $200 level); no other qualified candidate with all 5 entry signals met. Holding cash is correct today — not a passive default. Micron results support eventual AI semi deployment once gates clear. ✓

### Performance vs SPY (pre-market June 25)
- Bull: $98,902.39 = **−1.098%** since inception (May 21, $100K start)
- SPY TR as of June 24 close: ($732.24 + $1.76 div) / $739.44 = $734.00 / $739.44 = **−0.736% TR**
- SPY futures +0.1% pre-market June 25: estimated ~−0.636% TR
- **Bull TRAILS SPY ~0.46pp est** (improving from −0.54pp at June 24 close as NVDA recovers and futures positive)

### Planned trades for today

No trades planned.

```json
{
  "plan_date": "2026-06-25",
  "trades": []
}
```

No trades planned. LRCX ATR gate failing (4.15% June 24; 3.08% June 23 — both above 3%; counter 0/3). NVDA thesis renewed post-Micron blowout (HOLD — no scale-up yet; midday -7% rule at $198.48 applies). PWR deferred. Cash drag explicitly accepted pending ATR resolution.

EXECUTED: 2026-06-25T13:38Z (no trades — plan was empty)

---

## 2026-06-25 — Market-open (~09:36 ET)

### Live checks
- **ALPACA_BASE_URL:** contains "paper" ✓
- **Market clock:** `is_open: true` ✓ (next close 16:00 ET)
- **Plan:** `plan_date: 2026-06-25`, `trades: []` — no trades planned. Plan is from today ✓.
- **Idempotency:** No prior EXECUTED line found → first run today ✓.

### Account (live ~09:36 ET)

| Metric | Value |
|--------|-------|
| Equity | $99,127.33 |
| Cash | $67,261.73 (67.85%) |
| Long market value | $31,865.60 |
| Last equity (June 24 close) | $98,825.19 |
| Shock check | +$302.14 (+0.306%) — NO shock ✓ (threshold −4%) |
| HWM | $101,384.21 |
| Drawdown | −2.226% — NOT triggered ✓ (circuit breaker at −10%) |

### Positions (live ~09:36 ET)

| Symbol | Qty | Avg Entry | Current | Mkt Value | Unrealized P/L | % Portfolio |
|--------|-----|-----------|---------|-----------|----------------|-------------|
| LLY | 10 | $1,093.534 | $1,117.50 | $11,175.00 | +$239.66 (+2.19%) | 11.27% |
| NVDA | 33 | $213.421 | $198.93 | $6,564.69 | −$478.16 (−6.79%) | 6.62% ⚠️ |
| V | 22 | $323.57 | $333.555 | $7,338.21 | +$219.67 (+3.09%) | 7.40% |
| VST | 40 | $148.81 | $169.92 | $6,796.80 | +$844.40 (+14.19%) | 6.86% ⭐⭐ |

### Breaking-news gate
No trades planned — gate not applicable. No scan required.

### Step 4: Trade execution
No trades in today's plan. Skipped.

### Step 5: Stop audit (market-open June 25 — confirmed via Alpaca live orders ~09:36 ET)

| Symbol | Order ID | Qty | HWM | Stop | Buffer | Status |
|--------|----------|-----|-----|------|--------|--------|
| LLY | d4147484 | 7sh | $1,182.73 | $1,064.457 | $53.04 (4.75%) | ✓ active |
| LLY | 25989fb5 | 3sh | $1,182.73 | $1,064.457 | $53.04 (4.75%) | ✓ active |
| NVDA | dcba7429 | 33sh | $213.99 | $192.591 | $6.34 (3.19%) | ✓ active ⚠️ NARROW |
| V | 66033918 | 22sh | $336.8199 | $303.138 | $30.42 (9.12%) | ✓ active |
| VST | c4c200a5 | 40sh | $170.50 | $153.45 | $16.47 (9.69%) | ✓ active |

**Stop audit: 5/5 PASS ✓** No missing stops. No positions to add stops to.

**Exit reconciliation:** All 4 positions present (LLY 10sh, NVDA 33sh, V 22sh, VST 40sh). No stops filled since last run. closed-trades.md current ✓.

### NVDA ⚠️ CRITICAL WATCH
- Current: $198.93 (latest trade at 09:37 ET)
- Entry: $213.421; −7% threshold: **$198.48**
- Spread: $198.93 − $198.48 = **$0.45 above forced-cut threshold**
- Pre-market renewed HOLD decision (Micron blowout confirms thesis; $200 break was KOSPI contagion)
- Renewed invalidation: closes below $200 AGAIN without positive catalyst → exit pre-market next day
- **Midday routine MUST apply −7% rule at 12:30 ET WITHOUT EXCEPTION if NVDA ≤ $198.48**

### VST ⭐⭐ STRONG
- Current: $169.92 (+14.19% from entry) — strong recovery today +4.33%
- HWM: $170.50 | +15% tighten trigger: $148.81 × 1.15 = $171.13
- $169.92 vs $171.13 = $1.21 below tighten trigger — NOT yet triggered ✓
- Midday routine should tighten stop to 5% if VST hits $171.13+

### Sector exposure (market-open June 25)
- Healthcare (LLY): $11,175.00 = 11.27% | Tech/AI Semi (NVDA): $6,564.69 = 6.62% | Financials (V): $7,338.21 = 7.40% | Energy/Utilities (VST): $6,796.80 = 6.86% | Cash: $67,261.73 = 67.85%
- No sector above 60% cap ✓

### Performance vs SPY
- SPY latest trade ~09:37 ET: $737.34
- SPY TR since inception: ($737.34 + $1.76) / $739.44 = **−0.046%**
- Bull: $99,127.33 / $100,000 − 1 = **−0.873%**
- **Bull TRAILS SPY ~0.827pp** (gap improving from −0.540pp deficit at June 24 close as positions recover this morning)
- Today: Bull +0.306% vs SPY +0.552% (SPY June 24 close $733.32 → $737.34) — SPY outperforming today on broad recovery; Bull's 68% cash cushion dampening the upside

### Summary
No trades executed. Stop audit 5/5 PASS ✓. NVDA in critical watch zone ($198.93, only $0.45 above forced-cut $198.48). Midday routine must apply -7% rule at 12:30 ET. VST +14.19% — approaching +15% tighten trigger at $171.13.

---

## 2026-06-24 — Pre-market research (~08:02 ET)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓ — paper trading confirmed.

### Account snapshot (live Alpaca ~08:02 ET)

| Metric | Value |
|--------|-------|
| Equity | $98,773.54 |
| Cash | $67,261.73 (68.12%) |
| Long market value | $31,511.81 |
| Last equity (June 23 close) | $98,656.01 |
| Shock check | +$117.53 (+0.119%) — no shock ✓ (threshold −4%) |
| HWM | $101,384.21 |
| Drawdown | −2.576% — NOT triggered ✓ (circuit breaker at −10%) |

### Macro (pre-market June 24, 2026 ~08:02 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| S&P 500 futures | **+0.13%** | — | Stabilizing — bargain-hunt after 2-day tech selloff; Micron +4.5% pre-mkt (earnings beat) |
| 10yr Treasury yield | **~4.49%** | <4.75% | ✓ GATE PASSES — new buys permitted (if candidates qualify) |
| WTI crude | **~$80/bbl** | <$100 | ✓ — Iran peace deal holding |
| VIX | **~18** | <35 | ✓ — no cash-raise trigger |

**Narrative:** Futures bounced +0.13% on bargain-hunting after the 2-session KOSPI-driven chip selloff. Micron Technology +4.5% pre-mkt after strong earnings — positive readthrough for semi equipment and AI infrastructure names. 71% probability of higher open per Polymarket. NVDA Annual Meeting today at noon ET (Jensen Huang keynote, Blackwell/Vera production ramp) — intraday event but bullish catalyst. 10yr yield below gate. Risk-on posture resuming.

### Position thesis reviews

**LLY** ($1,111.00 pre-mkt; +1.60% from entry $1,093.534)
- _What changed since yesterday:_ Berenberg raised PT $1,050 → $1,135 (keeps Hold). Retatrutide Phase 3 obesity data promising — potential regulatory filing catalyst. Centessa acquisition High Court approval June 22 (closed). Centessa adds pipeline assets.
- Stop: HWM $1,182.73, stop $1,064.457 (buffer $46.54 = 4.19%) ✓
- Thesis intact. Medicare Bridge July 1 in 7 days — HOLD; explicit decision REQUIRED at pre-market June 30.
- Invalidation: price breaks below $1,064 (stop triggers) or CMS walks back Bridge coverage.
- review_by: 2026-07-01 (pre-market June 30)

**NVDA** ($201.50 pre-mkt; −5.563% from entry $213.421)
- _What changed since yesterday:_ Annual Meeting TODAY at 9AM PT (noon ET). Virtual; focus on Blackwell GPU production ramp, Vera CPU launch, AI ecosystem commercialization. FY2026 revenue $215.9B (+65% YoY) highlighted in proxy. Micron earnings beat adds positive AI semiconductor sector tone. Pre-mkt +0.73% from June 23 close ($200.04 → $201.50).
- ⚠️ USD 200 invalidation: pre-mkt $201.50 — $1.50 ABOVE gate. Thesis NOT broken (no NVDA-specific fundamental; KOSPI HBM4 contagion only; Annual Meeting is thesis-affirming event).
- Stop: HWM $213.99, stop $192.591 (buffer $8.91 = 4.42%) ✓
- HOLD. Midday routine MUST apply −7% rule if NVDA trades below $198.48 (7% below entry $213.421).
- No scale-up today: Annual Meeting intraday event risk.
- Invalidation: closes below $200 on volume; −7% midday threshold $198.48.
- review_by: 2026-07-22

**V** ($329.00 pre-mkt; +1.678% from entry $323.57)
- _What changed since yesterday:_ EU Parliament backed digital euro — minor long-term risk to EU processing volume; no near-term impact. Visa launched AI cashback program in UAE. Strong Buy consensus (36 analysts), avg PT $398.83.
- Stop: HWM $336.8199, stop $303.138 (buffer $25.86 = 7.86%) ✓
- Thesis intact. HOLD. review_by July 28 (Q3 FY26 earnings).
- Invalidation: stop triggers or revenue guidance cut on cross-border headwinds.

**VST** ($162.80 pre-mkt; +9.401% from entry $148.81)
- _What changed since yesterday:_ Wells Fargo issued Buy rating June 23. Analyst consensus: Strong Buy, avg PT $225.29 (+37.8% from current). Helix Digital Infrastructure (KKR+NVIDIA+Kuwait) confirmed as preferred data center power partner. VST dividend $0.229 (ex-date June 22, record June 23, payment June 30).
- Stop: HWM $170.50, stop $153.45 (buffer $9.35 = 5.75%) ✓
- THESIS MOST COMPELLING. HOLD. review_by July 7.
- Invalidation: stop triggers or Helix partnership materially changes.

### Stop audit (pre-market June 24)

| Symbol | Order ID | Qty | HWM | Stop | Buffer | Status |
|--------|----------|-----|-----|------|--------|--------|
| LLY | d4147484 | 7sh | $1,182.73 | $1,064.457 | $46.54 (4.19%) | ✓ |
| LLY | 25989fb5 | 3sh | $1,182.73 | $1,064.457 | $46.54 (4.19%) | ✓ |
| NVDA | dcba7429 | 33sh | $213.99 | $192.591 | $8.91 (4.42%) | ✓ |
| V | 66033918 | 22sh | $336.8199 | $303.138 | $25.86 (7.86%) | ✓ |
| VST | c4c200a5 | 40sh | $170.50 | $153.45 | $9.35 (5.75%) | ✓ |

**Stop audit: 5/5 PASS ✓** — No action required.

### Watchlist review (pre-market June 24)

**LRCX** (semi equipment): June 23 ATR = (376.95−365.52)/371.15 = 3.08% — ABOVE 3% gate ❌ (day 1 of 3 needed). June 22 ATR = 4.26%. Wells Fargo raised PT to $450 (Overweight) June 22 — thesis strong. Today (June 24) will be session 1 of the 3-consecutive-≤3% requirement. Track: if June 24 and June 25 also ≤3%, earliest entry is June 29 (Monday open). No LRCX buy today.

**PWR** (industrials): ATR still elevated; insider selling $123M (flagged). Defer; re-evaluate June 29+.

### Earnings window check (2 trading days = June 25–26)
- LLY next earnings: ~August 2026 ✓ (outside window)
- NVDA next earnings: August 26, 2026 ✓ (outside window)
- V next earnings: July 28, 2026 ✓ (outside window)
- VST next earnings: ~August 2026 ✓ (outside window)
- No held name reports within 2 trading days ✓

### Cash drag assessment
Cash 68.12% vs target 25–40% (now 4 positions). Cash drag rule: must either plan a qualifying entry or explicitly justify staying heavy. **Explicit justification:** LRCX ATR gate failing (3.08% June 23); NVDA intraday event risk (Annual Meeting); PWR deferred; no other qualified entry meeting all 5 signals. Holding cash is correct today — not a default.

No trades planned.

### Planned trades for today

```json
{
  "plan_date": "2026-06-24",
  "trades": []
}
```

No trades planned. LRCX ATR gate failing (session 1 of 3; check close tonight). NVDA Annual Meeting intraday event — no scale-up. PWR deferred. All 4 positions: HOLD.

EXECUTED: 2026-06-24T13:36Z — no trades (plan empty: no qualified candidates; LRCX ATR gate failing session 1/3; NVDA Annual Meeting intraday event risk); shock check +USD204 (+0.21%) ✓; drawdown −2.49% ✓; stop audit 5/5 PASS; NVDA ⚠️ USD200.72 monitoring USD200 invalidation; 4 positions held.

---
## 2026-06-23 — Pre-market research (~08:03 ET)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓ — paper trading confirmed.

### Account snapshot (live Alpaca ~08:03 ET)

| Metric | Value |
|--------|-------|
| Equity | $98,743.65 |
| Cash | $67,261.73 (68.11%) |
| Long market value | $31,481.92 |
| Last equity (June 22 close) | $99,043.58 |
| Shock check | −$299.93 (−0.303%) — no shock ✓ (threshold −4%) |
| HWM | $101,384.21 |
| Drawdown | −2.60% — NOT triggered ✓ (circuit breaker at −10%) |

### Macro (pre-market June 23, 2026 ~08:03 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| S&P 500 futures | **−1.43%** | — | ⚠️ RISK-OFF — broad tech/chip selloff |
| 10yr Treasury yield | **~4.50%** | <4.75% | ✓ GATE PASSES — new buys permitted (if candidates qualify) |
| KOSPI (South Korea) | **−9.99%** — circuit breakers triggered | — | Samsung −12.31%, SK Hynix −12.47%; AI/chip profit-taking |
| SK Hynix HBM4 | Slowing expansion; reallocating to conventional DRAM | — | Minor near-term supply signal; not a fundamental AI demand break |
| PCE report | Expected this week | — | Monitoring for inflation/Fed read |
| Iran/US peace deal | 60-day agreement intact | Oil <$100 | ✓ WTI ~$80/bbl; geopolitical OK |

**Macro posture: RISK-OFF.** KOSPI −9.99% triggered circuit breakers — largest single-day drop in months. Samsung and SK Hynix each fell >12% on AI-chip profit-taking and SK Hynix re-allocating HBM4 resources to conventional DRAM. Contagion spreading to US tech pre-market with S&P futures −1.43%. This is a crowded-AI-trade unwind event, not a fundamental demand break. 10yr ~4.50% below the 4.75% gate; Iran deal intact. Cash cushion (68.1%) provides structural protection.

### Thesis contract review

**LLY** (10sh @ $1,093.534 — pre-mkt ~$1,109; +1.41% from entry)
- What changed since yesterday: Nothing material; Eli Lilly declared Q3 2026 dividend $1.73/sh (payable Sept 10); BioHeartland Indiana launch. Stock +0.63% pre-mkt vs $1,102.08 yesterday — defensive healthcare holding up well in risk-off tape.
- Buffer: $1,109 − $1,064.457 = $44.54 (4.01%) ✓
- **Medicare Bridge July 1 in 8 days** — explicit hold/trim/exit required at pre-market June 30.
- invalidation: closes below $1,064.46 (stop fires), or July 1 bridge pricing reveals margin deterioration.
- review_by: **2026-07-01** (8 days — bridge effective date)
- **Decision: HOLD. Conviction: A.**

**NVDA** (33sh @ $213.421 — pre-mkt ~$203.90; −4.46% from entry)
- What changed since yesterday: KOSPI −9.99% chip selloff drove NVDA −2.28% pre-mkt ($208.65 → $203.90). SK Hynix slowing HBM4 expansion — affects future Vera Rubin supply timeline but NOT current Blackwell (HBM3e) demand. NVDA Vera Rubin platform launched at ISC High Performance 2026. Analyst consensus PT $324.95, strongly bullish. August 26 earnings confirmed (64 days — well outside 2-day window ✓). NVDA thesis (AI accelerator monopoly, Helix consortium, hyperscaler demand) INTACT.
- Buffer: $203.90 − $192.591 = $11.31 (5.55%) ✓
- **WATCH: $200 invalidation level** (closes below $200 on volume = thesis break). Pre-mkt $203.90 above this.
- **WATCH: −7% midday rule at $198.48** — if NVDA is at/below $198.48 at midday, close the position.
- invalidation: closes below $200 on volume, or trailing stop dcba7429 fires.
- review_by: **2026-07-22** (29 days)
- **Decision: HOLD. Conviction: B (starter, monitoring $200 level). No proactive trim yet — buffer ($11.31) remains >2pp above the −7% threshold ($198.48).**

**V** (22sh @ $323.57 — pre-mkt ~$328.45; +1.51% from entry)
- What changed since yesterday: Nothing material. Visa stablecoin/OpenAI integration thesis unchanged. Stock +0.57% pre-mkt vs $326.60 close — defensive financials holding up in risk-off.
- Buffer: $328.45 − $303.138 = $25.31 (7.72%) ✓
- invalidation: cross-border growth turns negative, or major regulatory action on payment rails.
- review_by: **2026-07-28** (35 days — Q3 FY26 earnings)
- Conviction tracking: B — 0/3 weeks at C. No mandatory trim.
- **Decision: HOLD. Conviction: B.**

**VST** (40sh @ $148.81 — pre-mkt ~$160.95; +8.16% from entry)
- What changed since yesterday: No negative catalyst. Pure risk-off profit-taking after 11% June run. Stock −3.77% pre-mkt ($167.26 → $160.95). Wells Fargo Buy (June 18), Goldman Sachs Buy (June 16), Bernstein Outperform — all recent. Helix Digital Infrastructure (KKR+NVIDIA+Kuwait) and Cogentrix (5,500 MW) thesis INTACT. Record Q1 2026 adj. EBITDA $1.5B. Consensus PT ~$230 — 43% upside from $160.
- Buffer: $160.95 − $153.45 = $7.50 (4.66%) ✓
- invalidation: nuclear regulatory reversal, Helix consortium dissolved, or stop fires.
- review_by: **2026-07-07** (14 days)
- **Decision: STRONG HOLD. Conviction: A. Thesis most compelling — stop at $153.45 is structural protection.** ⭐⭐

### Earnings-window check
- LLY: Next earnings ~August 2026 — outside 2-day window ✓
- NVDA: August 26, 2026 (CONFIRMED) — 64 days ✓
- V: July 28, 2026 — 35 days ✓
- VST: Next earnings ~July 2026 — outside 2-day window ✓

**No earnings within 2 trading days — no mandatory hold/trim/exit decisions required today.**

### Stop audit (pre-market June 23 — confirmed via live Alpaca orders)

| Order ID | Symbol | Qty | HWM | Stop | Status |
|----------|--------|-----|-----|------|--------|
| d4147484 | LLY | 7sh | $1,182.73 | $1,064.457 | ✓ live (status: new) |
| 25989fb5 | LLY | 3sh | $1,182.73 | $1,064.457 | ✓ live (status: new) |
| dcba7429 | NVDA | 33sh | $213.99 | $192.591 | ✓ live (status: new) |
| 66033918 | V | 22sh | $336.82 | $303.138 | ✓ live (status: new) |
| c4c200a5 | VST | 40sh | $170.50 | $153.45 | ✓ live (status: new) |

**Stop audit: 5/5 PASS ✓** All stops confirmed active.

### Risk posture check

**Drawdown circuit breaker:**
- HWM $101,384.21 | Current equity $98,743.65 | Drawdown: **−2.60%** — NOT triggered (−10% threshold) ✓

**Sector exposure (pre-market June 23 — live data):**
- Healthcare (LLY): $11,090.00 = 11.23%
- Tech/AI Semi (NVDA): $6,728.70 = 6.82%
- Financials (V): $7,225.89 = 7.32%
- Energy/Utilities (VST): $6,437.99 = 6.52%
- Cash: $67,261.73 = 68.11%
- No sector above 60% cap ✓

### Watchlist / candidates

**LRCX — DEFERRED (ATR gate failing; chip selloff environment)**
- KOSPI −9.99% chip selloff will almost certainly drive LRCX ATR well above 3% today.
- Gate requires 3 consecutive sessions ≤3% ATR — reset to 0 sessions by today's action.
- Citi PT $450 thesis intact. Earliest entry: **week of June 29** (3 clear sessions needed).

**PWR — DEFERRED (ATR elevated + insider selling)**
- ATR elevated; insider selling $123M in 3 months remains an active flag.
- Re-evaluate week of June 29+.

**MRVL (Marvell) — WATCHLIST CANDIDATE (from lessons.md)**
- AGGRO's MRVL position (added June 15) up +5.90% in one week. Custom AI silicon for hyperscalers (ASICs for AWS/Google) — cost-optimization play distinct from GPU sellers.
- Not yet adding: risk-off session; need confirmed signal for 4th slot. Research when calmer.

### Cash-drag check
- Cash $67,261.73 = 68.11% — above 25–40% target band for >2 weeks.
- No qualified candidate meets all entry signals today (risk-off, LRCX/PWR ATR elevated, no new high-conviction entry).
- **Explicit justification for holding cash:** Broad market risk-off (S&P futures −1.43%, KOSPI chip contagion). Entry in this environment risks deploying into the teeth of a selloff. Waiting for calmer tape is correct. Cash is a position. ✓

### Performance vs SPY (pre-market June 23)
- Bull: $98,743.65 = **−1.257%** since inception (May 21, $100K start)
- SPY TR as of June 22 close: ($744.69 + $1.76 div) / $739.44 = **+0.948%** since inception
- With SPY futures −1.43% today: estimated SPY TR narrows, but Bull's 68% cash provides significant cushion
- **Bull TRAILS SPY ~2.21pp** (widened from −1.87pp at EOD June 22 due to pre-mkt NVDA/VST weakness)

---

No trades planned today.

Planned trades for today:

```json
{
  "plan_date": "2026-06-23",
  "trades": []
}
```

EXECUTED: 2026-06-23T13:37Z — no trades (plan empty: risk-off KOSPI chip selloff, no qualified candidates); stop audit 5/5 PASS; NVDA ⚠️ $202.05 monitoring $200 invalidation; 4 positions held.

---

## 2026-06-22 — Pre-market research (~08:02 ET)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓ — paper trading confirmed.

### Account snapshot (live Alpaca ~08:02 ET)

| Metric | Value |
|--------|-------|
| Equity | $99,057.63 |
| Cash | $74,304.63 (74.97%) |
| Long market value | ~$24,753 |
| Last equity (June 18/19 close) | $99,039.61 |
| Shock check | +$18.02 (+0.018%) — no shock ✓ |
| HWM | $101,384.21 |
| Drawdown | −2.295% — NOT triggered ✓ (circuit breaker at −10%) |

### Macro (pre-market June 22, 2026 ~08:02 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| S&P 500 futures | Flat to −0.1% | — | ✓ Neutral; no macro shock overnight |
| 10yr Treasury yield | **4.49%** (+5bp from June 18 close 4.44%) | <4.75% | ✓ GATE PASSES — new buys permitted |
| Iran/US peace deal | 60-day agreement signed at Versailles June 18–19 | Oil <$100 | ✓ WTI ~$80/bbl; constructive risk-on |
| FOMC | COMPLETED June 17 — rate hold 3.50–3.75%; hawkish dot plot | — | ✓ Resolved; 10yr gate manages ongoing risk |
| Micron (MU) | +4% pre-market on AI memory demand | — | ✓ Positive AI sector read-through for NVDA |

**Macro posture: MODERATELY CONSTRUCTIVE.** Iran deal signed, FOMC complete, 10yr 4.49% well below 4.75% trigger. Micron pre-market strength confirms AI memory demand — positive read-through for NVDA. Futures flat but no macro shock. All buy gates clear.

### Thesis contract review

**LLY** (10sh @ $1,093.534 — pre-mkt ~$1,100; +0.59% from entry)
- Buffer: ~$1,100 − $1,064.457 = ~$35.54 (3.23%) ✓
- TuneLab bone health Phase 2 data (positive pipeline signal). Cathie Wood / ARK added 41K shares — institutional confirmation.
- **Medicare Bridge effective July 1 in 9 days** — thesis contract requires explicit hold/trim/exit at pre-market June 30.
- invalidation: closes below $1,064 (stop fires), or July 1 bridge pricing reveals margin deterioration.
- review_by: **2026-07-01** (9 days — bridge effective date)
- **Decision: HOLD. Conviction: A.**

**V** (22sh @ $323.57 — pre-mkt ~$327.50; +1.215% from entry)
- Buffer: ~$327.50 − $303.138 = ~$24.36 (7.44%) ✓
- OpenAI agentic commerce integration: AI agent wallets confirmed on Visa rails for autonomous payments — incremental volume catalyst.
- Cross-border slowdown monitoring (not thesis-breaking at current magnitude).
- invalidation: cross-border growth turns negative, or major regulatory action on payment rails.
- review_by: **2026-07-28** (Q3 FY26 earnings — 36 days)
- Conviction tracking: B — 0/3 weeks rated C. No mandatory trim.
- **Decision: HOLD. Conviction: B (0/3 C-weeks).**

**VST** (40sh @ $148.81 — pre-mkt ~$163.70; +10.006% from entry)
- Buffer: ~$163.70 − $153.297 = ~$10.40 (6.36%) ✓
- **EX-DIVIDEND TODAY:** $0.229/sh × 40sh = USD 9.16 credit payable June 30. Stock may open ~$0.229 lower — normal ex-div; trailing stop ($153.297) tracks live trade prices, NOT adjusted for dividend gap.
- Cogentrix acquisition closed (5,500 MW natural gas). Helix consortium (KKR+NVIDIA+Kuwait) preferred power partner confirmed.
- PT upgrades: Morgan Stanley $212 (OW), Bernstein Outperform, Seaport $230.
- invalidation: nuclear regulatory reversal, Helix consortium dissolved, or stop fires.
- review_by: **2026-07-07** (15 days)
- **Decision: STRONG HOLD. Conviction: A. Thesis most compelling in portfolio.** ⭐⭐

### Monday conviction-weighted holding review (2026-06-22)

| Symbol | Rating | C-streak | Notes |
|--------|--------|----------|-------|
| LLY | **A** | N/A | Medicare Bridge July 1 in 9 days; ARK buying; buffer 3.23% — monitoring |
| V | **B** | 0/3 | +1.215%; AI payments integration catalyst; July 28 earnings gate |
| VST | **A** | N/A | Cogentrix + Helix; +10.01%; ex-div TODAY USD 9.16; PT $212–$230 ⭐⭐ |
| NVDA | _pending fill_ | N/A | Plan 33sh at open; starter B conviction post-fill |

No mandatory trims (no name at C for 3+ consecutive weeks). ✓

### Earnings-window check
- LLY: Next earnings ~August 2026 — outside 2-day window ✓
- V: Q3 FY26 earnings July 28 — 36 days ✓
- VST: Next earnings ~July 2026 — outside 2-day window ✓
- NVDA: Next earnings August 26 — 65 days ✓

### Watchlist / candidates

**NVDA — ALL GATES CLEARED ✓ — PLAN BUY 33sh AT MARKET OPEN**
- Pre-market ~$210.10 > $205 price gate ✓
- ATR June 17: 2.80% ≤3% ✓ | ATR June 18: 2.32% ≤3% ✓ (2-session avg 2.56%)
- Earnings Aug 26 (65 days — well outside 2-day window ✓)
- 5/5 entry signals met: (1) FY26 data center +92% YoY beat/raise ✓; (2) Helix consortium catalyst ✓; (3) PEG <2.5 ✓; (4) above 50-day MA ~$195 ✓; (5) macro tailwind AI capex ✓
- Risk-budget sizing: 33sh × ~$210 = ~$6,930 = 7.0% portfolio; 10% stop-out = ~$693 = 0.70% equity (< 1.2% budget ✓); 20% cap clear ✓
- Sector after buy: Tech / AI Semi ~7% — no sector above 60% cap ✓
- Daily deployment: $6,930 / $99,058 = 7.0% — within 25% daily cap ✓
- Week of June 22: 0/3 new position slots used — slot 1 = NVDA ✓

**LRCX — DEFERRED (ATR gate failing)**
- Pre-market June 22 ATR: ~6.93% — well above ≤3% gate ❌
- Citi PT $450 thesis intact. Earliest entry: week of June 29.

**PWR — DEFERRED (ATR elevated + insider selling)**
- ATR ~3.97% (June 18); insider selling $123M in 3 months — active flag.
- Price ~$702 pre-mkt June 22. Valid thesis; needs calmer setup. Re-evaluate week of June 29+.

### Cash-drag check
- Cash $74,304.63 = 74.97% — above 25–40% target band for >1 week.
- NVDA buy today deploys 7.0% → cash drops to ~68%. Slots 2-3 (LRCX/PWR) still gate-blocked.
- Decision justified: deploy NVDA today; hold remaining cash until LRCX/PWR gates clear. ✓

### Stop audit (pre-market June 22)

| Order ID | Symbol | Qty | HWM | Stop | Status |
|----------|--------|-----|-----|------|--------|
| d4147484 | LLY | 7sh | $1,182.73 | $1,064.457 | ✓ confirmed |
| 25989fb5 | LLY | 3sh | $1,182.73 | $1,064.457 | ✓ confirmed |
| 66033918 | V | 22sh | $336.8199 | $303.138 | ✓ confirmed |
| c4c200a5 | VST | 40sh | $170.33 | $153.297 | ✓ confirmed |

**Stop audit: 4/4 PASS ✓** All stops confirmed active. NVDA stop to be placed immediately after fill at open.

### Performance vs SPY (pre-market June 22)
- Bull: $99,057.63 = **−0.942%** since inception (May 21, $100K start)
- SPY total return since inception: +1.323% (June 18 close $747.47 + $1.76 div vs $739.44 anchor)
- SPY futures flat pre-mkt June 22 → total-return ~+1.32% est.
- **Bull TRAILS SPY ~2.26pp est**

### Week of June 22 — position slots
- **Slot 1:** NVDA — 33sh at market open TODAY ✓
- **Slot 2:** LRCX — pending ATR ≤3% for 3+ sessions (earliest week of June 29)
- **Slot 3:** PWR — pending ATR normalization + insider selling abates

---

Planned trades for today:

```json
{
  "plan_date": "2026-06-22",
  "trades": [
    {
      "action": "buy",
      "symbol": "NVDA",
      "qty": 33,
      "thesis": "AI accelerator monopoly; Helix consortium (KKR+NVIDIA+Kuwait) embeds GPU demand in AI infra platform; above USD 205 gate (pre-market USD 210.10); ATR 2.32-2.80% for 2 sessions; FY2026 data center revenue +92% YoY; 5/5 entry signals met",
      "invalidation": "closes below USD 200 (prior consolidation floor) on volume, or trailing stop fires at 10% below fill price",
      "review_by": "2026-07-22"
    }
  ]
}
```

EXECUTED: 2026-06-22T13:41:19Z — NVDA 33sh filled avg $213.42, trailing-stop dcba7429 (10%, HWM $213.60, stop $192.24) placed and confirmed.

---

## 2026-06-19 — Weekly review research (~16:30 ET)

_Web research for Week 5 (June 16–19, 2026) weekly review routine._

### S&P 500 weekly performance
- SPY Jun 12 close: $741.75. Jun 18 close: $746.75 (+0.674% price). Plus $1.76 dividend (ex-date Jun 18) = **+0.911% total return for the week.**
- Week dominated by FOMC hawkish surprise (June 17, SPY −1.44%) offset by Iran/US peace deal recovery (June 18, SPY +0.74%). Juneteenth holiday June 19. Only 3 active trading days.
- S&P 500 futures ~7,498 heading into June 22 — constructive. Year-to-date S&P 500 +5.7%.

### Macro drivers
- **FOMC June 16–17 confirmed hawkish:** Rate held 3.50–3.75%. Dot plot removed 2026 rate cut; 9/18 members project hike. Bond yields surged; 10yr fell back to 4.44% by June 18 close. Below 4.75% gate ✓.
- **Iran/US peace deal signed at Versailles June 18–19:** 60-day formal agreement to reopen Strait of Hormuz and halt conflict. WTI ~$80/bbl — below $100 trigger ✓. Constructive risk-on tone into June 22.
- **Intel/Apple chip deal (June 18):** Trump announced Intel to design/build chips stateside for Apple. INTC spiked on the news. Semiconductor sector risk-on alongside NVDA recovery to $210.38 June 18 close.
- **Juneteenth (June 19):** NYSE + bond market closed.

### LLY (held 10sh @ $1,093.53)
- Current: ~$1,098. Stock is down ~7% from its recent $1,160–$1,183 high-water mark area but well above trailing stop $1,064.46.
- Q1 2026 revenue $19.80B (+55.5% YoY). Mounjaro alone $8.66B. Full-year 2026 guidance raised to USD 82–85B.
- 4E Therapeutics acquisition closed (neuroscience/CNS/non-addictive pain pipeline diversification).
- Cathie Wood / ARK added 41,000 shares — institutional conviction signal.
- Medicare Bridge effective July 1 (12 days). Thesis fully intact. ✓

### V (held 22sh @ $323.57)
- Current: ~$327. June 19 range $326.86–$332.33.
- 36 analysts Strong Buy; avg PT $398.83 (+21.9% upside).
- OpenAI agentic payments partnership active. Stablecoin/token capabilities (Payments Forum confirmed).
- Cross-border transaction growth slowdown flagged in analyst notes (monitoring; EU regulatory risk). Not thesis-breaking.
- July 28 FY Q3 earnings is next key date. Thesis intact. ✓

### VST (held 40sh @ $148.81)
- Current: $163.75. Cogentrix acquisition CLOSED June 17 — 5,500 MW natural gas capacity added at $4.0B.
- Helix Digital Infrastructure: KKR + NVIDIA + Kuwait Investment Authority + VST — $10B+ AI hyperscaler power venture. VST preferred power partner confirmed.
- Dividend record date June 22 (ex-date), payable June 30: USD 0.2290/sh × 40sh = USD 9.16.
- Q1 2026 record adjusted EBITDA $1.5B. Investment-grade rating achieved.
- PT upgrades: Morgan Stanley $212 (Overweight), Bernstein Outperform initiated, Seaport $230 (from $227). Avg analyst PT $188.44.
- Thesis strongest of three positions. ✓ ⭐⭐

### Watchlist candidates
- **NVDA:** June 18 close $210.38 cleared $205 price gate. ATR 2.32% (Jun 18) / 2.80% (Jun 17) — both ≤3%. Plan: 33sh at market Monday June 22 (~$6,930 = 7.0% portfolio). Deutsche Bank PT $220. Helix thesis intact. 5/5 entry signals.
- **LRCX:** Citi raised PT to $450 from $315 (large upgrade). ATR still elevated (3.54% Jun 18 — improving from 6.19% Jun 17). Need 3 consecutive sessions ≤3%. Earliest entry: week of June 29.
- **PWR:** ATR 3.97% June 18 elevated. Stock pulled back −10.78% from peak after TD Cowen conference. Notable insider selling $123.2M in 3 months. P/E ~95 elevated. Valid long-term thesis but needs better setup. Re-evaluate week of June 22 for calmer conditions.
- **INTC:** Apple chip deal announced June 18. Potential turnaround catalyst. Still a structural turnaround — validating Apple contract durability before watchlist addition. Monitor.
- **YTD top performers (research context):** SNDK +172.8% (NAND shortage + AI), TPL +75.8% (AI infrastructure land), MRNA +68.6% (pipeline). All too extended or too speculative for current strategy.

---

## 2026-06-19 — Pre-market research (~08:03 ET) — JUNETEENTH HOLIDAY (market closed)

**Today is Friday June 19, 2026 — Juneteenth federal holiday. Market CLOSED. Next open: Monday June 22, 09:30 ET. Week of June 22 begins Monday with 3 fresh position slots.**

**⭐ KEY: NVDA price gate CLEARED (June 18 close $210.38 > $205). ATR June 18: 2.32%, June 17: 2.80% — both ≤3%. NVDA eligible for Monday open entry. Planned buy: 33 shares ~$210 (~7.0% portfolio).**

---

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓ — paper trading confirmed.

---

### Macro (pre-market June 19, 2026 ~08:03 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| Market | **CLOSED — Juneteenth holiday (June 19, 2026)** | — | Next open June 22 |
| 10yr Treasury yield | **4.44%** (June 18 close per Fed H.15; fell from 4.49% post-FOMC) | <4.75% | ✓ GATE PASSES — below trigger |
| S&P 500 futures | **~7,498** (futures constructive heading into June 22) | — | ✓ Constructive; broad risk-on tone |
| FOMC | COMPLETED June 17 — rate hold 3.50–3.75%; hawkish dot plot (9/18 project hike) | — | ✓ Done; 10yr monitored |
| Iran/US peace deal | Signed at Versailles June 18 (formal agreement) | Oil <$100 | ✓ Constructive for equities |
| SPY ex-dividend | June 18 — $1.76/sh applied; total-return anchor $741.20 | — | ✓ Already updated |
| Juneteenth | Federal holiday; NYSE + bond market closed June 19 | — | Routine proceeds; plan for Monday |

**Macro posture: MODERATELY CONSTRUCTIVE heading into June 22.** Peace deal signed, FOMC completed, 10yr falling (4.44% — below 4.75% trigger). SPY futures constructive. All macro gates clear for Monday buys. FOMC overhang is resolved; only ongoing risk is hawkish dot-plot implication for rate path in H2 2026, which the 10yr gate at 4.75% manages.

---

### Account (pre-market June 19 — live Alpaca data ~08:03 ET)

| Metric | Value |
|--------|-------|
| Equity | $99,039.61 |
| Cash | $74,304.63 (74.97%) |
| Long market value | $24,734.98 |
| Last equity | $99,039.61 (EOD June 18 — market closed) |
| Buying power | ~$366,476 |

**Shock check:** Market closed (Juneteenth); equity = last_equity = $99,039.61 — no intraday movement. N/A.
**Drawdown circuit breaker:** HWM $101,384.21; current $99,039.61 = **−2.31%** — within −10% limit ✓ NOT triggered.

---

### Trailing stop audit (pre-market June 19 — confirmed via Alpaca open orders)

| Order ID | Symbol | Qty | HWM | Stop | Status |
|----------|--------|-----|-----|------|--------|
| d4147484 | LLY | 7sh | $1,182.73 | $1,064.457 | ✓ new — unchanged |
| 25989fb5 | LLY | 3sh | $1,182.73 | $1,064.457 | ✓ new — unchanged |
| 66033918 | V | 22sh | $336.8199 | $303.138 | ✓ new — unchanged |
| c4c200a5 | VST | 40sh | $170.33 | $153.297 | ✓ new — unchanged |

**Stop audit: 4/4 PASS ✓** All confirmed active, no changes since June 18 EOD.

---

### Open positions (pre-market June 19 — live Alpaca data, reflecting June 18 closing prices)

| Symbol | Qty | Avg Entry | June 18 Close | Mkt Value | Unrealized P/L | % of Portfolio |
|--------|-----|-----------|--------------|-----------|----------------|----------------|
| LLY | 10 | $1,093.534 | $1,098.57 | $10,985.70 | +$50.36 (+0.46%) | 11.09% |
| V | 22 | $323.57 | $327.24 | $7,199.28 | +$80.74 (+1.13%) | 7.27% |
| VST | 40 | $148.81 | $163.75 | $6,550.00 | +$597.60 (+10.04%) | 6.61% |

**Note:** VST last close $163.75 vs June 18 EOD session price $164.00 — minor end-of-day reconciliation. Stop HWM $170.33 and stop $153.297 unchanged.

---

### Sector exposure (pre-market June 19)
- Healthcare (LLY): $10,985.70 = 11.09%
- Financials (V): $7,199.28 = 7.27%
- Energy/Utilities (VST): $6,550.00 = 6.61%
- Cash: $74,304.63 = 74.97%
- No sector above 60% cap ✓

---

### Step 3b: Thesis contract review (June 19)

**LLY:**
- Invalidation: stop fires ($1,064.457) or Medicare Bridge reversed
- review_by: **July 1 — 12 DAYS AWAY** (approaching — explicit decision required at pre-market June 30)
- Current $1,098.57 >> stop $1,064.457 (buffer $34.11 = 3.11%). Buffer has narrowed on recent pullback. Monitor.
- News: 4E Therapeutics acquisition (June 16 — neuroscience/non-addictive painkillers). Retatrutide trial completed. Cathie Wood (ARK) purchased 41,000 shares — positive institutional sentiment signal. Germany investment reduction noted. No negative GLP-1 catalysts.
- **What changed since yesterday:** Cathie Wood/ARK added 41K shares — positive sentiment. No negative catalyst.
- **Decision: HOLD. Medicare Bridge July 1 in 12 days — this is the primary catalyst. Thesis intact. Explicit hold/trim/exit decision required at pre-market June 30.**

**V:**
- Invalidation: stop fires ($303.138) or regulatory mandate forces open access
- review_by: July 28 (39 days)
- Current $327.24 >> stop $303.138 (buffer $24.10 = 7.37%)
- News: OpenAI/agentic payments, stablecoin/token capabilities (Payments Forum). 36 analysts Strong Buy, avg PT $398.83 (21.9% upside). Cross-border slowdown noted (monitoring; not thesis-breaking). July 28 earnings upcoming.
- **What changed since yesterday:** No material new catalysts over the holiday. Thesis intact.
- **Decision: HOLD. July 28 earnings is next gate. Thesis intact.**

**VST:** ⭐⭐
- Invalidation: stop fires ($153.297) or WTI >$100 or FCF guidance cut or Helix cancellation
- review_by: July 7 (18 days)
- Current $163.75 >> stop $153.297 (buffer $10.45 = 6.38%)
- News: Cogentrix acquisition complete (5,500 MW, $4.0B). Helix Digital Infrastructure (KKR+NVIDIA+Kuwait) intact. Morgan Stanley raised PT to $212 (from $208), Overweight. Avg analyst PT $188.44. **DIVIDEND EX-DATE MONDAY JUNE 22** — $0.229/sh × 40sh = USD 9.16; payment date June 30.
- **What changed since yesterday:** VST thesis continues to strengthen. Peace deal formally signed — constructive energy backdrop. Analyst PT raised.
- **Decision: STRONG HOLD. Dividend ex-date Monday — market-open routine must confirm $9.16 credit timing (appears in account June 30 on payment date). Position buffer 6.38% — adequate but watch VST price at Monday open for stop ratchet potential.**

---

### Step 3c: Monday conviction-weighted holding review (REQUIRED — June 22 is Monday, this is the Friday preview)

Effective Monday June 22:

| Symbol | Rating | Rationale | 3-C-counter |
|--------|--------|-----------|-------------|
| LLY | **A** | Medicare Bridge July 1 in 12 days; thesis intact; Cathie Wood buying; stop buffer 3.11% (narrowed — worth monitoring) | N/A |
| V | **B** | Working but flat (1.13% from entry); thesis intact; cross-border slowdown monitoring; no C flag | 0/3 weeks C |
| VST | **A** | Cogentrix + Helix; +10.04% from entry; dividend Monday; analyst PT upgrades | N/A |

No position rated C. No mandatory trims. V continues B — tracking toward July 28 earnings catalyst.

---

### Earnings window check (June 19)

| Symbol | Next Earnings | Days Away | Window? |
|--------|---------------|-----------|---------|
| LLY (held) | ~Aug 6, 2026 | 48 | NO ✓ |
| V (held) | Jul 28, 2026 | 39 | NO ✓ |
| VST (held) | ~Aug 6, 2026 | 48 | NO ✓ |
| NVDA (buy candidate) | Aug 26, 2026 | 68 | NO ✓ |
| PWR (watch) | Jul 30, 2026 | 41 | NO ✓ |
| LRCX (watch) | Aug 5, 2026 | 47 | NO ✓ |

No earnings windows triggered. All clear for Monday entry. ✓

---

### Watchlist evaluation

**NVDA ($210.38 June 18 close; AH ~$209.97):** ⭐ **PRIORITY BUY FOR MONDAY**
- **Price gate:** June 18 close $210.38 — **PASSES** (above $205 threshold ✓). After failing the gate in the June 18 pre-market ($204.70 June 17 close), NVDA rallied convincingly on June 18.
- **ATR check:**
  - June 17: H=209.20, L=203.47, C=204.70 → Range 5.73, ATR% = 2.80% ✓
  - June 18: H=211.39, L=206.50, C=210.38 → Range 4.89, ATR% = 2.32% ✓
  - 2-session average ATR: **2.56% ≤ 3%** ✓ (both sessions qualify individually)
- **News:** $25B multi-tranche debt offering completed June 18 (large but signals confidence in growth capex). SLB partnership deepened. NVDA Ecosystem ETF debuted. Helix Digital Infrastructure (KKR+NVIDIA+Kuwait) thesis intact. Deutsche Bank PT raised to $220.
- **Earnings window:** Aug 26, 68 days ✓.
- **Thesis:** AI accelerator monopoly; Helix consortium embeds GPU demand in AI infrastructure platform; FY2026 data center revenue +92% YoY; 62 analysts Strong Buy; avg PT $298.93 (+42% upside from $210).
- **Entry signals (3+ required):** Earnings momentum ✓ (Q1 FY27 blowout); Catalyst ✓ (Helix, AI infrastructure cycle); Valuation OK (premium but monopoly justified); Technical ✓ (above $205 base, ATR normalizing); Macro tailwind ✓ (AI capex continues). **5/5 signals.**
- **Sizing:**
  - Risk budget: 1.2% × $99,039 = $1,188 loss max
  - 10% trailing stop → max position $11,880; NVDA at ~$210 → 56 shares max by risk budget
  - Starter conviction (7%): 7% × $99,039 = $6,933 / $210 = **33 shares = $6,930 = 7.0% of portfolio** ✓
  - Risk at 33sh: 33 × $210 × 10% = $693 = 0.70% of equity ✓ (well within 1.2% budget)
  - 20% cap: 20% × $99,039 = $19,808 / $210 = 94sh — far from cap ✓
  - Post-trade cash: $74,304 − $6,930 = $67,374 = **68%** (well above 5% minimum ✓)
  - Post-trade total deployment: 7.0% ≤ 25% daily cap ✓
- **ATR volatility check (playbook step 7):** 2-session avg ATR 2.56% — below 3% threshold. Full size appropriate. No halving required.
- **Decision: PLAN BUY Monday June 22 open — 33 shares NVDA at market (~$210). Place 10% trailing stop immediately after fill.**

**LRCX ($388.86 June 18 close):** DEFERRED — ATR 3.54% (June 18) ❌
- June 17 ATR 6.19%, June 18 ATR 3.54% — both above 3%. Improving but still disqualified.
- Citi raised PT to $450 (from $315) — significant upgrade. Thesis intact.
- Need 3 consecutive sessions at ≤3%. Earliest possible entry: week of June 29 if ATR normalizes.
- **Decision: NO BUY. Re-evaluate each pre-market next week if ATR drops to ≤3%.**

**PWR ($702.54 June 18 close):** DEFERRED — ATR 3.97% (June 18) ❌
- June 17 ATR 2.28%, June 18 ATR 3.97% — elevated on June 18 (down −1.71% on day after conference).
- Insider selling $123.2M in 3 months (worth monitoring as a caution flag). P/E ~95 is elevated.
- 30-day pullback −10.78% from peak — stock is in a correction from conference highs.
- **Decision: NO BUY. ATR elevated; stock in pullback; insider selling notable. Re-evaluate when ATR calms and stock stabilizes above support. PWR remains a valid thesis but needs better entry setup.**

---

### Cash-drag check
Cash: 74.97% — significantly above 25–40% target. Week of June 22 is the first week with a clear, qualified entry (NVDA). Planning 1 position = ~7% deployment. Still heavy in cash but deploying into the highest-conviction qualified name. NVDA is not a forced entry — it satisfies all 5 entry criteria. Holding the remaining 2 slots for LRCX (when ATR qualifies) and PWR (when ATR/setup calms). Cash deployment is progressing; not rushing.

---

### VST dividend note (CRITICAL for market-open June 22)
VST ex-dividend date: **Monday June 22, 2026**. Market-open routine must:
1. Note the ex-dividend price adjustment (~$0.229/sh drop in open price — VST may open slightly lower than June 18 close $163.75)
2. The trailing stop (HWM $170.33, stop $153.297) remains unchanged through ex-dividend — stop protects against downside regardless of dividend adjustment
3. Dividend payment (USD $9.16 for 40sh) credited to account on **June 30** (payment date)
4. Stop audit: confirm c4c200a5 remains active after ex-dividend open

---

### Performance vs S&P 500 (pre-market June 19)

| Period | Bull | SPY | Difference |
|--------|------|-----|------------|
| Inception (2026-05-21) | $99,039.61 = **−0.960%** | $741.20 anchor + ~$6.27 est. Jun 22+ = **+1.323% total-return** | **Bull TRAILS SPY ~2.28pp** |

_Note: SPY last close June 18 was $747.47. Total return anchor $741.20. Gap unchanged from EOD June 18 (−2.25pp) as market is closed today._

---

### Planned trades for Monday June 22, 2026

**Priority 1: NVDA — BUY 33 shares at market open Monday June 22**

All entry gates pass:
- Price: $210.38 close June 18 > $205 threshold ✓
- ATR: 2.32% (June 18) and 2.80% (June 17) — both ≤3% ✓
- Earnings: Aug 26, 68 days ✓
- Entry signals: 5/5 ✓
- Risk budget: $693 = 0.70% of equity ✓
- No macro gates blocking (10yr 4.44% < 4.75% ✓; FOMC done ✓)
- VST dividend ex-date June 22: does not conflict with NVDA entry

**Other candidates:** LRCX deferred (ATR 3.54%), PWR deferred (ATR 3.97%, insider selling, pullback).

```json
{
  "plan_date": "2026-06-22",
  "trades": [
    {
      "action": "buy",
      "symbol": "NVDA",
      "qty": 33,
      "thesis": "AI accelerator monopoly; Helix consortium (KKR+NVIDIA+Kuwait) embeds GPU demand in AI infra platform; closed convincingly above $205 gate (June 18 close $210.38) with ATR 2.32-2.80% for 2 sessions; FY2026 data center revenue +92% YoY; 5/5 entry signals met",
      "invalidation": "closes below $200 (prior consolidation floor) on volume, or trailing stop fires at 10% below fill price",
      "review_by": "2026-07-22"
    }
  ]
}
```

---

### Upcoming catalysts (updated June 19)
- **VST dividend ex-date MONDAY June 22** (USD 9.16 credit for 40sh; payment June 30)
- **LLY Medicare GLP-1 Bridge effective July 1** (12 days — explicit hold/trim/exit decision required at pre-market June 30)
- **VST thesis review_by July 7** (18 days)
- **V Q3 FY26 earnings July 28** (39 days — thesis review_by date)
- **NVDA thesis review_by July 22** (33 days — if buy executes Monday)
- **PWR next earnings July 30** (41 days)
- **LRCX next earnings ~Aug 5** (47 days)

---

## 2026-06-18 — Pre-market research (~08:03 ET)

**Today is Thursday June 18. Week of June 16: 0/3 new positions used. Post-FOMC gate LIFTED. SPY ex-dividend TODAY ($1.76/sh) — anchor updates to $741.20. 10yr at 4.49% — BELOW 4.75% gate — new buys permitted if individual candidate gates clear.**

---

### Macro (pre-market June 18, 2026 ~08:03 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| 10yr Treasury yield | **4.49%** (June 17 close; Alpaca/search confirmed) | <4.75% | ✓ GATE PASSES — new buys permitted |
| S&P 500 futures | **+0.87%** (pre-market rebound after digesting hawkish FOMC) | — | Constructive |
| FOMC | **COMPLETED June 17** — rate hold 3.50–3.75%; dot plot hawkish (median 3.8% year-end, up from 3.4%) | — | ✓ Done; 10yr gate operative |
| SPY ex-dividend | **TODAY June 18 — $1.76/sh** — total-return anchor updates: $739.44 → **$741.20** | — | Benchmark update applied |
| Iran/US peace deal | Continuing; WTI ~$80/bbl | Oil <$100 | ✓ |
| Import prices May | +1.9% (fuel/lubricants +12.5%), export prices +1.3% — 6th straight monthly rise | — | Note: mild inflationary pressure; 10yr held below trigger |
| SPY pre-market | **$744.55** (Alpaca latest trade 08:03 ET, up from $741.02 June 17 Alpaca daily close) | — | +0.48% from close |

**Macro posture: MODERATELY CONSTRUCTIVE.** 10yr gate passes at 4.49%. Hawkish dot plot is a known risk for high-multiple names but has not pushed 10yr above the trigger. Continued discipline required on entries. Rebound today consistent with post-FOMC digestion.

---

### Account (pre-market June 18 — live Alpaca data ~08:03 ET)

| Metric | Value |
|--------|-------|
| Equity | $99,128.29 |
| Cash | $74,304.63 (74.96%) |
| Long market value | $24,823.66 |
| Last equity (June 17 close) | $99,151.19 |
| Buying power | ~$366,725 |

**Intraday shock check:** $99,128.29 vs last_equity $99,151.19 = −$22.90 = −0.023% — no shock ✓  
**Drawdown circuit breaker:** HWM $101,384.21; current $99,128.29 = −2.22% — within −10% limit ✓ NOT triggered.

---

### Trailing stop audit (pre-market June 18 — confirmed via Alpaca open orders)

| Order ID | Symbol | Qty | HWM | Stop | Status |
|----------|--------|-----|-----|------|--------|
| d4147484 | LLY | 7sh | $1,182.73 | $1,064.457 | ✓ new — unchanged |
| 25989fb5 | LLY | 3sh | $1,182.73 | $1,064.457 | ✓ new — unchanged |
| 66033918 | V | 22sh | **$336.8199** ⬆️ RATCHETED | $303.138 | ✓ new — HWM hit $336.82 during June 17 session (daily high $336.75) |
| c4c200a5 | VST | 40sh | $162.44 | $146.196 | ✓ new — unchanged |

**Stop audit: 4/4 PASS ✓** V ratcheted to new HWM $336.82 yesterday.

---

### Held positions (pre-market June 18)

**LLY ($1,112.73 pre-mkt, +0.073% vs $1,112 lastday, +1.755% from avg entry $1,093.534):**
- **What changed since yesterday:** 4E Therapeutics acquisition announced — Austin-based neuroscience company developing non-addictive painkillers. Pipeline diversification into chronic pain beyond GLP-1. Modest positive.
- Medicare Bridge July 1 in **13 days** — thesis catalyst approaching.
- TRIUMPH-1 Phase 3 retatrutide data (28.3% weight loss at 80 weeks, bariatric-surgery equivalent) — unchanged, strongest pipeline data point in portfolio.
- Earnings window: Next Q2 earnings ~Aug 6 — 49 days ✓.
- Thesis contract: invalidation = stop fires ($1,064.457). review_by = July 1. **INTACT.**
- Stop buffer: $1,112.73 − $1,064.457 = $48.27 (4.34%) ✓; −7% threshold $1,017.00 — clear by $95.73 ✓
- **Decision: HOLD.**

**V ($330.00 pre-mkt, −0.115% vs $330.38 lastday, +1.987% from avg entry $323.57):**
- **What changed since yesterday:** No material new catalysts overnight. OpenAI/agentic commerce partnership active. Mintoak merchant partnership announced. Analyst note flagging slowing cross-border payments volume — worth monitoring; not thesis-breaking (core domestic payments still strong).
- V hit HWM $336.82 intraday June 17 (stop ratcheted). Pre-market soft but within noise.
- Earnings window: July 28 — 40 days ✓.
- Thesis contract: invalidation = stop fires ($303.138). review_by = July 28. **INTACT.**
- Stop buffer: $330.00 − $303.138 = $26.86 (8.14%) ✓; −7% threshold $300.92 — clear by $29.08 ✓
- **Decision: HOLD.**

**VST ($160.909 pre-mkt, +1.309% vs $158.83 lastday, +8.131% from avg entry $148.81):** ⭐⭐ HELIX — MATERIALLY STRENGTHENED
- **What changed since yesterday:** Cogentrix acquisition CLOSED in June 2026 — Vistra added 5,500 MW of modern natural gas capacity ($4.0B net: $2.3B cash + $0.9B stock + $1.5B debt). Announced Dec 31 2025, regulatory approvals cleared, closed on schedule. This dramatically expands VST's generation portfolio for AI hyperscaler power demand. Morgan Stanley and JPMorgan reiterate Overweight, raised PTs. Avg analyst PT $225.29 (+40% upside from current $160.91).
- Dividend ex-date June 22 in **4 days** — USD 9.16 credit ($0.229/sh × 40sh).
- Helix Digital Infrastructure (KKR+NVIDIA+Kuwait, $10B+ AI infra platform) — VST preferred power provider.
- Earnings window: Q2 earnings ~Aug 6 — 49 days ✓.
- Thesis contract: invalidation = stop fires ($146.196). review_by = July 7. **INTACT and STRENGTHENED.**
- Stop buffer: $160.909 − $146.196 = $14.71 (9.14%) ✓; −7% threshold $138.39 — clear by $22.52 ✓
- **Decision: STRONG HOLD. Cogentrix completion is the single most positive thesis development since Helix announcement. Pre-market up +1.31% while SPY only +0.48% — relative outperformance. Conviction highest since entry.**

---

### Earnings window check

| Symbol | Next Earnings | Days Away | Window? |
|--------|---------------|-----------|---------|
| LLY (held) | ~Aug 6, 2026 | 49 | NO ✓ |
| V (held) | Jul 28, 2026 | 40 | NO ✓ |
| VST (held) | ~Aug 6, 2026 | 49 | NO ✓ |
| NVDA (watch) | Aug 26, 2026 | 69 | NO ✓ |
| PWR (watch) | Jul 30, 2026 | 42 | NO ✓ |

No earnings windows triggered. All clear.

---

### Watchlist evaluation

**NVDA ($204.70 close June 17; pre-market ~$202–205):**
- Entry gate: "basing above $205 with ATR ≤3%"
- ATR check (2-day sample): June 17 range $203.47–$209.20 = $5.73, close $204.70 → ATR% = 2.80% ≤3% ✓
- **Price gate: FAILS** — June 17 close $204.70 is $0.30 below $205. Pre-market reportedly as low as $202.17. Stock is NOT basing above $205; it is drifting through it.
- Next earnings Aug 26 (69 days) ✓. No earnings window.
- **Decision: NO BUY. Price gate fails. Need NVDA to close convincingly above $205 and hold for 1+ session before entry is valid. Re-evaluate June 19+ if stock re-establishes above $205.**

**LRCX ($374.40 close June 17; pre-market reportedly ~$392):**
- ATR check: June 17 range $373.86–$397.05 = $23.19, close $374.40 → ATR% = **6.19% — DISQUALIFIED (>3%).**
- June 16 ATR: range $368.82–$392.825 = $24.005, close $369.37 → ATR% = **6.50%.**
- Pre-market gap to $392 (+4.7%) suggests intraday volatility will remain elevated today.
- **Decision: NO BUY. ATR ~6% — well above 3% gate. Must see ≤3% for 3+ consecutive sessions before entry. Not a near-term candidate.**

**PWR ($714.75 close June 17; pre-market ~$728):**
- ATR check: June 17 range $708.36–$724.69 = $16.33, close $714.75 → ATR% = 2.28% ✓
- June 16 ATR: range $719.34–$737.88 = $18.54, close $719.34 → ATR% = 2.58% ✓
- ATR PASSES. Next earnings July 30 (42 days) ✓.
- TD Cowen conference: **June 17 (YESTERDAY)** — condition "post-conference volatility settled" not yet met. Pre-market up $8.71 (+1.2%) = still in conference momentum window.
- Entry signals review: Earnings momentum ✓ (Q1 EPS +31.4%, rev +26.3%); Catalyst ✓ (AI grid/power demand, $4.7B backlog expansion); Valuation likely ✓ (PEG ~1.67 at 30%+ growth / ~50x P/E); Technical uncertain (need 50-day MA position); Macro tailwind ✓ — 3+ signals likely met.
- **Decision: NO BUY TODAY. Conference was yesterday; price still in conference-momentum window. Re-evaluate June 19+ once 1–2 sessions of stable price action confirm the post-conference base. PWR is the priority entry if NVDA fails to reclaim $205.**

---

### Cash-drag check
Cash: 74.96% — significantly above 25–40% target band. Week slots: 0/3 used. Tape is constructive (+0.87%). **Explicit reasoning for no entry today:** All three primary candidates fail specific gates: (1) NVDA below $205 price threshold; (2) LRCX ATR 6.2% — disqualified; (3) PWR conference ended yesterday — price not yet settled. Staying in cash today is the correct outcome — not a passive default. All gates are documented. NVDA and PWR are positioned for June 19+ entry once conditions normalize. Deploying into failing gates guarantees compressed stop buffers and suboptimal fills.

---

### Planned trades for today

No trades planned — all candidates fail entry gates today.

```json
{
  "plan_date": "2026-06-18",
  "trades": []
}
```

EXECUTED: 2026-06-18T09:36 ET — no trades placed; all candidate gates failed (NVDA below $205, LRCX ATR 6.2%, PWR post-conference); stop audit 4/4 PASS; VST stop ratcheted to HWM $164.1075.

---

## 2026-06-17 — Pre-market research (~08:03 ET)

**Today is Wednesday June 17. Week of June 16: 0/3 new positions used. FOMC ANNOUNCEMENT TODAY at 2 PM ET (⚠️ MEMORY CORRECTION: prior entries said "June 18" — June 17 IS Wednesday, announcement is TODAY). Gate lifts at 2 PM ET today. No new positions before then.**

---

### Macro (pre-market June 17, 2026 ~08:03 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| S&P 500 futures / SPY pre-mkt | **+0.28%** (modestly higher ahead of FOMC decision) | — | ✓ Constructive; awaiting FOMC |
| FOMC June 16–17 | **DAY 2 — announcement TODAY 2 PM ET** (Kevin Warsh's first meeting; rate hold 97% probability; CME FedWatch 0.6% implied hike probability) | Announcement TODAY June 17 2 PM ET | ⚠️ GATE ACTIVE until 2 PM ET today |
| Dot plot (SEP) | Expected to eliminate single projected cut; up to 3 FOMC members may project rate hikes; Warsh may withhold his own dot (opposed to forward guidance) | 10yr <4.75% | ⚠️ Key risk at 2 PM ET — watch 10yr |
| 10yr Treasury yield | ~4.47% (June 16 est.) | <4.75% | ✓ Below trigger — watch post-dot-plot |
| Iran/US peace deal | Still advancing; WTI ~$80/bbl; Strait of Hormuz reopening | Oil <$100 | ✓ Constructive |
| SPY pre-market | $750.61 (latest trade 08:01 AM ET; vs June 16 Alpaca close $750.58) | — | ~flat overnight |
| SPY yesterday close | $750.58 (Alpaca daily bar, June 16) | — | Note: post-FOMC SPY direction key |

**⚠️ MEMORY CORRECTION (material):** All prior memory files stated "FOMC announcement Wednesday June 18 2 PM ET." This is wrong — June 17 IS Wednesday (June 18 is Thursday). The announcement is TODAY June 17 at 2:00 PM ET; Warsh press conference 2:30 PM ET. Correcting this record. Gate lifts TODAY at 2 PM ET, not tomorrow.

**SPY ex-dividend TOMORROW June 18 (Thursday):** $1.76/sh. After June 18, SPY total-return anchor adjusts: $739.44 + $1.76 = $741.20 (effective anchor for post-June 18 benchmarking). This will narrow the reported gap by ~0.238pp.

**Macro posture: CAUTIOUS HOLD, FOMC ANNOUNCEMENT IMMINENT.** Futures modestly higher (+0.28%) as market expects a neutral rate hold but watches Warsh's dot plot and press conference closely. Warsh is known to oppose forward guidance — he may withhold his own dot entirely, reducing Fed predictability. Risk is hawkish surprise (dot plot shifts to no cuts + multiple hike signals). 10yr yield at ~4.47% below the 4.75% halt trigger for now. **Hard gate: NO new positions before 2 PM ET today (FOMC announcement).**

---

### Account (pre-market June 17, 2026 — live Alpaca data ~08:03 ET)

| Metric | Value |
|--------|-------|
| Equity | $99,212.67 |
| Cash | $74,304.63 (74.89%) |
| Long market value | $24,908.04 |
| Last equity (June 16 close) | $99,202.67 |
| Buying power | ~$366,961 |

**Intraday shock check:** $99,212.67 vs last_equity $99,202.67 = **+$10.00 = +0.010%** — POSITIVE (slight overnight mark-up). No shock. ✓

**Drawdown circuit breaker:** HWM $101,384.21 (confirmed from equity history); current $99,212.67 = **−2.141%** — well within −10% limit. ✓ FOMC gate is the operative constraint.

---

### Trailing stop audit (pre-market June 17 — confirmed via Alpaca open orders)

| Order ID | Symbol | Qty | HWM | Stop | vs Last | Status |
|----------|--------|-----|-----|------|---------|--------|
| d4147484 | LLY | 7sh | $1,182.73 | $1,064.457 | Unchanged | ✓ new |
| 25989fb5 | LLY | 3sh | $1,182.73 | $1,064.457 | Unchanged | ✓ new |
| 66033918 | V | 22sh | $333.08 | $299.772 | Unchanged (V pre-mkt $332.52 < HWM $333.08) | ✓ new |
| c4c200a5 | VST | 40sh | $161.48 | $145.332 | Unchanged (VST pre-mkt $160.05 < HWM $161.48) | ✓ new |

Stop audit: **4/4 confirmed active ✓** No ratchets in pre-market (all positions below respective HWMs).

---

### Held positions (pre-market June 17, 2026 — live Alpaca prices)

**LLY ($1,119.06 pre-mkt, −0.31% today from $1,122.50 June 16 close, +2.33% from avg entry $1,093.534):** ⭐ STRONG
- **What changed since yesterday:** Phase 3 TRIUMPH-1 retatrutide trial data: average weight loss 28.3% of body weight (70.3 lbs) over 80 weeks — comparable to bariatric surgery outcomes. Barclays Buy rating June 15 confirmed. AJX-101 Phase 1 data June 14 (pipeline diversification). Q1 2026 EPS $8.55 beat estimates by 24.82%. Medicare GLP-1 Bridge effective July 1 in **14 days** — thesis catalyst approaching. No negative catalysts.
- **Earnings window:** Next earnings August 6, 2026 — 50 days away ✓ (well outside 2-day window)
- **Thesis contract:** invalidation = stop fires ($1,064.457) or Medicare Bridge reversed. review_by = July 1 (14 days). Current $1,119.06 >> $1,064.457. **THESIS INTACT.** ✓
- **Stop buffer:** $1,119.06 − $1,064.457 = **$54.60 (4.88%)** ✓ Adequate (LLY currently below HWM $1,182.73, so stop remains at $1,064.457).
- **Decision: HOLD. TRIUMPH-1 data reinforces GLP-1 leadership. Medicare Bridge 14 days away. Thesis strongest in portfolio.**

**V ($332.52 pre-mkt, −0.18% today from $333.12 June 16 close, +2.77% from avg entry $323.57):** ✓ INTACT
- **What changed since yesterday:** No material new catalysts overnight. Visa-OpenAI integration announced June 10 (AI agent-driven transactions). AI/stablecoin capabilities at Payments Forum confirmed. Mild pre-market weakness consistent with FOMC-day caution on financials. Stock trading at $332.52 — analysts see 24.6% undervaluation, avg PT $398.83.
- **Earnings window:** Next earnings July 28, 2026 — 41 days away ✓
- **Thesis contract:** invalidation = trailing stop fires ($299.772) or regulatory mandate forces open access. review_by = July 28. Current $332.52 >> $299.772. **THESIS INTACT.** ✓
- **Stop buffer:** $332.52 − $299.772 = **$32.75 (9.85%)** ✓ Healthy. Note: V is near HWM $333.08 — if it trades above $333.08 today, stop ratchets.
- **Decision: HOLD. Flat performance in pre-market; FOMC-day caution on financials is temporary. OpenAI integration is direct thesis confirmation. Near HWM — watch for ratchet.**

**VST ($160.05 pre-mkt, +0.91% today from $158.61 June 16 close, +7.55% from avg entry $148.81):** ⭐⭐ HELIX — STRONG
- **What changed since yesterday:** Helix Digital Infrastructure (KKR+NVIDIA+Kuwait) thesis intact and strengthening. Vistra +12.3% in past month driven by AI power demand. Dividend ex-date **June 22 in 5 days** ($0.229/sh × 40sh = USD 9.16 credit). Quarterly dividend declared: $0.2290/sh payable June 30. Analyst avg PT $188.44. PJM capacity auction results were positive (VST announced strong results). No negative catalysts.
- **Earnings window:** Next earnings August 6, 2026 — 50 days away ✓
- **Thesis contract:** invalidation = WTI >$100 (NO — ~$80 ✓), FCF guidance cut (NO ✓), PPA/Helix cancellation (NO — Helix strengthening ✓), breaks $130 on volume (NO — $160.05 ✓). review_by = July 7 (20 days). **THESIS INTACT AND STRENGTHENED.** ✓
- **Stop buffer:** $160.05 − $145.332 = **$14.72 (9.19%)** ✓ Strong — near-full 10% trailing protection. VST trading below HWM $161.48; if it trades above $161.48 today, stop ratchets.
- **Decision: HOLD. Dividend ex-date June 22 in 5 days. Helix thesis is the strongest fundamental upgrade in portfolio. PJM auction results positive.**

---

### Thesis contract review (June 17)

- **LLY:** ✅ Intact. Stop $1,064.457. review_by July 1 (14 days). TRIUMPH-1 data exceptional. **CONTINUE.**
- **V:** ✅ Intact. Stop $299.772. review_by July 28. OpenAI integration confirmed. **CONTINUE.**
- **VST:** ✅ STRENGTHENED. Helix + PJM auction positive + dividend June 22. review_by July 7. **CONTINUE.**

No contracts triggered or expired. All holding. Next review trigger: LLY review_by July 1 (14 days — explicit hold/trim/exit decision required at pre-market June 30 or July 1).

---

### Risk posture check (pre-market June 17)

| Check | Value | Limit | Status |
|-------|-------|-------|--------|
| New positions this week | 0/3 | ≤3 | FOMC gate — no new positions before 2 PM ET today |
| Cash | $74,304.63 (74.89%) | ≥5% | ✓ Ample |
| LLY stop buffer | $54.60 (4.88%) | watch | ✓ Adequate |
| V stop buffer | $32.75 (9.85%) | watch | ✓ Healthy — near HWM; watch ratchet |
| VST stop buffer | $14.72 (9.19%) | watch | ✓ Near-full buffer — watch ratchet above $161.48 |
| Drawdown circuit breaker | $99,212 vs HWM $101,384 = −2.141% | <−10% | ✓ Not triggered |
| Intraday shock (vs last_equity $99,202.67) | +$10.00 = +0.010% | <−4% | ✓ Positive |
| 10yr yield | ~4.47% (est.) | <4.75% | ✓ Below trigger — watch post-dot-plot 2 PM |
| WTI oil | ~$80/bbl (Iran peace advancing) | <$100 | ✓ Well below trigger |
| All trailing stops active | 4/4 confirmed | required | ✓ |
| Sector caps | Healthcare 11.28%, Financials 7.37%, Energy 6.45%, Cash 74.89% | <60% each | ✓ |
| FOMC gate | No new positions before 2 PM ET today | — | ⚠️ ACTIVE (lifts 2 PM ET today, June 17) |
| −7% cut thresholds | LLY $1,016.99 (clear $102); V $300.92 (clear $31.60); VST $138.39 (clear $21.66) | — | ✓ All clear |

---

### Post-FOMC candidate research (reference for today 2 PM+ and Thursday June 18+)

**Slot 1 — LRCX (Lam Research): ATR STILL ELEVATED — DEFER**
- June 16 close: $369.34 (down ~5.03% on the day) — daily range still ~5%, above 3% threshold ❌
- Pattern: June 11 ~7.81%, June 12 ~5.01%, June 15 ~5.90%, June 16 ~5.03% — gradually declining but still far above 3%
- **Ex-dividend TODAY June 17:** $0.26/sh quarterly dividend — minor (~0.07% of price)
- **Next earnings:** August 5, 2026 — 49 days away ✓
- Analyst thesis intact: UBS PT $375, Oppenheimer $400, Cantor $425; WFE market now $140B; advanced packaging >50% growth 2026
- Entry condition: Need ATR ≤3% for 3+ consecutive sessions. Most optimistic scenario: if session June 17 and June 18 are both calm (<3% range), entry eligible Thursday June 19+ or Friday June 20+
- **Post-FOMC check (2 PM today):** If FOMC neutral and LRCX settles, check Thursday pre-market ATR

**Slot 2 — NVDA (Nvidia): IN BUY ZONE — post-FOMC eligible**
- June 16 close: $207.41; pre-market June 17 predicted ~$208.75 — above $205 re-entry threshold ✓
- **Next earnings:** August 25–26, 2026 (~69 days) ✓ Well outside window
- 62 analysts Strong Buy, avg PT $298.93 (+44% upside from current price)
- FY2026 revenue $215.94B (+65% YoY); data center revenue +92% — AI accelerator monopoly thesis intact
- Helix consortium (KKR+NVIDIA+VST) validates GPU demand for AI infrastructure
- **Post-FOMC check (2 PM today):** If FOMC neutral, NVDA above $205 with ATR normalizing → plan Thursday entry
- Sizing: 10-11 shares (~$210 × 11 = $2,310 or ~$210 × 15 = $3,150; target 7-9% of portfolio ≈ ~$7K = 33sh; risk budget 1.2% of $99K = $1,188 loss / 10% stop = $11,880 position = ~56sh but cap at 12%)

Actually, let me recalculate NVDA sizing:
- Risk budget: 1.2% of $99,212 = $1,190 loss max
- With 10% trailing stop: position size = $1,190 / 10% = $11,900 max
- NVDA at $208: $11,900 / $208 = ~57sh (rounds to 57sh at 12% portfolio — at the cap with full risk budget)
- Starter position (7-9%): 7% × $99,212 = $6,945 / $208 = ~33sh
- 20% hard cap: $19,842 / $208 = ~95sh
- Risk budget at 33sh: 33 × $208 × 10% = $686 loss = 0.69% of equity (within 1.2% limit) ✓
- **Target: 33 shares at ~$208 = ~$6,864 = 6.9% of portfolio** (starter conviction, within risk budget)

**Slot 3 — PWR (Quanta Services): MOVING UP — post-FOMC eligible**
- June 17 pre-market: $718.88–$737.82 range (conference day); latest $722 est.
- **Institutional investor presentations:** TD Cowen Conference TODAY June 17 in Toronto
- **Next earnings:** July 30, 2026 — 43 days away ✓ (well outside 2-day window)
- Q1 2026 adj EPS $2.68 (+50.6% YoY); revenue $7.87B (+26.4% YoY); record backlog $48.5B
- Raised 2026 guidance. Analyst avg PT $761.35 (4.47% upside from $722).
- Post-conference volatility possible today — wait for dust to settle before planning entry
- **Post-FOMC timing:** If TD Cowen presentation today is constructive and ATR calms, PWR eligible for Thursday/Friday entry post-gate

---

### Earnings window check
| Symbol | Next earnings | Days away | In 2-day window? |
|--------|---------------|-----------|------------------|
| LLY | August 6, 2026 | 50 days | ✗ Clear ✓ |
| V | July 28, 2026 | 41 days | ✗ Clear ✓ |
| VST | August 6, 2026 | 50 days | ✗ Clear ✓ |
| NVDA (candidate) | Aug 25–26, 2026 | ~69 days | ✗ Clear ✓ |
| LRCX (candidate) | August 5, 2026 | 49 days | ✗ Clear ✓ |
| PWR (candidate) | July 30, 2026 | 43 days | ✗ Clear ✓ |

No held positions or candidates have earnings within 2 trading days. ✓

---

### Cash-drag explicit decision (June 17)

Cash at 74.89% — above strategy target 25-40%. Explicit reasoning for holding:
1. **FOMC gate active through 2 PM ET TODAY** — announcement in ~6 hours; hawkish dot plot risk remains
2. **LRCX ATR ~5%** — still disqualified per volatility rule; entry needs 3+ consecutive ≤3% sessions
3. **NVDA above $205** — re-entry zone reached, but FOMC gate still active at market open; wait for 2 PM announcement
4. **PWR conference today** — TD Cowen presentation may cause intraday volatility; wait for settling
5. **Current positions (LLY, V, VST)** — all healthy with intact/strengthened theses; no urgency to force additional deployment before rate clarity

**Post-FOMC (from 2 PM ET today):**
Close routine will assess FOMC outcome and plan Thursday June 18 deployment if neutral/in-line:
- Priority 1: NVDA (33sh, above $205, ATR check at Thursday pre-market)
- Priority 2: LRCX (if ATR finally reaches ≤3% by Thursday)
- Priority 3: PWR (after conference volatility settles)

---

### Performance (pre-market June 17, 2026)

- **Bull equity pre-market:** $99,212.67 (−0.787% since inception $100,000)
- **SPY pre-mkt (latest trade):** $750.61 (vs anchor $739.44 = **+1.510% since inception**)
- **Estimated gap:** Bull −0.787% vs SPY +1.510% = **Bull TRAILS SPY by ~2.30pp**
- Note: After SPY ex-div June 18 ($1.76/sh), SPY total-return anchor becomes $741.20 — will narrow reported gap by ~0.238pp (effective gap ~2.06pp vs adjusted anchor).
- **Pre-market P/L (unrealized, vs last_equity):** LLY −$34.40 (−0.31%), V −$13.20 (−0.18%), VST +$57.60 (+0.91%) = net **+$10.00** (+0.010%) ✓

---

### Planned trades for today (Wednesday June 17, 2026)

**No new positions today. FOMC gate active — announcement TODAY June 17, 2 PM ET.**

Reasons: (1) FOMC announcement today 2 PM ET — market-open at 9:35 AM is before the announcement; dot plot hawkish risk (up to 3 members projecting hikes); Warsh may withhold his own dot (additional uncertainty); (2) LRCX ATR ~5% still disqualified; (3) NVDA above $205 but FOMC gate prevents entry before 2 PM; (4) PWR conference today may cause intraday volatility — wait for settling; (5) All 3 current positions healthy with intact theses and strong stop buffers.

**Hold LLY, V, VST.** Watch for VST ratchet if it trades above $161.48 today. Watch for V ratchet if it trades above $333.08.

**Post-FOMC (2 PM ET today onward):** Close routine to assess outcome. If neutral (rate hold + dot plot not wildly hawkish + 10yr stays below 4.75%):
1. NVDA — plan 33sh entry for Thursday June 18 open
2. LRCX — check ATR at Thursday pre-market; if ≤3%, plan 22-23sh entry (target 7% portfolio, halved if ATR borderline)
3. PWR — check post-conference ATR; if settled, plan 10-11sh entry Thursday

```json
{
  "plan_date": "2026-06-17",
  "trades": []
}
```

No trades planned.

EXECUTED: 2026-06-17T13:36:00Z — No trades; FOMC gate active (announcement 2 PM ET today, June 17); stop audit 4/4 ✓ (V HWM auto-ratcheted $333.08→$336.07, stop $299.772→$302.463 — V +0.76% intraday; LLY $1,116.33 (+2.09% from entry, −0.55% intraday); VST $158.62 (+6.59% from entry, +0.01% intraday)); shock check −$5.75 = −0.006% ✓; drawdown −2.157% vs HWM $101,384.21 ✓. All guardrails ✓.

**Upcoming catalysts:**
- **FOMC announcement TODAY June 17, 2 PM ET** — dot plot + rate hold; Warsh press conference 2:30 PM ET
- **SPY dividend ex-date TOMORROW June 18** ($1.76/sh — SPY total-return anchor → $741.20 post-June 18)
- **VST dividend ex-date June 22** (USD 9.16 credit for 40sh — 5 days)
- **LRCX ex-dividend TODAY June 17** ($0.26/sh — minor; opens ex-div today)
- **PWR TD Cowen Conference TODAY June 17** — watch for post-conference volatility
- **LLY Medicare GLP-1 Bridge effective July 1** (14 days — thesis review_by date; explicit decision required at June 30 pre-market)
- **VST thesis review_by July 7** (20 days)
- **PWR next earnings July 30** (43 days)
- **V Q3 FY26 earnings July 28** (41 days — thesis review_by date)

---

## 2026-06-16 — Pre-market research (~08:03 ET)

**Today is Tuesday June 16. Week of June 16: 0/3 new positions used. FOMC starts TODAY (June 16–17); announcement Wednesday June 18, 2 PM ET. Hard gate: no new positions until post-FOMC Wednesday afternoon.**

---

### Macro (pre-market June 16, 2026 ~08:03 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| S&P 500 futures / SPY | **Flat, −0.04%** (pausing after June 15 +1.7% Iran-deal rally) | — | ✓ Constructive; market taking a breather |
| FOMC June 16–17 | **STARTS TODAY** — Kevin Warsh's first meeting; rate hold 97% probability | Announcement Jun 18 2 PM ET | ⚠️ HARD GATE IN EFFECT |
| Dot plot (SEP) | Shift from easing bias → neutral stance expected; Warsh may alter framing; ~70% probability of at least one year-end hike | 10yr <4.75% | ⚠️ Key risk Wednesday afternoon |
| 10yr Treasury yield | ~4.47% est. (Jun 15) | <4.75% | ✓ Below trigger — watch post-FOMC dot plot |
| Iran/US peace deal | Still advancing; WTI ~$80/bbl; Strait of Hormuz reopening | Oil <$100 | ✓ Constructive; well below trigger |
| SPY pre-market (latest quote) | $754.87–$755.05 (+2.09% since inception $739.44) | — | ✓ Stable overnight |

**Macro posture: CAUTIOUSLY CONSTRUCTIVE, FOMC GATE DOMINANT.** The market is pausing after Monday's strong +1.7% Iran-deal rally. S&P 500 futures are essentially flat (−0.04%) as participants await Wednesday's FOMC announcement. Kevin Warsh's first meeting starts today; the dot plot is the key variable — a shift to neutral or hawkish bias (signaling no cuts and possibly hikes by year-end) could spike the 10yr above the 4.75% halt trigger. **Hard gate: NO new positions before Wednesday June 18, 2 PM ET.** This gate is absolute regardless of tape conditions.

**SPY ex-dividend June 18 ($1.76/sh):** Same day as FOMC announcement. After June 18, SPY total-return anchor adjusts: $739.44 + $1.76 = $741.20 (effective anchor for post-June 18 benchmarking).

---

### Account (pre-market June 16, 2026 — live Alpaca data ~08:03 ET)

| Metric | Value |
|--------|-------|
| Equity | $98,901.57 |
| Cash | $74,304.63 (75.1%) |
| Long market value | $24,596.94 |
| Last equity (June 15 close) | $98,862.97 |
| Buying power | ~$366,090 |

**Intraday shock check:** $98,901.57 vs last_equity $98,862.97 = **+$38.60 = +0.039%** — POSITIVE (overnight mark-up). No shock. ✓

**Drawdown circuit breaker:** HWM $101,384.21 (confirmed from equity history); current $98,901.57 = **−2.44%** — well within −10% limit. ✓ FOMC gate is the operative constraint.

---

### Trailing stop audit (pre-market June 16 — confirmed via Alpaca open orders)

| Order ID | Symbol | Qty | HWM | Stop | Status |
|----------|--------|-----|-----|------|--------|
| d4147484 | LLY | 7sh | $1,182.73 | $1,064.457 | ✓ new |
| 25989fb5 | LLY | 3sh | $1,182.73 | $1,064.457 | ✓ new |
| 66033918 | V | 22sh | $326.435 | $293.7915 | ✓ new |
| c4c200a5 | VST | 40sh | $155.43 | $139.887 | ✓ new |

All 4 trailing stops confirmed active. ✓

---

### Held positions (pre-market June 16, 2026)

**LLY ($1,131.07 pre-mkt, +0.15% today from $1,129.35 Jun 15 close, +3.43% from avg entry $1,093.534):** ⭐ STRONG
- **What changed since yesterday:** No LLY-specific negative catalyst. Phase 3 BRUIN CLL-322 trial met its primary endpoint (hematology pipeline diversification — positive, not GLP-1 related). Employer GLP-1 coverage concern remains a 2027 headwind only. Medicare GLP-1 Bridge effective July 1 in **15 days** — thesis catalyst approaching.
- **Earnings window:** Next earnings ~August 5, 2026 — 50 days away ✓
- **Thesis contract:** invalidation = stop fires ($1,064.457) or Medicare Bridge reversed. review_by = July 1 (15 days). Current $1,131.07 >> $1,064.457. **THESIS INTACT.** ✓
- **Stop buffer:** $1,131.07 − $1,064.457 = **$66.61 (5.89%)** ✓ Well protected.
- **Decision: HOLD. Medicare Bridge catalyst 15 days away. Thesis strongest in portfolio.**

**V ($323.011 pre-mkt, −0.25% today from $323.82 Jun 15 close, −0.17% from avg entry $323.57):** ✓ INTACT
- **What changed since yesterday:** No new material catalysts. Visa/OpenAI partnership confirmed; Visa trading in range $321.59–$326.44 today. Stock mildly soft with FOMC caution weighing on financials. Thesis unchanged.
- **Earnings window:** Next earnings July 28, 2026 — 42 days away ✓
- **Thesis contract:** invalidation = trailing stop fires ($293.7915) or regulatory mandate forces open access. review_by = July 28. Current $323.011 >> $293.7915. **THESIS INTACT.** ✓
- **Stop buffer:** $323.011 − $293.7915 = **$29.22 (9.04%)** ✓ Healthy.
- **Decision: HOLD. Flat performance within normal variance; no thesis break. FOMC caution on financials is temporary.**

**VST ($154.50 pre-mkt, +0.64% today from $153.52 Jun 15 close, +3.82% from avg entry $148.81):** ⭐⭐ HELIX — STRONG
- **What changed since yesterday:** Revenue forecast upgraded to $23.3B (from $18.8B) for 2026; EPS estimate raised to $9.40 (from $9.01) per analyst consensus. Helix Digital Infrastructure (KKR+NVIDIA+Kuwait) thesis intact. Dividend ex-date **June 22 in 6 days** (40sh × $0.229 = USD 9.16 credit). Stock up ~16% in the past week.
- **Earnings window:** Next earnings August 6, 2026 — 51 days away ✓
- **Thesis contract:** invalidation = WTI >$100 (NO — ~$80), FCF guidance cut (NO — upgraded), PPA/Helix cancellation (NO — Helix strengthening), breaks $130 on volume (NO — $154.50). review_by = July 7 (21 days). **THESIS INTACT AND STRENGTHENED.** ✓
- **Stop buffer:** $154.50 − $139.887 = **$14.61 (9.46%)** ✓ Near-full 10% trailing protection.
- **VST stop note:** HWM $155.43 (ratcheted EOD June 15). If VST trades above $155.43 today, stop auto-ratchets again.
- **Decision: HOLD. Revenue/EPS upgrades reinforce thesis. Dividend in 6 days. Strongest position.**

---

### Thesis contract review (June 16)

- **LLY:** ✅ Intact. Stop $1,064.457. review_by July 1 (15 days). Buffer $66.61 (5.89%). **CONTINUE.**
- **V:** ✅ Intact. Stop $293.7915. review_by July 28. Buffer $29.22 (9.04%). **CONTINUE.**
- **VST:** ✅ STRENGTHENED. Revenue/EPS upgrades. Dividend Jun 22. review_by July 7. Buffer $14.61 (9.46%). **CONTINUE.**

---

### Risk posture check (pre-market June 16)

| Check | Value | Limit | Status |
|-------|-------|-------|--------|
| New positions this week | 0/3 | ≤3 | All gated — FOMC through Jun 18 2 PM ET |
| Cash | $74,304.63 (75.1%) | ≥5% | ✓ Ample |
| LLY stop buffer | $66.61 (5.89%) | watch | ✓ Well protected |
| V stop buffer | $29.22 (9.04%) | watch | ✓ Healthy |
| VST stop buffer | $14.61 (9.46%) | watch | ✓ Near-full 10% buffer |
| Drawdown circuit breaker | $98,901 vs HWM $101,384 = −2.44% | <−10% | ✓ Not triggered |
| Intraday shock (vs last_equity $98,862.97) | +$38.60 = +0.039% | <−4% | ✓ Positive |
| 10yr yield | ~4.47% (Jun 15 est.) | <4.75% | ✓ Below trigger — watch Jun 18 2PM |
| WTI oil | ~$80/bbl (Iran peace advancing) | <$100 | ✓ Well below trigger |
| All trailing stops active | 4/4 confirmed | required | ✓ |
| Sector caps | Healthcare 11.43%, Financials 7.19%, Energy 6.25%, Cash 75.1% | <60% each | ✓ |
| FOMC gate | No new positions before Jun 18 2 PM ET | — | ⚠️ ACTIVE — starts TODAY |
| -7% cut thresholds | LLY $1,016.99 (clear $114); V $300.92 (clear $22); VST $138.39 (clear $16) | — | ✓ All clear |

---

### Post-FOMC candidate research (reference for Wednesday June 18+)

**Slot 1 — LRCX (Lam Research): ATR STILL ELEVATED — DEFER**
- Current price: ~$387.56 (June 15/16)
- June 15 daily move: **+5.90%** — ATR is still far above 3% threshold ❌
- Recent pattern: $366.75 (Jun 12) → $387.56 = +5.68% over 2-3 sessions — still extending, not basing
- For entry conditions to be met by Wednesday: need 2+ sessions with ATR ≤3% AND stock basing with contracting volume
- Revenue upgrades from analysts (UBS $375, Oppenheimer $400, Mizuho $380) confirm fundamental thesis
- CFO: WFE market now expected $140B (upgraded from prior estimates); advanced packaging revenue to exceed 50% growth in 2026
- **Next earnings: August 5, 2026 (50 days)** ✓
- **Re-evaluate Wednesday post-FOMC:** If FOMC neutral/in-line and LRCX settles down for 2 sessions by Wednesday, slot 1 may open Thursday.

**Slot 2 — NVDA (Nvidia): IN RE-ENTRY ZONE — post-FOMC eligible**
- Current price: ~$212.45 (June 15 close, +3.54%)
- Prior stop-out: $209.042 (June 5). Current $212.45 is above re-entry level of $205 ✓
- **Next earnings: August 25–26, 2026** (~71 days) ✓ Well outside 2-day window
- Strong fundamentals: FY2026 revenue $215.94B (+65% YoY), data center revenue up 92%
- Strong Buy from 62 analysts, avg target $298.93 (+40% upside from current price)
- Market cap ~$5T — AI accelerator monopoly thesis intact
- **Post-FOMC check Wednesday:** If FOMC neutral/in-line and NVDA closes above $205 with ATR ≤3%, eligible for Slot 2

**Slot 3 — PWR (Quanta Services): STRONG CANDIDATE — post-FOMC eligible**
- Current price: ~$707.74 (June 12 close)
- Q1 2026 adj EPS $2.68 (+50.6% YoY); revenue $7.87B (+26.4% YoY); record backlog $48.5B
- UBS PT $900, Oppenheimer PT $800 — significant upside potential
- **Institutional investor presentations TODAY (Truist Securities) and tomorrow (TD Cowen)** — potential catalyst for volatility
- Thesis: grid infrastructure + AI data-center power demand buildout
- **Need to check next earnings date post-FOMC** before entry
- Management conference this week is a catalyst watch — if stock moves strongly on conference presentations, wait for ATR to normalize before entry

---

### Cash-drag explicit decision (June 16)

Cash at 75.1% — well above the 25–40% strategy target. Explicit reasoning:
1. **FOMC gate** — Kevin Warsh's first meeting starts today; dot plot on Wednesday is the highest near-term risk event; even a neutral shift from easing to hold-for-longer could spike 10yr toward 4.75% halt trigger
2. **LRCX ATR ~5.9%** — still disqualified; extending, not basing; need 2+ quiet sessions
3. **NVDA and PWR** — both in the re-entry zone but FOMC gate takes precedence before Wednesday afternoon
4. **LLY, V, VST** — all three positions have intact/upgraded theses; VST dividend in 6 days; no urgency to add risk before rate clarity

**Post-FOMC Wednesday (June 18, 2 PM ET onwards):** Reassess with 3 full slots. Priority:
1. LRCX — only if ATR has normalized to ≤3% AND chart is basing
2. NVDA — if above $205 with calm ATR, post-FOMC clarity on rates
3. PWR — if post-conference volatility has settled and ATR is ≤3%

---

### Performance (pre-market June 16, 2026)

- **Bull equity pre-market:** $98,901.57 (−1.10% since inception $100,000)
- **SPY pre-mkt (latest quote):** ~$754.87–$755.05 (vs anchor $739.44 = **+2.09% since inception**)
- **Estimated gap:** Bull −1.10% vs SPY +2.09% = **Bull TRAILS SPY by ~3.19pp**
- Note: Gap stabilized from −3.07pp (EOD Jun 15); slight overnight improvement as positions positive. After SPY ex-div June 18 ($1.76/sh), SPY total-return anchor becomes $741.20 — will narrow reported gap by ~0.24pp.
- **Today P/L (pre-mkt unrealized):** LLY +$17.20 (+0.15%), V −$17.80 (−0.25%), VST +$39.20 (+0.64%) = net **+$38.60** (+0.039%) ✓

---

### Planned trades for today (Tuesday June 16, 2026)

**No new positions today. FOMC gate active — announcement Wednesday June 18, 2 PM ET.**

Reasons: (1) FOMC starts TODAY — Kevin Warsh's first meeting; dot plot Wednesday critical; hawkish shift risk with 70% probability of at least one year-end hike; (2) LRCX ATR ~5.9% on June 15 — disqualified; (3) All 3 current positions (LLY, V, VST) have intact/upgraded theses and healthy stop buffers — no urgency to deploy before rate clarity.

**Hold LLY, V, VST. Watch for VST to ratchet stop if trading above HWM $155.43 at market open.**

```json
{
  "plan_date": "2026-06-16",
  "trades": []
}
```

No trades planned.

EXECUTED: 2026-06-16T13:36:06Z — No trades; FOMC gate active (post-Jun 18 2PM ET); stop audit 4/4 ✓ (V HWM ratcheted $326.435→$326.905, stop $293.7915→$294.2145; VST HWM ratcheted $155.43→$158.49, stop $139.887→$142.641 — VST +3.03% intraday on Helix momentum); LLY $1,143.695 (+4.59% from entry, +1.27% intraday); V $326.18 (+0.81% from entry, +0.73% intraday); VST $158.17 (+6.29% from entry, +3.03% intraday). All guardrails ✓.

**Upcoming catalysts:**
- **FOMC June 16–17 (starts TODAY)** — announcement Wednesday June 18, 2 PM ET; dot plot key
- **VST dividend ex-date June 22** (USD 9.16 credit for 40sh — 6 days)
- **SPY dividend ex-date June 18** ($1.76/sh — SPY total-return anchor → $741.20 post-June 18)
- **LLY Medicare GLP-1 Bridge effective July 1** (15 days — thesis review_by date)
- **VST thesis review_by July 7** (21 days)
- **V Q3 FY26 earnings July 28** (42 days — thesis review_by date)
- **PWR institutional conferences:** Truist Securities June 16, TD Cowen June 17 — catalyst watch
- **Post-FOMC priority (June 18 2PM+):** (1) LRCX if ATR ≤3%; (2) NVDA if basing above $205; (3) PWR after conference dust settles

---

## 2026-06-15 — Pre-market research (~08:03 ET)

**Today is Monday June 15. Week of June 15: 0/3 new positions used. 3 fresh slots. FOMC gate: no new positions before Wednesday June 18, 2 PM ET announcement.**

---

### Macro (pre-market June 15, 2026 ~08:03 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| S&P 500 futures / SPY pre-mkt | **$751.37** (+1.31% from Jun 12 close $741.67) | — | ✓ Strong broad rally |
| FOMC June 16–17 | Rate hold 98–99% probability; dot plot hawkish shift risk | No new buys before Wed Jun 18 2 PM | ⚠️ HARD GATE IN EFFECT |
| Hawkish hike risk | ~70% probability of at least one rate hike by year-end 2026 (CME FedWatch) | 10yr <4.75% | ⚠️ Dot plot key — watch 10yr post-Wed |
| Iran/US peace deal | Advancing; WTI below $100 ✓ | Oil <$100 | ✓ Constructive |
| 10yr Treasury yield | ~4.47% (June 12 est.) | <4.75% | ✓ Below trigger — watch post-FOMC dot plot |
| Economic calendar today | Empire State Index, Industrial Production, NAHB Housing | — | Routine — not expected to be market-moving |

**Macro posture: BULLISH PRE-MARKET, BUT FOMC GATE ACTIVE.** SPY is +1.31% pre-market on continued Iran peace deal optimism and broad risk-on tone. However, FOMC June 16–17 (Kevin Warsh's first meeting as Fed Chair, with Summary of Economic Projections/dot plot) carries hawkish risk — ~70% probability of at least one rate hike by year-end. If the dot plot signals fewer cuts than market expects, 10yr could spike toward 4.75% trigger. **Hard gate: no new positions before Wednesday June 18, 2 PM ET announcement.** This gate applies regardless of how constructive the tape looks Monday/Tuesday.

**SPY dividend ex-date June 18, 2026 ($1.76/sh):** This is Wednesday, same day as the FOMC announcement. After June 18, SPY total return = price return + $1.76/$739.44 = +0.238pp adjustment to SPY benchmark.

---

### Account (pre-market June 15, 2026 — live Alpaca data ~08:03 ET)

| Metric | Value |
|--------|-------|
| Equity | $98,907.25 |
| Cash | $74,304.63 (75.1%) |
| Long market value | $24,602.62 |
| Last equity (June 12 close) | $98,648.01 |

**Intraday shock check:** $98,907.25 vs last_equity $98,648.01 = **+$259.24 = +0.263%** — POSITIVE (weekend mark-up). No shock. ✓

**Drawdown circuit breaker:** HWM $101,384.21 (confirmed from equity history); current $98,907.25 = **−2.44%** — well within −10% limit. ✓ No restriction (but FOMC gate supersedes).

---

### Trailing stop audit (pre-market June 15 — confirmed via Alpaca open orders)

| Order ID | Symbol | Qty | HWM | Stop | Status |
|----------|--------|-----|-----|------|--------|
| d4147484 | LLY | 7sh | $1,182.73 | $1,064.457 | ✓ new |
| 25989fb5 | LLY | 3sh | $1,182.73 | $1,064.457 | ✓ new |
| 66033918 | V | 22sh | $325.93 | $293.337 | ✓ new |
| c4c200a5 | VST | 40sh | $150.50 | $135.45 | ✓ new |

All 4 trailing stops confirmed active. ✓

**VST ratchet note:** VST pre-market $152.24 is above HWM $150.50. When market opens and VST trades above $150.50, stop auto-ratchets: estimated new HWM ~$152.24, new stop ~$137.02 (10% below). Market-open routine to confirm.

---

### Held positions (pre-market June 15, 2026)

**LLY ($1,140.47 pre-mkt, +0.66% today from $1,133 Jun 12 close, +4.29% from avg entry $1,093.534):** ⭐ STRONG
- **What changed since last run (Jun 12 EOD):** Weekend news: some employers (~10% of those currently covering weight-loss drugs) plan to discontinue coverage in 2027 as costs surge. Cigna dropped GLP-1 coverage for its own employees effective July. 67% of large employers still maintain coverage in 2026. This is a 2027 headwind but does NOT invalidate the July 1 Medicare GLP-1 Bridge catalyst — Medicare EXPANDS access to ~20-30M new beneficiaries, moving in the opposite direction of employer retrenchment.
- **Earnings window:** Next earnings ~August 5, 2026 — 51 days away ✓ (well outside 2-day window)
- **Thesis contract:** invalidation = stop fires ($1,064.457) or Medicare Bridge reversed. review_by = July 1 (16 days). Current $1,140.47 >> $1,064.457. **THESIS INTACT. No invalidation.** ✓
- **Stop buffer:** $1,140.47 − $1,064.457 = **$76.01 (6.67%)** ✓ Well protected.
- **Monday conviction rating: A** — original thesis intact, working, conviction still high. Medicare Bridge July 1 approaching.
- **Decision: HOLD. Employer coverage concern is a 2027 headwind, not a July 1 invalidation. Medicare Bridge expansion is the near-term driver.**

**V ($323.10 pre-mkt, +0.22% today from $322.39 Jun 12 close, −0.15% from avg entry $323.57):** ✓ INTACT
- **What changed since last run:** No new material catalysts. OpenAI partnership and stablecoin/token capabilities (announced Jun 10-12) remain the thesis drivers. Stock flat over the week. Financials sector lagging in tech-driven rallies.
- **Earnings window:** Next earnings July 28, 2026 — 43 days away ✓
- **Thesis contract:** invalidation = trailing stop fires ($293.337) or regulatory mandate forces open access. review_by = July 28. Current $323.10 >> $293.337. **THESIS INTACT.** ✓
- **Stop buffer:** $323.10 − $293.337 = **$29.76 (9.21%)** ✓ Healthy.
- **Monday conviction rating: B** — working but flat (−0.15% from entry in 5 sessions). Thesis intact but sector rotation lag continuing. No C risk.
- **Decision: HOLD. Flat performance within normal variance for a 5-session-old position. No thesis break. July 28 earnings is the next major catalyst gate.**

**VST ($152.24 pre-mkt, +2.85% today from $148.02 Jun 12 close, +2.31% from avg entry $148.81):** ⭐⭐ HELIX THESIS — STRONG
- **What changed since last run:** VST broke significantly higher over the weekend — up 2.85% to $152.24, above the HWM of $150.50 (set June 12). No specific new news found for Monday, but Helix Digital Infrastructure (KKR+NVIDIA+Kuwait) thesis continues to strengthen in market perception. Dividend ex-date June 22 in **7 days** — $0.229/sh × 40sh = USD 9.16 credit. Current price $152.24 vs entry $148.81 = **+2.31%**.
- **Earnings window:** Next earnings August 6, 2026 — 52 days away ✓
- **Thesis contract (REVISED for current price):** invalidation = WTI >$100 (NO ✓ — ~$85/bbl per Iran deal), FCF guidance cut (NO ✓), PPA/Helix cancellation (NO ✓ — Helix strengthening), breaks $130 on volume (NO ✓ — $152.24). review_by = July 7 (22 days). **THESIS INTACT AND MATERIALLY STRENGTHENED.** ✓
- **Stop buffer (estimated after ratchet):** $152.24 − $137.02 (new stop after ratchet) = **~$15.22 (10.0%)** — full 10% buffer after market-open ratchet.
- **Monday conviction rating: A** — thesis upgraded (Helix), working, conviction very high. Dividend in 7 days.
- **Decision: HOLD. Let trailing stop ratchet as VST trades above $150.50. Dividend credit in 7 days. Strongest thesis upgrade in portfolio.**

---

### Thesis contract review (June 15)

- **LLY:** ✅ Intact. Stop $1,064.457. review_by July 1 (16 days). Employer coverage 2027 headwind ≠ Medicare Bridge invalidation. **CONTINUE.**
- **V:** ✅ Intact. Stop $293.337. review_by July 28. Flat but no thesis break. **CONTINUE.**
- **VST:** ✅ MATERIALLY STRENGTHENED. Invalidation criteria all clear. review_by July 7. Helix + dividend June 22. **CONTINUE.**

---

### Monday conviction-weighted holding review (3b — required every Monday)

| Symbol | Rating | Rationale |
|--------|--------|-----------|
| LLY | **A** | Original thesis intact and working (+4.29% from entry); Medicare Bridge July 1 in 16 days; pipeline expansion positive; employer coverage concern is a 2027 issue, not a current invalidation |
| V | **B** | Working but flat (−0.15% from entry); thesis intact; financials sector rotation lag is expected not thesis-specific; no C flag |
| VST | **A** | Thesis materially upgraded (Helix Digital Infrastructure); +2.31% from entry; dividend June 22 in 7 days; pre-market +2.85% breakout above prior HWM |

No position rated C. No mandatory trims. Both A-rated positions holding well; V (B) needs watchful eye through July 28 earnings gate.

---

### Risk posture check (pre-market June 15)

| Check | Value | Limit | Status |
|-------|-------|-------|--------|
| New positions this week | 0/3 | ≤3 | 3 slots available — FOMC gate holds all |
| Cash | $74,304.63 (75.1%) | ≥5% | ✓ Ample |
| LLY stop buffer | $76.01 (6.67%) | watch | ✓ Well protected |
| V stop buffer | $29.76 (9.21%) | watch | ✓ Healthy |
| VST stop buffer | ~$15.22 (10.0%) est. post-ratchet | watch | ✓ Full buffer |
| Drawdown circuit breaker | $98,907 vs HWM $101,384 = −2.44% | <−10% | ✓ Not triggered |
| Intraday shock (vs last_equity $98,648) | +$259.24 = +0.263% | <−4% | ✓ Positive |
| 10yr yield | ~4.47% (Jun 12 est.) | <4.75% | ✓ Below trigger — watch post-FOMC |
| WTI oil | ~$85/bbl (Iran peace) | <$100 | ✓ Well below trigger |
| All trailing stops active | 4/4 confirmed | required | ✓ |
| Sector caps | Healthcare 11.53%, Financials 7.19%, Energy 6.16%, Cash 75.1% | <60% each | ✓ |
| FOMC gate | No new positions before Jun 18 2 PM ET | — | ⚠️ ACTIVE |

---

### LRCX ATR check (Slot 1 candidate — post-FOMC)

**LRCX snapshot (June 12 close, from Alpaca):**
- June 12: H $373.665 / L $355.28 / C $366.75 → range **$18.39 = 5.01%** ❌ (>3% threshold)
- June 11: H $364.59 / L $336.285 / C $362.58 → range **$28.31 = 7.81%** ❌
- June 10 (from log): H $347.66 / L $319.01 → range **8.91%** ❌
- **3-day average ATR: ~7.24%** — still far above 3% threshold

LRCX continues consolidating near the $360-$375 range. Entry conditions remain unmet: need 3 consecutive sessions with ATR ≤3%. If the FOMC-driven market is calm this week (rate hold + neutral dot plot), LRCX could begin to base. Re-check Thursday/Friday pre-market for ATR compliance. Next earnings August 5, 2026 (51 days away ✓).

---

### NVDA check (Slot 2 candidate — post-FOMC)

- Pre-market June 15: ~$205-$210 range (web search confirms ~$205-$210)
- Bull's prior stop-out: $209.042 (June 5)
- Next earnings: **August 26, 2026** (72 days away ✓ — well outside 2-day window)
- NVDA is basing near the $205 re-entry level flagged in the weekly review
- Post-FOMC entry eligible if: (a) stock closes above $205 with normalizing ATR, (b) FOMC is not hawkish shock (10yr stays below 4.75%), (c) Helix consortium (KKR+NVIDIA) thesis validates demand for NVDA GPU capacity
- Re-evaluate post-FOMC Wednesday afternoon

---

### Cash-drag explicit decision (June 15)

Cash at 75.1% (above strategy target 25-40%). No new positions this week before FOMC (Wednesday June 18 afternoon). Explicit reasoning:
1. **FOMC gate** — highest near-term risk event; rate hold expected but hawkish dot plot with 70% probability of year-end hike could spike 10yr above 4.75% and trigger halt-new-buys rule
2. **LRCX ATR ~7%** — still disqualified; needs 3+ sessions at ≤3%
3. **NVDA** — in the re-entry zone ($205-210) but FOMC gate takes precedence; better to wait for rate clarity before adding AI semi exposure
4. **LLY, V, VST all healthy** — existing 3 positions with intact theses and ample stop buffers; no urgency to force a 4th today

After FOMC Wednesday: reassess with full 3 slots available. Priority: (1) LRCX if ATR compliant; (2) NVDA if basing above $205; (3) PWR (Quanta Services) as new candidate.

---

### Performance estimate (pre-market June 15)

- **Bull equity pre-market:** $98,907.25 (−1.09% since inception $100,000)
- **SPY pre-mkt June 15:** $751.37 (vs anchor $739.44 = **+1.61% since inception**)
- **Estimated gap:** Bull −1.09% vs SPY +1.61% = **Bull TRAILS SPY by ~2.70pp**
- Note: Gap widened significantly from −1.62pp (EOD June 12) because SPY rallied +1.31% pre-market. With 75% cash, Bull captures only ~25% of that move. This is expected behavior; cash cushion will protect on down days.
- **SPY dividend June 18 reminder:** After Jun 18 ex-date, add $1.76 to SPY total-return anchor ($741.75 + $1.76 = $743.51 adjusted for total-return benchmarking post-June 18)
- Today P/L (unrealized, pre-mkt): LLY +$74.70 (+0.66%), V +$15.62 (+0.22%), VST +$168.92 (+2.85%) = net **+$259.24** (+0.263%) ✓

---

### Planned trades for today (Monday June 15, 2026)

**No new positions today. FOMC gate active through Wednesday June 18, 2 PM ET.**

Reasons: (1) FOMC June 16–17 (announcement June 18 2 PM ET) — Kevin Warsh's first meeting with dot plot; hawkish bias risk with 70% probability of at least one year-end hike; (2) LRCX ATR ~7.24% — disqualified per volatility rule; (3) NVDA re-entry zone but FOMC gate prevents entry before Wednesday; (4) All 3 current positions (LLY, V, VST) have intact/upgraded theses and healthy stop buffers — no urgency.

**Hold LLY, V, VST. Let VST trailing stop ratchet above HWM $150.50 at market open.**

**VST watch:** When market opens, VST trading above $150.50 triggers automatic stop ratchet to ~$137.02. Market-open routine to confirm.

**Post-FOMC Wednesday June 18 (2 PM ET onwards):** Reassess with full 3 slots. Priority order:
1. LRCX — only if ATR has normalized to ≤3% for 3+ sessions by Wednesday
2. NVDA — re-entry if basing above $205 with calm ATR; thesis: AI accelerator monopoly + Helix consortium
3. PWR (Quanta Services) — new candidate; Q1 EPS +31.4% beat, revenue +26.3% beat; AI data-center grid infrastructure

```json
{
  "plan_date": "2026-06-15",
  "trades": []
}
```

EXECUTED: 2026-06-15T13:36:13Z — No trades; FOMC gate active (post-Jun 18 2PM ET); stop audit 4/4 ✓ (VST HWM ratcheted $150.50→$153.21, stop $135.45→$137.889); LLY $1,116.47 (+2.10% from entry, −1.46% intraday); V $323.53 (−0.01% from entry, +0.35% intraday); VST $151.92 (+2.09% from entry, +2.64% intraday). All guardrails ✓.

No trades planned.

**Upcoming catalysts (refreshed June 15):**
- **FOMC June 16–17, announcement June 18 2 PM ET** — rate hold expected, hawkish dot plot risk (70% year-end hike probability)
- **SPY dividend ex-date June 18** ($1.76/sh — same day as FOMC; add to benchmark total-return anchor post-June 18)
- **VST dividend ex-date June 22** (USD 9.16 credit for 40sh — 7 days)
- **LLY Medicare GLP-1 Bridge effective July 1** (16 days — thesis review_by date)
- **VST thesis review_by July 7** (22 days)
- **V Q3 FY26 earnings July 28** (43 days — thesis review_by date)
- **LLY Q2 FY26 earnings ~August 5** (51 days)
- **VST Q2 FY26 earnings August 6** (52 days)
- **NVDA Q2 FY27 earnings August 26** (72 days — re-entry candidate, well outside window ✓)
- **LRCX next earnings ~August 5** (51 days — not in window ✓)

---

## 2026-06-12 — Weekly Review research (~16:30 ET)

_Dated research findings for the weekly review of the week of June 8–12, 2026._

### Macro — week of June 8–12 review

- **S&P 500 weekly performance:** SPY +0.58% for the week ($737.45 → $741.75 actual close). Market driven by Iran/US peace deal progress — WTI crude fell to ~$85/bbl. Roller-coaster week: Monday oil spike ($93.67 on Iran/Israel strikes), then steady recovery. June 10 worst day (CPI 4.2% YoY, Iran strikes, VIX +12%, SPY −1.67%). June 11–12 recovered on peace-deal optimism. Source: Schwab weekly update 2026-06-12, Alpaca bars.
- **FOMC June 16–17 (next week):** 89% probability of rate hold. Possible bias shift from easing to neutral/tightening — first explicit hawkish pivot signal. Announcement Wednesday June 18, 2 PM ET. 10yr yield watch: any spike above 4.75% post-FOMC is the halt-new-buys trigger. New Fed Chair Kevin Warsh known to be hawkish. Source: IndexBox FOMC preview 2026-06-12.
- **SpaceX SPCX IPO June 12:** Debuted $135 → closed $161 (+19%). Largest IPO in history ($1.77T). Tech capital rotation explains Nasdaq 100 −0.5% vs S&P +0.34% on June 12. Source: market context, today's routines.
- **Iran/US peace deal:** Draft agreement largely complete. WTI $85/bbl — below $100 trigger ✓. Strait of Hormuz to reopen within 30 days. Constructive for market; slight VST nuclear relative economics headwind as natural gas improves when oil falls (but nuclear 24/7 reliability advantage intact). Source: Schwab update, today's pre-market.
- **10yr yield:** ~4.47% — below 4.75% watch trigger ✓. Constructive despite hot CPI.

### Held positions — week review (2026-06-12)

- **LLY:** +4.50% week per VantagePoint AI. ATH $1,182.73 hit June 8. EOD $1,138.355 (+4.10% from entry). Medicare GLP-1 Bridge July 1 in 19 days. Pipeline expansion: Phase 2 trials initiated for chronic low back pain and osteoarthritis. GLP-1 market leadership intact. THESIS: STRONGEST. Sources: VantagePoint AI June 2026, today's research.
- **VST:** Fell ~4.82% week-over-week from prior highs but recovered strongly by June 12. Helix Digital Infrastructure launch June 11 (KKR+NVIDIA+Kuwait, $10B+, VST preferred power partner) — major thesis upgrade. Ex-dividend June 22 ($0.23/sh, $9.20 credit for 40sh). Analyst PT $230.50 median; 19 Buy. EOD $147.98 (−0.56% from entry). Source: Finviz, stockinvest.us, today's routine data.
- **V:** Flat week. EOD $322.34 (−0.42% from entry $323.57). Trading range $319–$325 all week. OpenAI partnership confirms AI-commerce thesis. 52-week low $293.89 (Apr 1). Source: MarketBeat, Yahoo Finance.

### Watchlist research (2026-06-12)

- **LRCX:** Consolidating. June 9 close $327.16 (vs June 3 peak $343.71 = −4.8% from peak). ATR ~5.85% at June 9 — still above 3% threshold ❌. Cantor Fitzgerald PT raised to $425 (from $320) June 10. Barclays PT raised to $335. MACD bullish; above 20-day SMA. Re-evaluate June 16+: need 3+ sessions with <3% daily range. Source: historicaloptiondata.com June 9, 2026, Cantor/Barclays upgrades.
- **NVDA:** Senate Banking hearing passed without CEO Huang testimony — regulatory overhang reduced. Helix consortium (KKR+NVIDIA+VST) is a positive real-world AI contract signal. Bull stopped out at $209.04 June 5. Re-entry possible post-FOMC if stock bases above $205 with normalized ATR.
- **PWR (Quanta Services) — NEW CANDIDATE:** Q1 2026 EPS +31.4% beat, revenue +26.3% beat. Infrastructure play on AI data-center grid buildout. Not on watchlist yet — add to research queue for June 16+ evaluation. Fits "real-economy AI beneficiary" theme from strategy thesis. Source: top performers search June 2026.

---

## 2026-06-12 — Pre-market research (~08:04 ET)

**Today is Friday June 12. Week of June 8: 2/3 new positions used (VST June 9, V June 10). Slot 3 expires unused today (deliberate). Week of June 16 starts Monday — 3 fresh slots.**

---

### Macro (pre-market June 12, 2026 ~08:04 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| S&P 500 futures | **+0.41%** (ESM26) | — | ✓ Extending yesterday's +1.75% — Iran peace deal imminent |
| S&P 500 June 11 close | ~7,394 (SPY ~$737-740) | — | ✓ +1.75% yesterday — broad risk-on |
| Iran/US peace deal | Trump signals imminent signing — Polymarket 83% chance higher open | Oil <$100 | ✓ Oil FALLING — massive tailwind |
| 10yr Treasury yield | ~4.47% (est., post-Iran rally) | <4.75% | ✓ Below trigger |
| WTI crude | Falling on Iran peace signal (<$90 est.) | <$100 | ✓ Well below trigger — NEW BUYS ELIGIBLE |
| SpaceX Nasdaq IPO | USD 75B raise / USD 1.77T valuation (largest IPO in history) | — | ⚡ Broad risk appetite signal |

**Macro posture: CONSTRUCTIVELY BULLISH.** Iran peace deal signal drove S&P +1.75% Thursday and futures are extending +0.41% Friday. Oil is falling rapidly as the geopolitical risk premium unwinds — this is a direct VST thesis tailwind (cheap natural gas prices make nuclear power more competitive on margin; and oil/war de-escalation removes the "risk premium" that was crushing VST). The SpaceX IPO captures discretionary capital but broad risk appetite is healthy. Both market conditions and sector-specific factors are favorable for our three holdings. No new positions today (Friday weekend risk + slot 3 intentionally expired + LRCX ATR ~10%).

---

### Account (pre-market June 12, 2026 — live Alpaca data ~08:04 ET)

| Metric | Value |
|--------|-------|
| Equity | $98,949.03 |
| Cash | $74,304.63 (75.1%) |
| Long market value | $24,644.40 |
| Buying power | ~$366,222 |
| Last equity (June 11 close) | $98,788.43 |

**Intraday shock check:** $98,949.03 vs last_equity $98,788.43 = **+$160.60 = +0.16%** — POSITIVE. No shock. ✓

**Drawdown circuit breaker:** HWM $101,384.21 (from equity history); current $98,949.03 = **-2.40%** — well within -10% limit. ✓ No restriction on new buys.

---

### Trailing stop audit (pre-market June 12 — confirmed via Alpaca open orders)

| Order ID | Symbol | Qty | HWM | Stop | Status |
|----------|--------|-----|-----|------|--------|
| d4147484 | LLY | 7sh | $1,182.73 | $1,064.457 | ✓ new |
| 25989fb5 | LLY | 3sh | $1,182.73 | $1,064.457 | ✓ new |
| 66033918 | V | 22sh | $325.51 | $292.959 | ✓ new |
| c4c200a5 | VST | 40sh | $150.2999 | $135.270 | ✓ new |

All 4 trailing stops confirmed active. ✓

---

### Held positions (pre-market June 12, 2026)

**LLY ($1,165.35 pre-mkt, +0.38% today from $1,160.95 June 11 close, +6.57% from avg entry $1,093.534):** ⭐ EXCEPTIONAL
- **What changed since yesterday:** New pipeline expansion announced — Phase 2 trial initiated for Chronic Low Back Pain Relief; new Osteoarthritis trial added. Both expand Lilly's addressable market beyond obesity/diabetes into chronic pain. This is positive — pipeline diversification reduces single-catalyst dependency. June 11 all-time portfolio HWM was set at $1,182.73 (June 8); today's pre-mkt $1,165.35 is $17.38 below HWM. Medicare GLP-1 Bridge July 1 in 19 days — key thesis catalyst approaching.
- **Earnings window:** Next earnings August 5, 2026 — 54 days away ✓ (well outside 2-day window)
- **Thesis contract:** invalidation = stop fires ($1,064.46) or Medicare Bridge reversed. review_by = July 1. Current $1,165.35 >> $1,064.46. **THESIS INTACT. No invalidation triggered.** ✓
- **Stop buffer:** $1,165.35 - $1,064.457 = **$100.89 (8.66%)** ✓ Excellent.
- **Decision: HOLD. Thesis strengthening (pipeline expansion). Medicare Bridge catalyst 19 days away.**

**V ($320.55 pre-mkt, +0.47% today from $319.05 June 11 close, -0.93% from avg entry $323.57):** ✓ INTACT
- **What changed since yesterday:** Visa announced new AI, stablecoin, and token capabilities at its Payments Forum 2026 — directly confirms the AI-driven digital commerce thesis. The OpenAI partnership (agentic transactions) plus new stablecoin/token layer reinforces Visa's payments infrastructure moat. However, V dropped -1.24% on June 11 despite SPY +1.75% — persistent underperformance in risk-on rallies suggests financial sector rotation lag vs tech/energy. Not thesis-specific.
- **Earnings window:** Next earnings July 28, 2026 — 46 days away ✓
- **Thesis contract:** invalidation = trailing stop fires ($292.96) or regulatory mandate forces open access. review_by = July 28. Current $320.55 >> $292.96. **THESIS INTACT.** ✓
- **Stop buffer:** $320.55 - $292.959 = **$27.59 (8.60%)** ✓ Healthy.
- **Note on underperformance:** V has lagged the market on 3 of 4 positive trading days since entry. This is not thesis-breaking — financials rotate slower than tech/energy in AI-driven rallies. But it is worth noting. Will track whether V begins to participate as Iran-deal risk-off unwinds and payment volumes re-accelerate. Current -0.93% from entry is within normal variance for a 3-day-old position. **HOLD.**

**VST ($148.47 pre-mkt, +1.43% today from $146.38 June 11 close, -0.23% from avg entry $148.81):** ⭐⭐ THESIS MAJOR UPGRADE
- **What changed since yesterday:** MAJOR CATALYST — KKR, Kuwait Investment Authority, NVIDIA, and Vistra jointly launched **Helix Digital Infrastructure** (June 11, 2026). Helix is a new $10B+ AI infrastructure platform. Key details:
  - **Vistra is the PREFERRED POWER PARTNER** for Helix — not just a PPA counterparty but embedded as the preferred provider for the entire KKR/NVIDIA AI infrastructure ecosystem
  - $10B+ in total long-duration capital commitments secured at launch
  - Led by Adam Selipsky (former AWS CEO) — credibility signal
  - Kuwait Investment Authority as co-investor — sovereign wealth validation
  - Helix serves as single coordination point for hyperscalers' data centers, power, connectivity needs
  - NVIDIA as cornerstone strategic partner — means NVIDIA is directing GPU customers to Helix-powered infrastructure where VST provides the power
  - This transcends the existing Meta/Amazon PPAs: VST is now EMBEDDED in a NEW AI infrastructure platform backed by the most important names in AI capital (KKR) and compute (NVIDIA)
- **Earnings window:** Next earnings August 6, 2026 — 55 days away ✓
- **Thesis contract (REVISED):** invalidation = WTI >$100 (FALLING — further away ✓), FCF guidance cut, PPA/Helix partnership cancellation, or breaks below $130 on volume. review_by = July 7. Current $148.47. WTI well below $100. Helix launch REINFORCES and EXPANDS thesis. **THESIS INTACT AND MATERIALLY STRENGTHENED.** ✓
- **Stop buffer:** $148.47 - $135.270 = **$13.20 (8.89%)** ✓ Strong recovery.
- **-7% cut threshold:** $138.39 — VST at $148.47 is **$10.08 above it** ✓ CLEAR
- **Dividend ex-date:** June 22 (10 days) — USD 9.20 for 40 shares (confirmed $0.23/sh × 40sh)
- **Decision: HOLD. Helix launch is a material thesis upgrade. VST is now more than a "nuclear PPA story" — it is the preferred power infrastructure backbone for KKR+NVIDIA's AI infrastructure platform. Do not let the trailing stop close this prematurely. Current stop at $135.27 is $13.20 below market.**

---

### Thesis contract review (June 12)

- **LLY:** ✅ Intact. Stop $1,064.46. review_by July 1. Distance to stop: $100.89. No invalidation triggered. **CONTINUE.**
- **V:** ✅ Intact. Stop $292.96. review_by July 28. Distance to stop: $27.59. No invalidation triggered. **CONTINUE.**
- **VST:** ✅ MATERIALLY STRENGTHENED. Invalidation criteria: WTI >$100 (NO ✓ — falling), FCF cut (NO ✓), PPA/Helix cancellation (NO ✓ — Helix JUST LAUNCHED), breaks $130 on volume (NO ✓ — $148.47). review_by July 7. **CONTINUE. Thesis upgrade.**

---

### Risk posture check (pre-market June 12)

| Check | Value | Limit | Status |
|-------|-------|-------|--------|
| New positions this week | 2/3 (VST Jun 9, V Jun 10) | ≤3 | Slot 3 expires unused today |
| Cash | $74,304.63 (75.1%) | ≥5% | ✓ Ample |
| LLY stop buffer | $100.89 (8.66%) | watch | ✓ Well protected |
| V stop buffer | $27.59 (8.60%) | watch | ✓ Healthy |
| VST stop buffer | $13.20 (8.89%) | watch | ✓ Strong — Helix catalyst |
| VST above -7% threshold ($138.39)? | $10.08 above | — | ✓ Clear |
| Drawdown circuit breaker | $98,949 vs HWM $101,384 = -2.40% | <-10% | ✓ Not triggered |
| Intraday shock (vs last_equity $98,788) | +$160.60 = +0.16% | <-4% | ✓ Positive |
| 10yr yield | ~4.47% (est.) | <4.75% | ✓ Below trigger |
| WTI oil | Falling (Iran peace deal) | <$100 | ✓ Well below trigger |
| All trailing stops active | 4/4 confirmed | required | ✓ |
| Sector caps | Healthcare 11.78%, Financials 7.13%, Energy 6.01%, Cash 75.1% | <60% each | ✓ |

---

### New position research — Slot 3 (Week of June 8, expires today)

**LRCX (Lam Research): DEFER — ATR still elevated; stock extended**

**ATR check (3-day, June 9-11 — from Alpaca bars):**
- June 11: H $364.59 / L $336.285 / C $362.58 → range **$28.305 = 7.81%** ❌ (WAY above 3%)
- June 10: H $347.66 / L $319.01 / C $321.74 → range **$28.65 = 8.91%** ❌
- June 9: H $349.00 / L $306.03 / C $327.195 → range **$42.97 = 13.13%** ❌
- **3-day average ATR: ~9.95%** — still far above the 3% ATR threshold

**Extension check:** LRCX +12.7% on June 11 alone ($321.74 → $362.58). In 6 trading days since June 5 ($303.26), LRCX is up +19.5%. This is a parabolic extension, not a controlled basing pattern. The stock needs to consolidate for several sessions before a clean risk-defined entry is possible.

**Additional factors against Friday entry:**
- Weekend risk: opening a position on Friday that's +19.5% in 6 days with ~10% ATR creates substantial gap risk over the weekend
- Slot 3 was explicitly deferred all week — the discipline of that decision should hold

**Decision: SLOT 3 EXPIRES UNUSED. Deliberate and correct.**

**LRCX re-evaluation week of June 16:**
Conditions for re-entry:
1. ATR normalizes to ≤3% (needs 3+ consecutive quiet sessions with ranges <3%)
2. Stock bases (2-3 sessions with tight closes, contracting volume, no new lows)
3. Not extended >10% above 50-day SMA (need to verify — but at $362.58 after +19.5% 6-day run, extension is likely significant)
4. No earnings in next 2 trading days (confirmed: August 5, 2026 ✓)

---

### Cash-drag explicit decision (June 12 — Friday)

Cash at 75.1% remains above strategy target (25-40%). Slot 3 of June 8 week expires unused today — fourth consecutive deferral since Monday. Explicit reasoning:
1. **LRCX ATR ~10%** — structurally inadvisable; even halved position creates unacceptable stop exposure
2. **LRCX extended** — +19.5% in 6 sessions, not a controlled base entry
3. **Friday weekend risk** — new position on a Friday after a parabolic run carries gap risk
4. **VST Helix upgrade** — the preferred power provider thesis is now materially stronger; the existing portfolio (LLY + V + VST) has improved quality while maintaining low drawdown risk

Next week (June 16) brings 3 fresh slots. No urgency to force any position today.

---

### Performance estimate (pre-market June 12)

- **Bull equity pre-market:** $98,949.03 (−1.05% since inception $100,000)
- **SPY June 11 close (est.):** ~$737.62
- **SPY pre-mkt estimate (futures +0.41%):** ~$740.65 → +0.16% since inception ($739.44)
- **Estimated gap:** Bull −1.05% vs SPY +0.16% = **~−1.21%** (gap widening slightly as SPY continues recovering from June 10 selloff; 75% cash limits upside capture)
- **Today P/L (unrealized, pre-mkt):** LLY +$44 (0.38%), V +$33 (0.47%), VST +$83.60 (1.43%) = net +$160.60 ✓

---

### Planned trades for today (Friday June 12, 2026)

**No new positions today.**

Reasons: (1) LRCX ATR ~9.95% — disqualified per volatility rule; stock extended +19.5% in 6 sessions; (2) Friday weekend risk — no new position opens with parabolic, high-ATR names before weekend; (3) Slot 3 of June 8 week intentionally expired unused — disciplined decision upheld all week; (4) Existing 3 positions (LLY, V, VST) all have intact/strengthened theses and healthy stop buffers. No urgency to force a fourth.

**Hold LLY, V, VST.** Let trailing stops work.

**Next week (June 16+):** 3 fresh slots. Priority research:
1. **LRCX** — re-evaluate if ATR normalizes and chart bases after 3+ quiet sessions
2. **NVDA** — Senate hearing passed (Huang didn't testify; hearing proceeded without CEO testimony). Re-evaluate post-hearing regulatory clarity. Prior stop-out was at $209.042. Would be a fresh entry.
3. **One new name** — COST (consumer defensive quality compounder), or MSFT (Azure AI thesis intact, may have re-based since stop-out at $419).

**VST watch:** Dividend ex-date June 22 in 10 days. Helix launch is thesis-upgradeable — monitor if market reprices VST significantly higher into next week. If VST breaks above HWM $150.30, stop auto-ratchets higher — protecting expanded gains.

```json
{
  "plan_date": "2026-06-12",
  "trades": []
}
```

EXECUTED: 2026-06-12T13:36:00Z — No trades; stop audit 4/4 passed (VST HWM ratcheted to $150.50, stop $135.45); LLY $1,167.985 (+6.81%), V $320.75 (-0.87%), VST $148.39 (-0.28%/-7% threshold clear by USD 10.00). All guardrails ✓.

No trades planned.

**Upcoming catalysts:**
- **VST Helix Digital Infrastructure** — ongoing (KKR+NVIDIA platform positioning) — thesis upgrade watch
- **VST dividend ex-date June 22** (USD 9.20 credit for 40sh = $0.23/sh — 10 days)
- **LLY Medicare GLP-1 Bridge July 1** (19 days — thesis review_by date)
- **VST thesis review_by July 7** (25 days)
- **V Q3 FY26 earnings July 28** (46 days — thesis review_by date)
- **LLY Q2 FY26 earnings ~August 5** (54 days)
- **VST Q2 FY26 earnings August 6** (55 days)
- **LRCX next earnings ~August 5** (54 days — not in window ✓)
- **Weekly review today at 4:30 PM** — Friday routine (separate from this pre-market)

---

## 2026-06-11 — Pre-market research (~08:05 ET)

**Today is Thursday June 11. Week of June 8: 2/3 new positions used (VST June 9, V June 10). 1 slot remaining.**

### Macro (pre-market June 11, 2026 ~08:05 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| S&P 500 futures | **+0.78%** | — | ✓ Rebounding after Wed -1.62% selloff |
| SPY June 10 close (Alpaca) | **$724.73** (prev $737.07 = Jun 9 close) | — | SPY -1.67% Wednesday — bigger than recorded |
| May PPI | **Due 8:30 AM ET today** | 10yr <4.75% | ⏳ KEY RISK — if hot, rate spike possible |
| Iran/US conflict | Ongoing military strikes; market watching oil/inflation | Oil <$100 | ⚠️ Monitor |
| NVDA Senate hearing | 10 AM ET today — Huang declined; non-NVDA witnesses testify | — | ⚠️ AI semi risk during market hours |
| 10yr Treasury yield | ~4.54% (June 10 estimate) | <4.75% | ✓ Below trigger |
| WTI crude | ~$88-90 area (easing) | <$100 | ✓ Below trigger |

**Macro posture: CAUTIOUSLY CONSTRUCTIVE.** Futures +0.78% — broad rebound from Wednesday's -1.62% SPY selloff (driven by Trump Iran military threat escalation). However, two key risk events unfold TODAY during the session: (1) May PPI at 8:30 AM — if hot, 10yr could spike above 4.75% and halt any new buys; (2) NVDA Senate Banking hearing at 10 AM — Huang declined to testify but panel proceeds; AI semi sector sentiment may shift during the session. No new positions until both events have cleared. The recovery in futures is constructive but not yet confirmed.

---

### Account (pre-market June 11, 2026 — live Alpaca data ~08:05 ET)

| Metric | Value |
|--------|-------|
| Equity | $98,438.13 |
| Cash | $74,304.63 (75.5%) |
| Long market value | $24,133.50 |
| Buying power | ~$364,792 |
| Last equity (June 10 close) | $98,315.05 |

**Intraday shock check:** +$123.08 = +0.13% above last_equity — POSITIVE. No shock. ✓

**Drawdown circuit breaker:** Equity $98,438.13 vs HWM $101,384.21 = **-2.91%** — well within -10% limit. ✓ NO RESTRICTION ON NEW BUYS (subject to other conditions).

---

### Trailing stop audit (pre-market June 11 — confirmed via Alpaca open orders endpoint)

| Order ID | Symbol | Qty | HWM | Stop | Status |
|----------|--------|-----|-----|------|--------|
| d4147484 | LLY | 7sh | $1,182.73 | $1,064.457 | ✓ new |
| 25989fb5 | LLY | 3sh | $1,182.73 | $1,064.457 | ✓ new |
| 66033918 | V | 22sh | $325.51 | $292.959 | ✓ new |
| c4c200a5 | VST | 40sh | $150.30 | $135.270 | ✓ new |

All 4 trailing stops confirmed active. ✓

---

### Held positions (pre-market June 11, 2026)

**LLY ($1,136.26 pre-mkt, -0.68% today from $1,143.94 June 10 close, +3.90% from avg entry $1,093.534):** ⭐ STRONG
- **What changed since yesterday:** No material negative events. Foundayo safety: FDA requested post-approval safety studies; 34 adverse event reports since April 9 launch including one liver failure case (April 30, 56-year-old male) — Lilly's Global Patient Safety team assessed the event as **unlikely to be connected to Foundayo**. This is manageable; the oral GLP-1 with a shorter safety track record than tirzepatide warranted FDA caution, but Lilly investigated and cleared the case. Three pipeline acquisitions announced (~USD 4B total): Curevo, LimmaTech Biologics, and other entities — expanding into vaccines/infectious disease. POSITIVE diversification. Jefferies PT $1,350 confirmed ✓. Medicare GLP-1 Bridge July 1 now 20 days away.
- **Stop buffer:** $1,136.26 - $1,064.457 = **$71.80 (6.32%)** ✓ Well protected.
- **Thesis contract:** invalidation = stop fires ($1,064.46) or Medicare Bridge reversed. review_by = July 1. Current $1,136.26 >> $1,064.46. **THESIS INTACT. HOLD.**
- **Decision: HOLD. Foundayo safety concern is immaterial (cleared by Lilly). Thesis strengthening.**

**V ($322.94 pre-mkt, -0.66% today from $325.05 June 10 close, -0.19% from avg entry $323.57):** ✓ FLAT/INTACT
- **What changed since yesterday:** Visa-OpenAI partnership announced — Visa to be integrated into OpenAI's platform, enabling online retailers to accept AI agent-driven transactions. POSITIVE — directly confirms the AI-driven commerce secular growth thesis. $38 billion swipe fee settlement resolved — removes long-standing regulatory overhang. POSITIVE. Pre-market weakness (-0.66%) is market-correlated, not Visa-specific.
- **Stop buffer:** $322.94 - $292.959 = **$29.98 (9.27%)** ✓ Healthy.
- **Thesis contract:** invalidation = trailing stop fires ($292.96) or Visa loses major network exclusivity, or regulatory mandate forces open access. review_by = July 28. Current $322.94 >> $292.96. **THESIS INTACT. HOLD.**
- **Decision: HOLD. OpenAI integration is direct thesis confirmation. No action.**

**VST ($141.40 pre-mkt per positions API, +2.06% today from $138.54 June 10 close, -4.98% from avg entry $148.81):** ✓ RECOVERING ⬆️
- **What changed since yesterday:** SIGNIFICANT RECOVERY. VST closed June 10 at $138.51-$138.54 (only $0.12-$0.15 above the -7% cut threshold of $138.39 — even more critical than the $138.91 recorded at 15:52 ET). In pre-market June 11, VST is +2.06% to $141.40 — the recovery is driven by broad market rebound (+0.78% futures). No VST-specific news beyond the pre-market strength. Morgan Stanley and JPMorgan maintained Overweight and raised price targets. Dividend ex-date June 22 in 11 days (USD 9.16 credit for 40sh). Nuclear PPAs with Meta + AWS unchanged.
- **Stop buffer:** $141.40 - $135.270 = **$6.13 (4.33%)** ✓ Improved from Wednesday's critical 2.62%.
- **-7% cut threshold:** $138.39 — VST is $3.01 above it (2.18% cushion). Much improved.
- **Thesis contract:** invalidation = WTI >$100, FCF guidance cut, hyperscaler PPA cancellation, or breaks below $130 on volume. review_by = July 7. Current $141.40 >> $130 invalidation. WTI ~$88 ✓. PPAs unchanged ✓. **THESIS INTACT. HOLD.**
- **Decision: HOLD. Pre-market recovery is encouraging. Stop at $135.27 provides defined floor. Midday: verify -7% rule compliance (VST must be > $138.39 at 12:30 ET). Do NOT pre-empt the stop unless -7% rule is breached.**

---

### Thesis contract review (June 11)

- **LLY:** ✅ Intact. Stop $1,064.46. review_by July 1 (Medicare Bridge). No invalidation triggered. **CONTINUE.**
- **V:** ✅ Intact. Stop $292.96. review_by July 28 (earnings). No invalidation triggered. OpenAI partnership positive. **CONTINUE.**
- **VST:** ✅ Intact with pre-market recovery. Invalidation: WTI >$100 (NO ✓), FCF cut (NO ✓), PPA cancellation (NO ✓), breaks $130 on volume (NO — $141.40 >> $130 ✓). review_by July 7. **CONTINUE.**

---

### Guardrail check (pre-market June 11)

| Check | Value | Limit | Status |
|-------|-------|-------|--------|
| New positions this week | 2/3 (VST Jun 9, V Jun 10) | ≤3 | 1 slot remaining |
| Cash | $74,304.63 (75.5%) | ≥5% | ✓ Ample |
| LLY stop buffer | $71.80 (6.32%) | watch | ✓ Well protected |
| V stop buffer | $29.98 (9.27%) | watch | ✓ Healthy |
| VST stop buffer | $6.13 (4.33%) | watch | ✓ Improved — watch at midday |
| VST above -7% threshold ($138.39)? | $3.01 above | — | ✓ Improved |
| Drawdown circuit breaker | $98,438 vs HWM $101,384 = -2.91% | <-10% | ✓ Not triggered |
| Intraday shock (vs last_equity $98,315) | +$123 = +0.13% | <-4% | ✓ Positive |
| 10yr yield | ~4.54% | <4.75% | ✓ — Watch post-PPI 8:30 AM |
| WTI oil | ~$88 | <$100 | ✓ Below trigger |
| All trailing stops active | 4/4 confirmed | required | ✓ |

---

### New position research — Slot 3

**LRCX (Lam Research): DEFER — ATR disqualifies entry this week**

- **Price:** $321.74 (June 10 close)
- **Next earnings:** August 5, 2026 — well outside 2-day window ✓
- **Q3 2026:** EPS $1.46 (+40% YoY), revenue $5.84B (+24% YoY), both beat estimates ✓
- **June quarter guidance:** $6.6B ±$400M revenue (record), EPS $1.65 ±$0.15 ✓
- **UBS raised PT:** $375 from $310 on June 9 ✓
- **Dividend ex-date:** June 17, 2026 (6 days away) — NOT an earnings event, dividend only ✓

**ATR check (2-day sample, June 9-10):**
- June 10: H $347.66 / L $319.01 / C $321.74 → range **8.91%** ❌ (>3% threshold)
- June 9: H $349.00 / L $306.03 / C $327.195 → range **13.13%** ❌ (>3% threshold)
- 2-day average: **~11.0%** — WAY above 3% ATR threshold

Per the volatility check rule, ATR > 3% requires halving position size. But at 11% ATR, even a halved position means a 10% trailing stop provides only ~1 average day of cushion. This is not a manageable risk profile — LRCX is too volatile to enter this week.

**NVDA hearing factor:** The Senate Banking hearing begins 10 AM ET today. Huang declined to testify, reducing the risk of damaging CEO testimony. However, the hearing unfolds during the trading session, and AI semi sentiment may shift intraday. LRCX (semi equipment) is directly correlated.

**Decision: DEFER LRCX to next week (June 16+) when:**
1. ATR normalizes to ≤3% (requires 3+ quiet sessions)
2. NVDA hearing outcome is known and AI semi sentiment has stabilized
3. LRCX shows clear basing (≥2 consecutive days with tight closes and low volume)

**Week of June 8 Slot 3: UNUSED.** This is a deliberate, disciplined decision — not a passive default.

---

### Cash-drag explicit decision (June 11)

Cash at 75.5% is above the strategy target band (25-40% in build phase with 6-8 positions). The week's 1 remaining slot (Slot 3) will expire unused. This is correct for three reasons:
1. **LRCX ATR ~11%** makes entry this week structurally inadvisable even with halved sizing
2. **NVDA hearing today 10 AM** introduces mid-session AI semi risk that would directly affect LRCX
3. **May PPI 8:30 AM** creates early-session rate risk — if hot, 10yr spikes above 4.75% and no new buys today

Next week (June 16) brings 3 fresh slots. LRCX entry with a stabilized ATR, post-hearing clarity, and full week of slots is a better setup than forcing entry this week under elevated volatility.

---

### Performance estimate (pre-market June 11)

- **Bull equity pre-market:** $98,438.13 (−1.56% since inception $100,000)
- **SPY June 10 close (Alpaca):** $724.73 → −1.99% since inception $739.44
- **June 10 close gap:** Bull −1.69% ($98,315.05) vs SPY −1.99% ($724.73) = **Bull leads SPY by +0.30%** ✓
- **Pre-mkt SPY estimate:** $724.73 × 1.0078 ≈ $730.39 → −1.22% since inception
- **Pre-mkt estimated gap:** Bull −1.56% vs SPY −1.22% = −0.34% (Bull slightly trails as SPY recovers)
- Today P/L pre-mkt: LLY −$77.80 (−0.68%), V −$18.04 (−0.66%), VST +$114.40 (+2.06%) = net +$18.56 (+0.02%)

---

### Planned trades for today (Thursday June 11, 2026)

**No new positions today.**

Reasons: (1) LRCX ATR ~11% — disqualified per volatility rule even with halved sizing; (2) NVDA Senate hearing at 10 AM creates mid-session AI semi volatility; (3) May PPI at 8:30 AM creates early-session rate risk. Slot 3 intentionally expires unused — a disciplined cash decision, not a passive default.

**Hold LLY, V, VST.** Let all trailing stops work.

**VST watch at midday:** VST must remain > $138.39 at 12:30 PM check. Pre-market $141.40 shows cushion, but the session outcome matters.

```json
{
  "plan_date": "2026-06-11",
  "trades": []
}
```

No trades planned.

EXECUTED: 2026-06-11T13:36:00Z — No trades; stop audit passed (4/4 active); LLY $1,133.20 (+3.63%), V $321.845 (-0.53%), VST $141.06 (-5.21%/-7% threshold clear). All guardrails ✓.

**Upcoming catalysts:**
- **May PPI 8:30 AM ET TODAY** — rate risk trigger
- **NVDA Senate hearing 10 AM ET TODAY** — AI semi sentiment
- **VST dividend ex-date June 22** (USD 9.16 credit for 40sh — 11 days)
- **LLY Medicare GLP-1 Bridge July 1** (20 days)
- **V Q3 FY26 earnings July 28** (review_by date)
- **VST thesis review_by July 7**
- **LRCX re-evaluation next week (June 16+)** — Slot 1 of 3

---

## 2026-06-10 — Pre-market research (~08:08 ET)

**Today is Wednesday June 10. Week of June 8: 1/3 new positions used (VST June 9). 2 slots remaining.**

### Macro (pre-market June 10, 2026 ~08:08 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| WTI crude oil | **~$88/bbl** (−3% as Iran/Israel halt attacks) | <$100 halt-new-buys | ✓ FALLING — new buys eligible |
| S&P 500 futures | **−0.47%** | — | ⚠️ Weak — Polymarket 22% chance positive open |
| 10yr Treasury yield | ~4.54% (June 9 close; pre-mkt unchanged) | <4.75% watch | ✓ Below trigger — but CPI risk |
| **May CPI — due 8:30 AM ET TODAY** | Expected 4.2% YoY (core 2.9%) | 4.75% 10yr trigger | ⏳ KEY EVENT — first above 4% since May 2023 |
| Iran/US conflict | US and Iran exchanged military strikes overnight; Israel-Iran agreed to halt attacks; WTI falling | Oil <$100 | ⚠️ Volatile but de-escalating |
| Tech sector | AI names extending losses — overheating AI concern + inflation | — | ⚠️ Headwind |

**Macro posture: CAUTIOUS.** The dominant risk is the May CPI report at 8:30 AM ET. Expected headline 4.2% YoY — the highest reading since May 2023. If CPI prints hot or the 10yr yield spikes above 4.75% post-release, NO new buys today. The US-Iran exchange of strikes was alarming overnight, but WTI fell ~3% to ~$88 after a halt agreement, pulling the $100 oil trigger further away. Net oil direction: constructive for new buys. But the CPI gating condition is paramount — the market-open routine MUST check the actual CPI print and 10yr yield at 9:35 AM before executing any buy.

---

### Account (pre-market June 10, 2026 — live Alpaca data ~08:08 ET)

| Metric | Value |
|--------|-------|
| Equity | $98,568.84 |
| Cash | $72,753.19 (73.8%) |
| Long market value | $25,815.65 |
| Buying power | ~$363,297 |

---

### Held positions (pre-market June 10, 2026)

**Active trailing stops confirmed via Alpaca orders (08:08 ET):**

| Symbol | Order ID | Live HWM | Live Stop | Pre-mkt price | vs Entry | Pre-mkt % change |
|--------|----------|----------|-----------|--------------|---------|-----------------|
| LLY | d4147484 | $1,182.73 | $1,064.457 | $1,137.01 | **+3.98%** | −0.67% today |
| LLY | 25989fb5 | $1,182.73 | $1,064.457 | $1,137.01 | (same) | — |
| META | 4ea07e91 | $642.38 | $578.142 | $580.00 | **−6.55%** | **−0.785% today** ⚠️ CRITICAL |
| VST | c4c200a5 | $150.30 | $135.270 | $143.638 | −3.48% | −1.765% today |

**LLY ($1,137.01 pre-mkt, −0.67% today, +3.98% from avg entry $1,093.534):** ⭐ STRONG
- Jefferies raised price target to $1,350 (from $1,330) — analyst conviction increasing.
- LLY down modestly pre-market; no negative thesis events. Retatrutide Phase 3 data, all PBMs covering, Medicare Bridge July 1 (21 days) all intact.
- Stop buffer: $1,137.01 − $1,064.457 = **$72.55 (6.38%)** ✓ Well protected.
- **No action needed. Thesis strongest in portfolio.**
- What changed since yesterday: analyst PT raise positive; mild pre-market weakness consistent with broad market tone; thesis unchanged.

**META ($580.00 pre-mkt, −0.785% today, −6.55% from entry $620.637):** ⚠️ CRITICAL
- Stop 4ea07e91: HWM $642.38, stop **$578.142** — buffer **$1.858 (0.32%) CRITICAL**.
- -7% cut threshold: $577.19 — META is only **$2.81 above it**.
- Dividend ex-date: June 15 ($0.525 × 15sh = $7.875 credit) — 5 days away. If META stops out before June 15, we miss this dividend.
- Next earnings: July 29, 2026.
- No META-specific negative catalyst today; weakness is macro-driven (market -0.47%, CPI risk, AI sector headwind).
- AI ad thesis (Q1 revenue +33% YoY, enterprise AI agents, BofA Buy $856 PT) remains intact.
- **With market futures −0.47% and hot CPI risk at 8:30 AM, META's trailing stop may fire at market open. This is the stop doing its job. DO NOT manually intervene. Let the stop manage the exit.**
- What changed since yesterday: no company-specific news; broader market pressure continues; stop buffer narrowed from 1.39% EOD to 0.32% pre-market.

**VST ($143.638 pre-mkt, −1.765% today, −3.48% from entry $148.81):** ✓ WITHIN RANGE
- Stop c4c200a5: HWM $150.30, stop **$135.270** — buffer **$8.368 (5.83%)** ✓
- Dividend ex-date: June 22 ($0.229 × 40sh = $9.16 credit) — 12 days away. ✓
- -7% cut threshold: $138.39 — VST is $5.24 above it. NOT triggered.
- Thesis: Nuclear PPAs with Meta + AWS unchanged. Q1 2026 adj EBITDA +20% YoY; revenue +43% YoY confirmed.
- Pre-market weakness consistent with broader market tone and energy sector correlation.
- **No action. Thesis intact. Stop protecting.** ✓
- What changed since yesterday: dividend ex-date confirmed June 22; no thesis changes; mild pre-market weakness is market-correlated.

---

### Thesis contract review (June 10)

- **LLY:** invalidation = stop fires ($1,064.457) or Medicare GLP-1 Bridge reversed. review_by = July 1 (Bridge effective). Current $1,137 >> invalidation. Thesis intact. **CONTINUE.** ✓
- **META:** invalidation = price hits $577.19 (-7% threshold, co-located with stop $578.142). review_by = June 15. At $580 pre-market, META is at the invalidation boundary. **Decision: HOLD and let stop manage. If stop fires, the position exits automatically — that is correct process.** The AI ad thesis is not broken; the price action is responding to macro shock. Do NOT manually force an exit or extension.
- **VST:** invalidation = WTI >$100, FCF guidance cut, hyperscaler PPA cancellation, or breaks below $130 on volume. review_by = July 7, 2026 (set today — 4 weeks from June 9 entry). Thesis intact on all invalidation criteria. WTI $88 ✓. No guidance changes ✓. PPAs unchanged ✓. **CONTINUE.** ✓

---

### Guardrail check (pre-market June 10)

| Check | Value | Limit | Status |
|-------|-------|-------|--------|
| New positions this week | 1/3 (VST June 9) | ≤3 | 2 slots remaining |
| Cash | $72,753 (73.8%) | ≥5% | ✓ Ample |
| LLY stop buffer | $72.55 (6.38%) | watch | ✓ Well protected |
| META stop buffer | $1.858 (0.32%) | WATCH | ⚠️ CRITICAL — may fire at open |
| META above −7% cut threshold ($577.19)? | Yes — $2.81 above | — | ⚠️ Barely |
| VST stop buffer | $8.368 (5.83%) | watch | ✓ Adequate |
| WTI oil | ~$88 (−3%) | <$100 | ✓ ELIGIBLE |
| 10yr yield | ~4.54% (June 9) | <4.75% | ✓ — WATCH post-CPI 8:30 AM |
| Drawdown circuit breaker | $98,568 vs HWM $101,384 = −2.78% | <−10% | ✓ Not triggered |
| Intraday shock (vs last_equity $98,817) | −$248.80 = −0.25% | <−4% | ✓ |
| Week of Jun 8: slots used | 1/3 | ≤3/week | ✓ |

---

### New position research

**Slot 2 — V (Visa): CONDITIONAL BUY — concern RESOLVED**

**BLOCKER RESOLVED:** CFO Chris Suh's May 12 sale of 10,639 shares at $324.88 was executed under a **pre-arranged Rule 10b5-1 trading plan** (confirmed via SEC filing). This was NOT a discretionary open-market sale. The concern that has blocked V for two weeks is now cleared.

**Current price:** $325.055 (June 9 close). V is trading ABOVE the CFO's $324.88 sale price — constructive.

**Thesis:**
Visa is the world's largest payments network — an asset-light moat that processes every dollar of digital commerce, earns a fee on each transaction, and benefits structurally from cash-to-card conversion and the secular growth in AI-driven digital commerce. Q2 FY26: net revenue $11.2B (+17% YoY), non-GAAP EPS $3.31 (beat). $20B buyback just authorized — signals management confidence. The company faces no existential threat from crypto or CBDCs in the near term. Adds Financials sector diversification to a portfolio currently heavy in Healthcare/Tech/Energy.

**Entry signal check (need ≥3 of 5):**
1. ✓ Earnings momentum: Q2 FY26 +17% revenue YoY, EPS beat by 2.8%; strong track record
2. ✓ Clear catalyst: $20B buyback authorized; AI commerce growth driving transaction volumes; Q3 earnings July 28
3. ✓ Reasonable valuation: Visa's durable moat and minimal capex justify premium; reasonable vs. history given rate environment
4. ✓ Technical: V closed $325 on June 9, up from $319.72 June 8 — recovering after CFO-overhang suppressed price. Now trading at/above CFO sale price. Momentum is constructive.
5. ✓ Macro tailwind: Strong US consumer; digital payments penetration growing; AI-driven commerce volumes accelerating. Financials sector not correlated with AI semi volatility.

**Result: 5 of 5 criteria met → STRONG BUY signal (conditional on CPI).**

**Earnings window:** V Q3 FY26 earnings July 28, 2026 — **48 days away**. Well outside 2-day earnings window. ✓

**ATR check:** V June 9 range: $325.45−$317.13 = $8.32 (2.56%). June 8 range: $4.88 (1.53%). Estimated 20-day ATR ~2.0% — well below 3% threshold. No position halving needed. ✓

**Sizing:**
- 22 shares × $325 = **$7,150 = 7.3% of portfolio** (starter conviction)
- Cash after fill: $72,753 − $7,150 = $65,603 = 66.5% >> 5% minimum ✓
- Daily deployment: $7,150 = 7.3% ≤ 25% cap ✓
- Single position cap: 7.3% ≤ 20% cap ✓
- Sector: Financials — adds diversification ✓
- New positions this week: 2/3 (VST June 9, V June 10) ✓
- Risk budget: 22sh × $325 × 10% stop = $715 loss = 0.73% of equity ✓ (≤1.2%)

**Stop:** 10% trailing stop immediately after fill.

**CPI condition (CRITICAL):** The market-open routine MUST verify at 9:35 AM:
(1) Actual May CPI headline ≤ 4.2% YoY AND 10yr Treasury below 4.75% at market open time.
(2) V opens in the $310–$340 range (not gapping beyond 5% from prior close).
If CPI comes in hot (> 4.2%) or 10yr spikes above 4.75% → DEFER V to Thursday or next week.

---

**Slot 3 — LRCX: DEFER**
- LRCX closed $327 on June 9 but had a massive intraday range: high $349, low $306 (13.1% single-day range). Still too volatile.
- NVDA Senate Banking Committee hearing June 11 (tomorrow) — CEO Huang declined to testify; hearing proceeds. This is primarily an AI semi regulatory catalyst. Semi equipment sector (LRCX) will react to hearing outcome.
- Pre-market LRCX: ~$309 — still below recent closes. Not basing cleanly.
- **Decision: DEFER. Re-evaluate Thursday or next week once post-hearing AI semi sentiment clarifies.** Slot 3 remains open.

---

### Performance estimate (pre-market June 10)

- **Bull equity pre-market:** $98,568.84 (−1.43% since inception $100,000)
- **SPY estimate:** ~$729.6 (futures −0.47% from $733.06 June 9 close) → −1.33% since inception
- **Estimated gap:** ~−0.10% (essentially at par — SPY weakness pre-market bringing it toward Bull)
- Today P/L (unrealized, pre-mkt): LLY −$76.70, META −$68.85, VST −$103.25 = **−$248.80** (−0.25%)

---

### Planned trades for today (Wednesday June 10, 2026)

**Primary: BUY V (Visa) 22 shares — CONDITIONAL on CPI and 10yr yield**

**Conditions (market-open routine must verify before executing):**
- Actual May CPI ≤ 4.2% YoY headline AND 10yr Treasury yield < 4.75% at 9:35 AM
- V opens in the $310–$340 range
- Market not in freefall (SPY not down > 1.5% at open)

**Hold LLY, META (stop active), VST.**

```json
{
  "plan_date": "2026-06-10",
  "trades": [
    {"action": "buy", "symbol": "V", "qty": 22, "thesis": "Payments infrastructure compounder; Q2 FY26 revenue +17% YoY; CFO 10b5-1 sale confirmed (not discretionary); $20B buyback; sector diversification into Financials; 5-of-5 entry signals met",
     "invalidation": "V closes below entry × 0.90 (10% trailing stop fires), or Visa loses major network exclusivity, or regulatory mandate forces open access",
     "review_by": "2026-07-28"}
  ]
}
```

EXECUTED: 2026-06-10T13:39:48Z — BUY V 22sh @ $323.57 avg; 10% trailing stop 66033918 (HWM $323.735, stop $291.362) placed and confirmed ✓

**CPI hot-case (10yr > 4.75% at open):** No trades today. Defer V to Thursday/Friday once rate shock is absorbed.

**META watch:** If META opens at or below $578.142, the trailing stop fires automatically — no manual intervention needed. If META opens at $578–$582, it is on life support; midday -7% rule at $577.19 is the next guardrail.

**Upcoming catalysts:**
- **May CPI TODAY 8:30 AM ET** — key rate trigger for V buy decision
- **NVDA Senate Banking hearing June 11 (tomorrow)** — CEO Huang declined; hearing proceeds; AI semi reaction watch
- **META dividend ex-date June 15** ($7.875 credit — hold if possible)
- **VST dividend ex-date June 22** ($9.16 credit)
- **LLY Medicare GLP-1 Bridge July 1** — 21 days away
- **V Q3 FY26 earnings July 28** — review_by date set

---

## 2026-06-09 — Pre-market research (~08:07 ET)

**Today is Tuesday June 9. Week of June 8: 0/3 new positions used. 3 fresh slots.**

### Macro (pre-market June 9, 2026 ~08:07 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| WTI crude oil | **$90.20** (−1.2% today) | <$100 halt-new-buys | ✓ FALLING — Iran/Israel tensions easing |
| Brent crude | ~$93.30 | — | ✓ Pulling back from recent highs |
| S&P 500 futures | **+0.71%** | — | ✓ Strong rebound; chip stocks leading |
| 10yr Treasury yield | ~4.55–4.57% (est; post-NFP level) | <4.75% watch | ✓ Below trigger |
| Iran/Israel | Pause in attacks overnight — tensions easing | Oil <$100 | ✓ Improving; WTI falling |
| NVDA CEO testimony | Jensen Huang **DECLINED** Senate testimony June 11 | — | ✓ Reduces CEO testimony tail risk |
| Economic data today | Wholesale inventories, existing home sales, NFIB small biz sentiment | — | Watch — not expected to be market-moving |

**Macro posture: CONSTRUCTIVE.** Iran/Israel easing is the dominant overnight development. WTI fell −1.2% to $90.20, pulling the $100 halt trigger $9.80 further away — and moving in the right direction. S&P futures +0.71% led by chip stock rebound. NVDA CEO declining Senate testimony removes the tail risk of CEO-testifies-and-makes-damaging-admissions scenario; the hearing proceeds without NVDA's cooperation. New positions are **ELIGIBLE** today (WTI <$100 ✓, 10yr <4.75% ✓, oil direction improving ✓).

---

### Account (pre-market June 9, 2026 — live Alpaca data ~08:07 ET)

| Metric | Value |
|--------|-------|
| Equity | $99,135.90 |
| Cash | $78,705.60 (79.3%) |
| Long market value | $20,430.30 |
| Buying power | ~$372,027 |

---

### Held positions (pre-market June 9, 2026)

**All 3 trailing stop orders confirmed ACTIVE (verified via Alpaca orders 08:07 ET):**

| Symbol | Order ID | Live HWM | Live Stop | Pre-mkt price | vs Entry (avg) | Pre-mkt % change |
|--------|----------|----------|-----------|--------------|---------|-----------------|
| LLY | d4147484 | $1,182.73 | $1,064.457 | $1,155.00 | **+5.62%** | **+0.51% today** ⭐ |
| LLY | 25989fb5 | $1,182.73 | $1,064.457 | $1,155.00 | (same 10-share position) | — |
| META | 4ea07e91 | $642.38 | $578.142 | $592.02 | **−4.61%** | **+1.13% today** ✓ (recovering) |

**LLY ($1,155.00 pre-mkt, +0.51% today, +5.62% from avg entry $1,093.534):** ⭐ EXCEPTIONAL
- **BREAKING (June 6): Positive Phase 3 data for retatrutide at ADA 86th Scientific Sessions.**
  - Retatrutide is Lilly's NEXT-GENERATION triple-agonist (GIP + GLP-1 + glucagon receptors) vs tirzepatide's dual-agonist
  - TRIUMPH-1 and TRANSCEND-T2D-1 trials: substantial weight loss + improvements in knee osteoarthritis pain, obstructive sleep apnea, and type 2 diabetes
  - This is the step-change beyond Mounjaro/Zepbound; significantly widens LLY's moat vs Novo Nordisk
- Foundayo oral GLP-1 pill: FDA-approved, no food/water restrictions — addressing needle aversion, the primary adoption barrier. CVS formulary already active.
- Medicare GLP-1 Bridge program effective July 1 — now **22 days away**. ~20-30M Medicare beneficiaries eligible.
- All 3 major PBMs (CVS, Express Scripts, OptumRx) covering full LLY obesity portfolio.
- Q1 FY2026 revenue +56% YoY; full-year guidance raised $2B.
- **Stop buffer:** $1,155.00 − $1,064.457 = $90.54 (7.84%) ✓ Well protected.
- **Distance from HWM:** $1,182.73 − $1,155.00 = $27.73 (2.34% below HWM). If LLY breaks $1,182.73 today, stops ratchet higher automatically.
- **No action needed. Thesis is the strongest in the portfolio and getting stronger with retatrutide data.**

**META ($592.02 pre-mkt, +1.13% today, −4.61% from entry $620.637):** ✓ RECOVERING
- **Alert status: CLEAR.** Pre-market $592.02 is well above $582 Monday alert level and above $577.19 cut threshold.
- NEW CATALYST: Meta launched enterprise AI business agent across WhatsApp, Instagram, and Messenger — enables companies to automate lead qualification, booking, sales closing, and customer escalation. Validates the AI ad platform thesis with a new revenue layer.
- Bank of America maintained Buy rating. Analyst consensus: 64 Buy, 6 Hold, avg target $856 (44% upside).
- Stop buffer: $592.02 − $578.142 = **$13.88 (2.34%)** — improved from 1.75% at yesterday's close.
- −7% cut threshold: $577.19 — META is $14.83 above it. NOT triggered.
- Pre-market recovery +1.13% shows market beginning to re-price AI ad thesis positively.
- **No action. Stop is active and properly positioned. Hold and let enterprise AI catalyst work.**

---

### Guardrail check (pre-market June 9)

| Check | Value | Limit | Status |
|-------|-------|-------|--------|
| New positions this week | 0/3 | ≤3 | 3 slots available |
| Cash | $78,705.60 (79.3%) | ≥5% | ✓ Ample |
| LLY stop buffer | $90.54 (7.84%) | watch | ✓ Well protected |
| META stop buffer | $13.88 (2.34%) | watch | ✓ Improved from 1.75% yesterday |
| META above −7% cut threshold? | Yes — $14.83 above $577.19 | $577.19 | ✓ Safe |
| WTI oil | $90.20 (−1.2%) | <$100 halt-new-buys | ✓ FALLING — eligible for new buys |
| 10yr yield | ~4.55–4.57% est | <4.75% | ✓ |
| Week of Jun 8: slots used | 0/3 | ≤3/week | ✓ |

---

### New position research

**Slot 1 — VST (Vistra Energy): CONDITIONAL BUY TODAY**

**Current price:** $146.885 (June 8 close). Last week's range: $147.52–$154.29 (Jun 5).

**Thesis:**
VST is a nuclear power operator that has locked in **20-year PPAs with Meta Platforms and Amazon** for baseload AI data-center electricity supply. As AI hyperscalers demand 24/7 clean baseload power (not intermittent solar/wind), nuclear is the only reliable answer at scale. VST is uniquely positioned: it owns the Perry nuclear plant (restarting), has existing nuclear fleet capacity, and has secured long-term contracted revenue streams with two of the world's largest AI buildout spenders.

**Entry signal check (need ≥3 of 5):**
1. ✓ Earnings momentum: Q1 2026 EPS +10.52% beat, revenue +8%, adj EBITDA +20% YoY. Stock jumped +14% on Q1 results.
2. ✓ Clear catalyst: 20-yr PPAs with Meta + AWS locked; Perry nuclear plant restart; AI power demand secular — hyperscaler electricity consumption doubling every 2 years.
3. ✓ Valuation: $220-225 analyst consensus target vs $146.89 current = **50%+ upside**. FCF yield highly attractive. 19 analysts Strong Buy.
4. ✗ Technical: VST at $146.885 is BELOW its 50-day SMA (~$154). ⚠️ Stock down 7% YTD.
   _Note: Below 50-day SMA is a genuine technical caution flag. However, the Q1 +14% jump and subsequent pullback to $146 may represent a "buy the dip after Q1 pop" opportunity._
5. ✓ Macro: WTI falling (eases near-term energy market uncertainty); Iran/Israel easing reduces commodity shock risk; AI data-center buildout continuing at accelerating pace. VST non-correlated to AI semi volatility (held up far better during June 5 AI semi selloff — −2.0% vs NVDA −4.4%).

**Result: 4 of 5 criteria met (strategy requires ≥3) → QUALIFIES with noted technical caution.**

**Sizing:**
- 40 shares × ~$147 = ~$5,880 = **5.9% of portfolio** (starter conviction)
- Cash after fill: $78,705.60 − $5,880 = $72,825.60 = ~73.4% of equity >> 5% minimum ✓
- Daily deployment: $5,880 = 5.9% of portfolio ≤ 25% cap ✓
- Single position cap: 5.9% ≤ 20% cap ✓
- Sector diversification: Adds Energy/Utilities. Current sectors: Healthcare (LLY 11.65%), Ad-tech (META 8.97%). VST brings sector balance ✓

**Stop:** 10% trailing stop immediately after fill.

**Entry condition:** VST must open at or above $145. If VST opens below $145 (making new lows), defer to Wednesday. This ensures we're not buying into a gap-down.

**Invalidation criteria:** WTI crude >$100 (macro shock), VST cuts FCF guidance, AI hyperscaler PPA cancellation or major modification, VST breaks below $130 on volume.

**This is Slot 1 of 3 for week of June 8.**

---

**Slot 2 — V (Visa): DEFER AGAIN**
- V closed $319.72 (June 8) — BELOW CFO's May 12 sale price of $324.88. Mildly concerning (CFO sold at $324.88 believing that was a fair price; V has since dropped −$5.16 = −1.6% from his sale level).
- CEO Ryan McInerney exercised options and sold 31,455 shares at $340.14 on April 29 under a **10b5-1 plan dated May 15, 2025** — PLANNED, not discretionary.
- CFO Chris Suh sold 10,639 shares at $324.88 on May 12 via **open-market transaction** — NO 10b5-1 confirmation found. This was after the CEO's planned 10b5-1 sale, suggesting the CFO acted independently.
- The CFO sold 51.9% of his directly held stake at market highs ($324.88) via what appears to be a discretionary open-market sale. This is the most meaningful negative insider signal.
- **Decision: DEFER V until CFO situation resolves.** May re-evaluate next week if V Form 4 details confirm 10b5-1, or if a new positive catalyst outweighs the insider signal.

---

**Slot 3 — LRCX (Lam Research): DEFER**
- June 8 close: need to check, but June 5 was $303.26 (−9.87% from $336.44 June 4).
- NVDA CEO declined Senate testimony → slightly positive for AI semis broadly, but LRCX still needs time to base.
- RSI was elevated even after the drop (70-72 on longer timeframe). Not enough consolidation yet.
- **Decision: DEFER. Target re-evaluation late next week once post-hearing sentiment clarifies.**

---

### Performance estimate (pre-market June 9)

- **Bull equity pre-market:** $99,135.90 (−0.87% since inception)
- **SPY estimate:** ~$744 (futures +0.71% on June 8 close $739.30) = +0.62% since inception
- **Estimated gap:** ~−1.49% (widened slightly from −0.96% at June 8 close as SPY gapped up strongly)
- Note: Gap widening is expected when market recovers sharply and Bull holds 79% cash. This will narrow as new positions are deployed.

---

### Planned trades for today (Tuesday June 9, 2026)

**Primary: BUY VST 40 shares at market open — CONDITIONAL**

**Thesis for VST starter:**
Nuclear power operator with locked 20-year PPAs with Meta + Amazon for AI data-center baseload electricity. The secular AI power demand story is the mirror image of the hyperscaler AI infra build — someone has to power those data centers reliably, and VST owns contracted nuclear capacity to do exactly that. Q1 adj EBITDA +20% YoY confirms the financial momentum. At $147 vs $220+ consensus target, the market is still valuing this as a traditional utility. Non-correlated to AI semi volatility — portfolio diversification benefit.

**Entry condition:** VST opens at or above $145. If VST opens below $145, defer to Wednesday.
**Size:** 40 shares (whole shares, trailing-stop eligible).
**Stop:** 10% trailing stop placed immediately after fill.
**Slot:** 1 of 3 for week of June 8.

**Secondary: HOLD LLY and META.**
- LLY: Let trailing stops ratchet with price. Retatrutide ADA data is fresh positive news — thesis strengthening.
- META: Stop at $578.142 is active. Pre-market recovery +1.13% is encouraging. Enterprise AI agent launch is a new positive. Hold and let stop manage risk. Do NOT manually intervene.

**Explicit non-trades:**
- V (Visa): DEFER. CFO 51.9% open-market stake sale unresolved.
- LRCX: DEFER. Still needs basing action.
- No NVDA re-entry yet (hearing June 11 still pending even without CEO testimony).

**Upcoming catalysts:**
- **NVDA Senate Banking hearing June 11** — proceeds without CEO Huang; watch for market reaction
- **META dividend ex-date ~June 15** ($0.525/sh × 15sh = $7.875 credit)
- **LLY Medicare GLP-1 Bridge July 1** — now 22 days away
- **Existing home sales + NFIB today** — minor macro releases

---

## 2026-06-08 — Pre-market research (~08:12 ET)

**Today is Monday June 8. Week of June 8: 0/3 new positions used. 3 fresh slots.**

### ⚠️ CRITICAL: WTI OIL AT $93.67 — Approaching $100 halt trigger

Iran and Israel exchanged strikes over the weekend (June 7–8 local time). WTI crude futures jumped **+3.46% to $93.67** (Brent $96.47). This is only **$6.33 below the $100 halt-new-buys trigger**. The direction is upward. This dramatically changes new-buy appetite for today — no new positions until oil direction clarifies.

---

### Macro (pre-market June 8, 2026 ~08:12 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| WTI crude oil | **$93.67** (+3.46% today) | <$100 halt-new-buys | ⚠️ RISING FAST — $6.33 below trigger |
| Brent crude | $96.47 | — | ⚠️ Iran/Israel escalation |
| S&P 500 futures / SPY pre-mkt | $742.81 (+0.73% from Jun 5 close $737.45) | — | ✓ Slightly constructive |
| 10yr Treasury yield | ~4.47% est (post-NFP, stable over weekend) | <4.75% watch | ✓ Constructive |
| Iran/Israel | Exchanged strikes Jun 7–8 — fragile ceasefire threatened | Oil <$100 | ⚠️ HIGH ALERT |
| MRVL | +9% pre-mkt (added to S&P 500 Jun 22) | — | ✓ Positive for semis broadly |

**Macro posture: Cautious.** Iran/Israel escalation creates oil-price risk. WTI at $93.67 with upward trajectory means no new buys today. Market is slightly up pre-market (S&P futures edging higher) but Iran/oil is the dominant risk factor. Hold positions; research candidates for later this week.

---

### Account (pre-market June 8, 2026 — live Alpaca data 08:12 ET)

| Metric | Value |
|--------|-------|
| Equity | $99,157.77 |
| Cash | $78,705.60 (79.4%) |
| Long market value | $20,452.17 |
| Buying power | ~$372,088 |

---

### Held positions (pre-market June 8, 2026)

**All 3 trailing stop orders confirmed ACTIVE (verified via Alpaca orders 08:12 ET):**

| Symbol | Order ID | Live HWM | Live Stop | Pre-mkt price | vs Entry (avg) | Pre-mkt % change |
|--------|----------|----------|-----------|--------------|---------|-----------------|
| LLY | d4147484 | $1,166.29 | $1,049.661 | $1,150.62 | **+5.22%** | **+1.70% today** ⭐ |
| LLY | 25989fb5 | $1,166.29 | $1,049.661 | $1,150.62 | (same 10-share position) | — |
| META | 4ea07e91 | $642.38 | $578.142 | $596.40 | **−3.91%** | **+0.57% today** ✓ |

**LLY ($1,150.62 pre-mkt, +1.70% today, +5.22% from avg entry $1,093.534):** ⭐ EXCEPTIONAL
- **BREAKING: Eli Lilly hits $1.01 TRILLION market capitalization today** (FX Leaders, June 8).
- Foundayo: FDA-approved GLP-1 pill that can be taken any time of day — widening moat.
- All three major PBMs (CVS, Express Scripts, OptumRx) covering full LLY obesity portfolio.
- Medicare GLP-1 Bridge program: effective July 1 — expands to ~20-30M Medicare beneficiaries.
- Q1 FY2026 revenue +56% YoY; full-year guidance raised by $2B.
- **Stop buffer:** $1,150.62 − $1,049.661 = $100.96 (8.77%) ✓ Well protected.
- **Distance from HWM:** $1,166.29 − $1,150.62 = $15.67 (1.36% below HWM). If LLY breaks $1,166.29 today, stops ratchet higher automatically.
- **No action needed. Thesis is the strongest in the portfolio. Let it run.**

**META ($596.40 pre-mkt, +0.57% today, −3.91% from entry $620.637):** ✓ ABOVE ALERT THRESHOLD
- **ALERT CLEARED:** META is above the $582 Monday-open alert level. Buffer from alert level: $14.40.
- Stop buffer: $596.40 − $578.142 = **$18.26 (3.07%)** — improved from 2.26% at EOD June 5.
- Thesis intact: Q1 2026 revenue +33% YoY (reported April 29 — strong beat). AI ad targeting improving conversion rates. $145B capex at scale. Subscription layer (Instagram Plus / Facebook Plus) live.
- June 5 selloff (-5.75% that day) was macro-driven (NFP shock + broad risk-off), not META-specific.
- June 7: Motley Fool "Why Meta Platforms Stock Is Worth Buying Despite It Being 'Speculative'" — bullish analysis continuing.
- Meta's selloff called "mispriced against its AI-driven earnings power" by Investing.com.
- **Watch if META approaches $582 intraday today — but pre-market signal is constructive.**
- **No action. Let stop protect.** 

---

### Guardrail check (pre-market June 8)

| Check | Value | Limit | Status |
|-------|-------|-------|--------|
| New positions this week | 0/3 (fresh week) | ≤3 | 3 slots available |
| Cash | $78,705.60 (79.4%) | ≥5% | ✓ Ample |
| LLY stop buffer | $100.96 (8.77%) | watch | ✓ Well protected |
| META stop buffer | $18.26 (3.07%) | watch | ✓ Improved |
| META above alert ($582)? | Yes — $596.40 | $582 threshold | ✓ Alert cleared |
| WTI oil | $93.67 (+3.46%) | <$100 halt-new-buys | ⚠️ APPROACHING TRIGGER |
| 10yr yield | ~4.47% est | <4.75% | ✓ |
| Week of Jun 8: slots used | 0/3 | ≤3/week | ✓ |

---

### New position research

**Slot 1 — V (Visa): CONTINUE DEFER**
- Q2 FY2026: Net revenue $11.2B (+17% YoY), EPS $3.31 (beat by 2.8%). $20B buyback authorized.
- Held up well June 5 (closed $323.66, essentially flat vs market −2.41%) — positive relative strength.
- ⚠️ **CFO Chris Suh: open-market sale of 10,639 shares @ $324.88 on May 12, 2026 — total $3.46M.**
  After sale, holds only 9,872 shares. Pre-sale position: ~20,511 shares. **SOLD 51.9% of his stake.**
  This is an open-market transaction — NOT confirmed as 10b5-1 plan. No secondary insiders confirmed selling, but this is a single CFO disposing of >50% of holdings at highs. Highly concerning.
- Visa stock at $323.66 (June 5) — around the CFO's sale price. If the CFO thought $324 was a good sale price, that's a valuation signal.
- **Decision: DEFER again.** Research whether sale was 10b5-1 plan-based or discretionary. Need to verify. Will not buy until CFO concern resolved.

**Slot 2 — LRCX (Lam Research): DEFER**
- June 5 close: $303.26. LRCX fell **−9.87% on June 5** (from $336.44 June 4) — massive single-session selloff.
- Prior to that: all-time high close $343.71 (June 3). Stock went $343 → $303 in two sessions = −11.7%.
- RSI at ~71-72 (approaching overbought) even after the drop — still technically extended on longer timeframe.
- 52-week return +304.79% — massive run before correction.
- Semi equipment sector faces near-term headwinds: NVDA Senate Banking hearing June 11 (regulatory noise), Iran/Israel geopolitical uncertainty.
- Entry signal #4 (technical): stock needs to stabilize/base before clean entry. −9.87% in one day is not a controlled pullback.
- Strategy.md: "not extended >10% above its 50-day moving average." Need 50-day SMA data — but after a +304% run, the 50-day is far below current levels. The stock is likely still well above it even at $303.
- **Decision: DEFER. Wait for stable basing action. Could revisit Tuesday/Wednesday once Iran/oil settles and semi sector finds a floor post-NVDA hearing.**

**Slot 3 — VST (Vistra Energy): RESEARCH CANDIDATE for mid-week**
- Current price: $148.75 (June 5 close). Down 7% YTD.
- Strong Buy consensus from 19 analysts. Avg target $225.29 (51% upside).
- Q1 2026: EPS $1.46 vs $1.32 est (+10.52% surprise). Revenue $5.64B vs $5.22B est (+8.0%).
- 20-year PPAs with Meta (AI data centers) and Amazon for PJM nuclear power.
- Restarting Perry nuclear plant (additional baseload capacity for AI power demand).
- **Iran/Israel impact:** WTI spiking today is bullish for natural gas prices and VST's conventional fleet. However, macro uncertainty may weigh on the stock short-term. Want to see how VST opens today before committing.
- Non-correlated to AI semi sector (didn't correlate with the June 5 AI semi selloff as badly as NVDA/MSFT/AVGO).
- Entry signal check:
  1. Earnings momentum: Q1 +10.52% EPS beat ✓
  2. Clear catalyst: 20-yr PPAs with Meta+Amazon locked; nuclear restart; AI power demand secular ✓
  3. Valuation: At $148, FY26 FCF yield looks attractive. 51% upside to consensus $225 target ✓
  4. Technical: Stock down 7% YTD in rising market = lagging. Need 50-day SMA confirmation.
  5. Macro: Iran/Israel adds near-term uncertainty but could BENEFIT VST (rising energy prices)
- **Decision: RESEARCH for Tuesday/Wednesday buy once WTI direction clarifies and VST opens cleanly.**
  Starter size would be 40-45 shares (~$6,000-6,700 = 6-7% of portfolio). Full thesis pending.

**Also consider (not yet researched for week of June 8):**
- **COST (Costco):** Consumer defensive. Q4 FY2026 earnings due mid-August — but pre-earn entry possible.
- **META add?** If META recovers past $620 (back above entry), a scale-up could be considered.

---

### Planned trades for today (Monday June 8, 2026)

**No new positions today.**

WTI crude at $93.67 (+3.46%) due to Iran/Israel strikes is approaching the $100 halt-new-buys trigger. Entering new positions into a macro shock day is poor process. All three slot candidates (V, LRCX, VST) require more research or cleaner technical setups.

- **LLY:** Hold. Approaching HWM $1,166.29 (+1.70% pre-mkt). Let stops ratchet if LLY breaks the HWM today. No manual intervention needed.
- **META:** Hold. Above $582 alert — constructive recovery. Monitor if META drifts toward $582 intraday. Stop at $578.142. If META opens strongly, watch for HWM approach ($642.38 is far away).
- **All 3 stops active** (d4147484, 25989fb5, 4ea07e91) — confirmed via Alpaca ✓

**Planned for Tuesday/Wednesday:**
- Research VST (Vistra) fully — complete pre-trade checklist. Target entry if WTI stabilizes below $95, macro settles.
- Check Visa Form 4 details — was May 12 sale a 10b5-1 plan or discretionary? This determines whether V slot can open.
- Monitor LRCX for stable base after -9.87% June 5 drop.
- Watch NVDA Senate Banking hearing June 11 — potential catalyst for AI semi recovery or further pressure.

**Upcoming catalysts (week of June 8):**
- META dividend ex-date ~June 15 ($0.525/sh × 15sh = $7.875 credit)
- LLY Medicare GLP-1 Bridge program effective July 1
- NVDA Senate Banking Committee hearing June 11 — regulatory noise
- Iran/Israel ceasefire status — key oil price driver
- V (Visa) Form 4 investigation — determines slot availability

---

## 2026-06-05 — Pre-market research (~08:08 ET)

**Today is Friday June 5. Week of June 1: 1/3 new positions used (META June 1). 2 slots remaining.**

### CRITICAL EVENT: May Nonfarm Payrolls — due 8:30 AM ET today

The NFP report drops 22 minutes from now. This is the dominant macro event for today and the swing
factor for whether to execute the LLY scale-up at the 9:35 AM open.

**Pre-release consensus:**
- NFP expected: 85K–125K (FactSet median 105K; FXStreet 85K)
- April actual: +115K; March: +178K
- Unemployment rate: 4.3% expected (unchanged)
- Average Hourly Earnings: +3.4% YoY expected (vs +3.6% April) — softening
- Article headline: "NFP set to show US job creation slowed in May, yet not enough to shift Fed's hawkish tilt"

**S&P 500 futures: -0.61% pre-NFP** — market cautious but not alarmed (also dragged by Lululemon
earnings miss/guidance cut after close June 4).

**NFP decision rule for LLY scale-up:**
- **PROCEED with LLY scale-up** if: jobs 50K–250K, AHE not shocking (monthly < 0.4%), 10yr stays
  below 4.75% post-release
- **HOLD (no trades)** if: jobs < 50K (recession fear) OR jobs > 300K + hot wages (hawkish shock)
  OR 10yr crosses 4.75% post-NFP

---

### Macro (pre-market June 5, 2026 ~08:08 ET)

| Indicator | Value | Threshold | Status |
|-----------|-------|-----------|--------|
| WTI crude oil | $92.13/bbl | <$100 halt-new-buys | ✓ Constructive (Iran ceasefire largely holding; oil in $89.72–$94.91 range) |
| 10yr Treasury yield | 4.46% | <4.75% watch | ✓ Constructive (-4 bps from Thursday; Israel-Lebanon ceasefire + Iran deal hopes) |
| S&P 500 futures | -0.61% | — | ⚠️ Pre-NFP caution; Lululemon guidance cut weighing |
| May NFP | TBD (8:30 AM) | 50K–250K benign | ⏳ KEY EVENT — decision pending |
| Iran deal | Fragile ceasefire; stalled talks | Oil <$100 | ✓ Below trigger |

---

### Held positions (pre-market June 5, 2026 — live Alpaca data 08:08 ET)

**Account:** Equity $99,844 | Cash $67,471.82 (67.6%) | Long market value $32,372.18

**All 4 trailing stops confirmed ACTIVE (verified via Alpaca orders 08:08 ET):**

| Symbol | Order ID | Live HWM | Live Stop | Pre-mkt price | vs Entry | Pre-mkt % change |
|--------|----------|----------|-----------|--------------|---------|-----------------|
| LLY | d4147484 | $1,149.10 | $1,034.19 | $1,137.24 | **+5.99%** | **+1.06% today** |
| META | 4ea07e91 | $642.38 | $578.142 | $624.30 | +0.59% | -0.52% today |
| MSFT | a55a3db6 | $466.32 | $419.688 | $429.55 | +1.71% | +0.35% today |
| NVDA | 8c6b9680 | $232.28 | $209.052 | $215.20 | **-0.51%** | **-1.58% today** ⚠️ |

**LLY ($1,137.24 pre-mkt, +1.06% today, +5.99% from entry $1,072.944):** ⭐ SCALE-UP CANDIDATE
- CVS Health announced "fantastic news" on June 5 (Motley Fool headline) — likely related to
  Zepbound/Foundayo coverage expansion. Reinforces the Medicare/Medicaid GLP-1 Bridge July 1 thesis.
- Lilly cutting German investment (EUR 2.3B → ~EUR 1.15B) to focus on US manufacturing — capital
  discipline signal; redirecting to Pennsylvania site or new US facility.
- LLY approaching HWM $1,149.10 (currently $11.86 below it, 1.04%). If LLY breaks $1,149.10
  today, trailing stop ratchets higher automatically.
- GF Score 98 (GuruFocus) — exceptional fundamental quality rating.
- **Stop buffer:** $1,137.24 - $1,034.19 = $103.05 (9.1% from current price). Well protected. ✓
- **PLAN: ADD 3 shares at open (Slot 2) — subject to NFP being benign.**

**META ($624.30 pre-mkt, -0.52% today, +0.59% from entry $620.637):**
- Minor softness. No significant new catalysts. AI ad thesis intact.
- Dividend ex-date revised to June 15 (earlier than June 25 previously noted — confirm at open).
- Stop buffer: $624.30 - $578.142 = $46.16 (7.4%) ✓
- No action.

**MSFT ($429.55 pre-mkt, +0.35% today, +1.71% from entry $422.31):**
- Essentially flat, constructive. Morgan Stanley "time to act" — "bullish on upside potential."
- Azure AI thesis intact. Post-Build conference digestion ongoing.
- Stop buffer: $429.55 - $419.688 = $9.86 (2.3%) — narrow but within tolerance.
  Watch if NFP causes a broad risk-off that pushes MSFT down materially.
- No action.

**NVDA ($215.20 pre-mkt, -1.58% today, -0.51% from entry $216.302):** ⚠️ WATCH
- Down -1.58% pre-market. Specific catalyst: Senator Elizabeth Warren invited NVDA CEO Jensen
  Huang to testify before the Senate Banking Committee June 11 about China business and US export
  controls. This introduces regulatory overhang noise but is NOT a thesis break.
- AI accelerator monopoly thesis intact. China business hearing is a known risk, not new.
- Stop buffer: $215.20 - $209.052 = $6.15 (2.9%) — narrowing. With S&P futures -0.61%, NVDA
  could face additional pressure at open.
- **If NVDA opens ≤ $209.05, stop fires automatically. DO NOT intervene.**
- Ex-div credit $7.50 should have posted to cash; verify at market open.

---

### Guardrail check (pre-market June 5)

| Check | Value | Limit | Status |
|-------|-------|-------|--------|
| New positions this week | 1/3 (META June 1) | ≤3 | 2 slots remaining |
| Cash | $67,471.82 (67.6%) | ≥5% | ✓ Ample |
| Cash after LLY +3sh add | $67,472 - ~$3,412 = ~$64,060 (64.1%) | ≥5% | ✓ |
| LLY position after add | 10sh × ~$1,137 = ~$11,370 = 11.4% portfolio | ≤20% | ✓ |
| Daily new-buy deployment (LLY add only) | ~$3,412 = 3.4% of portfolio | ≤25% ($24,961) | ✓ |
| WTI oil | $92.13 | <$100 | ✓ |
| 10yr yield | 4.46% | <4.75% | ✓ |
| NVDA stop buffer | $215.20 vs $209.052 (2.9%) | watch | ⚠️ Narrow |
| MSFT stop buffer | $429.55 vs $419.688 (2.3%) | watch | ⚠️ Narrow-ish |

---

### New position research

**Slot 2 — LLY scale-up (+3 shares):**
Fully researched above. Execute at open conditional on NFP.

**Slot 3 — V (Visa):**
- Q2 FY2026: Net revenue $11.2B (+17% YoY), non-GAAP EPS $3.31 (beat by 2.8%). $20B buyback authorized.
- Stock up +3.36% on June 4 — strong momentum.
- Payments infrastructure, sector diversification from AI-heavy book.
- ⚠️ **CONCERN: CFO Chris Suh reduced his position by >50% in May** (insider selling). Significant.
  Per strategy.md entry signals, insider selling clusters are a flag to "dig deeper." Not an
  automatic skip, but warrants scrutiny.
- **Decision: DEFER Visa to next week.** Insider selling flag is unresolved. With LLY scale-up
  already in plan for today, no need to rush Slot 3. Research V thoroughly next week before committing.

---

### Planned trades for today (Friday June 5, 2026)

**Primary: BUY LLY +3 shares at market open (Slot 2 of 3 for week of June 1) — CONDITIONAL**

**Thesis for LLY scale-up:**
GLP-1 franchise dominance is strengthening: Medicare/Medicaid GLP-1 Bridge program effective
July 1 expanding access to ~20-30M beneficiaries; all three major PBMs covering full Lilly portfolio;
CVS additional positive announcement today (June 5); Q1 revenue +56% YoY; GLP-1 market share 60.1%.
Stock at $1,137.24 pre-market is +5.99% from our entry — scale-up adds to a thesis that is
actively confirming. Adding to a winner on fundamental confirmation, not chasing.
Scale from 7 shares (7.97% portfolio weight) to 10 shares (~11.4% portfolio weight).

**Condition:** NFP must be in the "benign" range (50K–250K, AHE not shocking, 10yr stays below 4.75%).
The market-open routine should check the NFP result and 10yr yield at 9:35 AM before executing.

**Stop for added 3 shares:** Place new 10% trailing stop on 3 additional shares immediately after fill.
(Existing stop d4147484 covers 7 shares. Need separate stop for +3.)

**Secondary: HOLD all 4 existing positions.**
Watch NVDA at open — stop $209.052, 2.9% buffer.

**Slot 3 (V/Visa): DEFER to next week.** CFO insider selling requires more research.

**If NFP is NOT benign (yield spike >4.75%, or extreme print):**
- No new buys. Hold all positions. Tighten attention on NVDA stop.
- Flag in next routine.

**Upcoming catalysts:**
- May NFP **TODAY** 8:30 AM ET — gates today's trade
- META dividend ex-date likely June 15 (15sh × $0.525 = $7.875 credit) — verify at open
- LLY Medicare GLP-1 Bridge program effective July 1
- NVDA Senate Banking Committee hearing June 11 (regulatory noise; not thesis break)
- V (Visa) — research for Slot 3 next week

---

## 2026-06-04 — Pre-market research (~08:07 ET)

**Today is Thursday June 4. Week of June 1: 1/3 new positions used (META June 1). 2 slots remaining.**

### CRITICAL: AVGO earnings — post-earnings gap down

**AVGO reported Q2 FY2026 after close June 3. Results were MIXED:**

| Metric | Actual | Estimate / Guide | vs. Expectation |
|--------|--------|-----------------|-----------------|
| Revenue | $22.19B | $22.27B est | Slight miss |
| EPS (adj) | $2.44 | $2.40 est | Beat ✓ |
| AI semiconductor revenue | $10.8B (+143% YoY) | $10.7B guide | Marginal beat ✓ |
| Infrastructure software | $7.18B | $7.32B est | **MISS** ✗ |
| Q3 revenue guidance | $29.4B | $28.53B est | Beat ✓ |
| Q3 AI semiconductor guide | $16.0B | >$11.5B threshold | Crushed threshold ✓ |
| Full-year AI semi guidance | Reaffirmed >$100B (FY2027) | Expected raise | **Not raised** ✗ |

**Market reaction: AVGO -14.93% pre-market at ~$408.98.**
- Stock gapped from official June 3 close ~$478.62 to ~$408-409 overnight
- "Buy the rumor, sell the news" — stock ran +17.98% from entry before print
- Software miss ($7.18B vs $7.32B) and failure to raise full-year AI guidance disappointed bulls
- Options implied ±10.65% move; actual move is ~15%

**AVGO trailing stop situation:**
- Stop (a8e344f4): HWM $495.00, stop **$445.50** — ACTIVE (confirmed in Alpaca orders)
- Pre-market AVGO: ~$408.98 — well below $445.50 stop
- **The trailing stop WILL FIRE at market open.** AVGO exits at ~$408-410 (gap risk: stop fills at market price, not $445.50)
- Result: 20 shares × ~($409 − $417.37) = ~**−$170 loss** from entry (−2.0%)
- This is gap risk — the stop protects against further decline but cannot prevent the gap itself

**Scale-up decision: DO NOT SCALE UP. CANCELLED.**
- Technical conditions were met (AI rev $10.8B > $10.7B guide; Q3 AI $16.0B >> $11.5B threshold)
- BUT: buying into a −15% post-earnings gapper is chasing a falling knife
- Market's verdict is clearly negative; software miss + guidance-not-raised disappointed
- Additionally, the trailing stop fires at open — AVGO exits automatically; can't scale up a closing position
- The scale-up plan's spirit was "add on confirmation with positive market reaction" — that condition is NOT met
- **No action needed. Trailing stop handles AVGO exit.**

---

### Macro (June 4, 2026 pre-market)

- **S&P futures:** Likely under pressure from AVGO's -15% move. AI semi sector broader sympathy selling possible.
- **10yr Treasury yield:** ~4.44–4.50% (constructive range, unchanged)
- **WTI crude:** **$95.68** — rising for 3rd consecutive session on US-Iran peace-talk uncertainty. Only $4.32 away from $100 halt-new-buys trigger. ⚠️ WATCH.
- **Market posture:** Cautious today. AVGO fallout will pressure AI/tech names at open. WTI elevated. No defensive pivot warranted but no new buys today.

---

### Held positions (pre-market June 4, 2026 — live Alpaca data 08:07 ET)

**Account:** Equity $99,461.64 | Cash $59,299.64 (59.6%) | Long market value $40,162.00

**Active trailing stops (confirmed via Alpaca orders):**

| Symbol | Order ID | HWM | Stop | Pre-mkt price | vs Entry | Status |
|--------|----------|-----|------|--------------|---------|--------|
| AVGO | a8e344f4 | $495.00 | **$445.50** | ~$408.98 | **−2.01%** | ⚠️ FIRES AT OPEN |
| META | 4ea07e91 | $624.81 | $562.329 | $618.24 | −0.39% | ✓ Active |
| MSFT | a55a3db6 | $466.32 | $419.688 | $433.50 | +2.65% | ✓ Active |
| LLY | d4147484 | $1,149.10 | $1,034.19 | $1,098.51 | +2.38% | ✓ Active |
| NVDA | 8c6b9680 | $232.28 | $209.052 | $212.53 | **−1.76%** | ⚠️ WATCH — 1.6% buffer |

**AVGO (~$408.98, trailing stop fires at open):**
- Trailing stop at $445.50 will execute at market open. Position closes at ~$408-410 (gap-filled below stop)
- Entry $417.37; proceeds ~$8,180; net loss from entry ~−$170 (−2.01% on cost basis)
- The big gain (+$1,357 at June 3 close) is wiped by the gap-down — this is gap risk
- THESIS STATUS: Mixed print. AI semi thesis partially intact (Q3 $16B guide is extraordinary) but software miss and FY guidance not raised weaken the thesis. Not a name to reload in the short term.
- **NO scale-up. Let stop execute.**

**META (~$618.24, −0.76% today, −0.39% from entry $620.64):**
- Minor softness, consistent with AI-sector sympathy selling
- Stop $562.329 ($55.91 above current — safe 8.3% buffer). Thesis intact.
- No action.

**MSFT (~$433.50, +1.44% today, +2.65% from entry $422.31):**
- Strong pre-market recovery. AVGO earnings' Q3 AI revenue guide ($16B) is bullish for MSFT's Azure AI demand
- Stop $419.688 ($13.81 above current — safe 3.3% buffer). Thesis intact.
- No action.

**LLY (~$1,098.51, +1.83% today, +2.38% from entry $1,072.94):**
- Medicare GLP-1 Bridge program July 1 catalyst confirmed. Medicare/Medicaid coverage agreement
  announced — estimated 20–30M Medicare beneficiaries eligible. LLY 2026 revenue guidance $80–83B.
- Strong pre-market move validating thesis.
- HWM $1,149.10, stop $1,034.19 ($64.32 above current — safe 6.2% buffer). Thesis STRONGEST in portfolio.
- No action. Could scale up to 10% with Slot 2 or 3 — evaluate at June 5 pre-market.

**NVDA (~$212.53, −1.05% today, −1.76% from entry $216.302):** ⚠️ WATCH
- Stop $209.052; buffer only $3.48 = 1.6%.
- AI sector selling at open (AVGO fallout) could pressure NVDA toward the stop.
- Ex-dividend credit $7.50 (30sh × $0.25) should post today or next business day.
- Thesis intact (AI accelerator monopoly, no credible competitor). Stop is there for a reason — let it run.
- **Key watch at open.** If NVDA opens ≤$209.05, stop fires. DO NOT intervene.

---

### Guardrail check (pre-market June 4)

| Check | Value | Limit | Status |
|-------|-------|-------|--------|
| New positions this week | 1/3 (META June 1) | ≤3 | 2 slots remaining |
| Cash | $59,299.64 (59.6%); ~$67,480 after AVGO exit | ≥5% | ✓ Ample |
| Any position below −7% from entry? | Worst: NVDA −1.76% | −7% threshold | ✓ None triggered |
| AVGO trailing stop | $445.50, pre-mkt $408.98 | Fires at open | ⚠️ Automatic |
| NVDA stop buffer | $212.53 vs $209.052 | 1.6% gap | ⚠️ Narrow — watch |
| WTI oil | $95.68 | <$100 watch | ⚠️ Rising, $4.32 below trigger |
| 10yr yield | ~4.44–4.50% | <4.75% | ✓ |

---

### New position research

**No new positions today.** Reasons:
1. AVGO gap-down creates AI sector uncertainty at open — observe before deploying
2. NVDA's stop buffer is critically narrow; watch first
3. WTI $95.68 is approaching $100 halt trigger — no new buys until oil direction clarifies
4. After AVGO stop fires, cash rises to ~$67K (68%); plenty of room — no urgency
5. Slots 2 and 3 remain available; better to deploy with higher conviction next week or after sector settles

**Candidate evaluation deferred to June 5 pre-market:**
- **LLY scale-up** (+3 shares, ~10% portfolio weight) — Medicare July 1 catalyst, thesis strengthening
- **V (Visa)** — payments infrastructure, sector diversification from AI-heavy book
- Re-evaluate after AVGO and NVDA situations resolve today

---

### Planned trades for today (Thursday June 4, 2026)

**No trades planned.**

The AVGO trailing stop (a8e344f4, stop $445.50) will execute automatically at market open — no action needed from me. AVGO position closes at ~$408-410. No scale-up.

Watch NVDA at open: stop $209.052, pre-market $212.53 (1.6% buffer). Potential AI-sector sympathy selling from AVGO fallout. DO NOT manually intervene; let the trailing stop protect if triggered.

All other positions (MSFT, META, LLY) have adequate stop buffers (3.3%, 8.3%, 6.2% respectively).

**Post-AVGO-exit portfolio plan:**
- 4 positions remain (MSFT, META, LLY, NVDA — contingent on NVDA stop not triggering)
- Cash rises to ~$67,480 (68%)
- No new positions this week. Evaluate at June 5 pre-market.
- **Slot 2:** LLY scale-up +3 shares OR new name — decide June 5
- **Slot 3:** V (Visa) or other name — decide June 5+

**Upcoming catalysts:**
- NVDA ex-dividend credit $7.50 today (June 4) or next business day
- META dividend payable June 25 ($7.875)
- LLY Medicare GLP-1 Bridge program effective July 1
- May nonfarm payrolls (Friday June 5) — key macro read

---

## 2026-06-03 — Pre-market research (~08:07 ET)

**Today is Wednesday June 3. Week of June 1: 1/3 new positions used (META June 1). 2 slots remaining.**

### Macro

- **S&P 500 futures:** -0.11% (S&P futures 7,615.50, -8.25 pts). Dow futures -0.3%, Nasdaq flat.
  All three major indices closed at all-time highs June 2. Taking a breather pre-open. No defensive
  signal — constructive risk-on environment continues.
- **SPY pre-market:** ~$760 (June 2 close $759.47). Since inception $739.44 → SPY +2.71%.
- **10yr Treasury yield:** ~4.4–4.5% range (constructive, below 4.75% halt-new-buys trigger). ✓
- **WTI crude:** ⚠️ $93.64–$96.04, rising for a 3rd consecutive session. Gaining on ongoing
  US-Iran peace-talk uncertainty. Still below $100 watch level but **direction is upward**.
  This reduces appetite for new buys today and adds urgency to monitoring the threshold.
  Watch trigger unchanged: halt new buys if WTI crosses $100.
- **Economic data today:** ADP private payrolls (May); durable goods and factory orders (April).
- **Market posture:** Constructive, but with rising oil acting as a modest headwind. No defensive
  pivot required — broad market at ATH. AVGO earnings tonight is the dominant event.

### Held positions (pre-market June 3, 2026 — live Alpaca data 08:07 ET)

**Account:** Equity $101,380.98 | Cash $51,823.36 (51.1%) | Long market value $49,557.62

**All 6 trailing stop orders confirmed ACTIVE (verified via Alpaca orders endpoint):**

| Symbol | Order ID | Live HWM | Live Stop | Pre-mkt price | vs Entry |
|--------|----------|----------|-----------|--------------|---------|
| AVGO | a8e344f4 | $488.82 (⬆ ratchets at open) | $439.938 | $492.42 | +17.98% |
| MSFT | a55a3db6 | $466.32 | $419.688 | $439.87 | +4.16% |
| META | 4ea07e91 | $624.81 | $562.329 | $602.69 | −2.89% |
| LLY | d4147484 | $1,149.10 | $1,034.19 | $1,066.46 | −0.60% |
| AMZN | bbcd70fa | $274.75 | $247.275 | $256.01 | −4.88% |
| NVDA | 8c6b9680 | $232.28 | $209.052 | $224.20 | +3.65% |

**AVGO ($492.42 pre-mkt, +2.25% today, +17.98% from entry $417.37):** ⭐ KEY EVENT TONIGHT
- EARNINGS AFTER CLOSE TONIGHT (2 PM PT / 5 PM ET). Options imply ±10.65% post-earnings move.
- **Consensus:** Revenue $22.08B (guided $22.0B, +47% YoY); EPS $2.40 (range $2.36–$2.54).
- **KEY METRIC: Q2 AI semiconductor revenue.** Broadcom guided $10.7B for Q2 in its March Q1 report
  (+140% YoY vs $4.6B in Q2 FY25). This is the number the market is watching — does the actual
  print beat this guide, and what does Q3/FY guidance look like?
  - ⚠️ **NOTE: Prior strategy.md scale plan used ">$5B AI revenue" as the bar — this was outdated.**
  The Q2 guide itself was $10.7B. The real bar for tonight is: (1) AI revenue BEATS $10.7B, and
  (2) Q3 AI guidance is raised materially above $10.7B.
- Custom silicon roster: 4 hyperscaler customers now (Alphabet TPU v7 locked for 2027, Meta MTIA
  accelerating, ByteDance ASIC announced May — NEW 4th hyperscaler). CEO Hock Tan: "line of sight
  to $100B+ AI chip revenue in 2027."
- AVGO pre-market $492.42 is ABOVE yesterday broker HWM $488.82 → broker will ratchet HWM to
  ~$492.42+ at open → stop ratchets to ~$443.18 (still 10% below new HWM). No action needed.
- **+15% tighten rule:** AVGO is now +17.98% from entry ($417.37 × 1.15 = $479.98). Rule would
  normally apply. WAIVED — earnings tonight. Tightening from 10% to 7% risks being stopped out
  on post-earnings volatility. Existing 10% stop locks in ~+8% from entry if triggered.
- **DO NOT ADD before earnings.** Post-earnings scale plan below.

**MSFT ($439.87 pre-mkt, −0.33% today, +4.16% from entry $422.31):**
- Build Day 2 (TODAY, Fort Mason SF). Major announcements confirmed day 2:
  - **Autopilots** — new category of always-on AI agents with Entra ID governance (Microsoft Scout)
  - **GitHub Copilot** — native desktop app (Windows/Mac/Linux), Autopilot mode, parallel sessions
  - **Azure AI Foundry** — Hosted Agents reaching GA end of June 2026; hypervisor-isolated runtime
  - **Aion 1.0** — 14B parameter reasoning model ships in-box with Windows for on-device AI
  - **Fabric Data Warehouse** — GPU-accelerated, 7× faster than cloud peers
- Theme: AI moves from passive assistants → autonomous agents running entire workflows.
- MSFT mildly soft pre-market (−0.33%). Build Day 1 "sell the news" pattern appears to be
  moderating. Stop $419.688 is $20.18 below current — safe. Thesis STRONGER after Day 2 reveals.
- No action needed.

**META ($602.69 pre-mkt, +0.85% today, −2.89% from entry $620.64):**
- Recovering. Quarterly dividend $0.525/sh payable June 25 (15sh × $0.525 = $7.875 credit).
- HWM $624.81, stop $562.329 ($40.36 above current). AI ad moat thesis intact.
- No action needed.

**LLY ($1,066.46 pre-mkt, +0.22% today, −0.60% from entry $1,072.94):**
- Stable. Medicare GLP-1 Bridge program effective July 1 (expanding access for Medicare patients
  through 2027). All three major PBMs covering full LLY portfolio. Phase 3 Libretto-432 met
  primary endpoint. Thesis is strongest long-term in portfolio.
- HWM $1,149.10, stop $1,034.19 ($32.27 above current — 3.0% buffer).
- No action needed.

**AMZN ($256.01 pre-mkt, −0.20% today, −4.88% from entry $269.13):** ⚠️ WATCH
- Continued softness. Headwinds: regulatory scrutiny (European AWS government contract risk),
  heavy capex cycle depressing FCF, AWS "regretted attrition" concerns, child-safety lawsuits.
- Positives: Prime Day June 23–26 catalyst; strong Q1 results; AWS backlog $364B; 57/60 analysts
  buy, avg target $312+.
- **Cut threshold: $250.29 (entry $269.13 × 0.93). Current $256.01 = $5.72 above cut.**
- Stop $247.275 ($8.74 below current).
- **AT MIDDAY CHECK: close AMZN if price < $250.29 per −7% rule.**

**NVDA ($224.20 pre-mkt, +0.62% today, +3.65% from entry $216.302):**
- **EX-DIVIDEND TODAY.** $0.25/sh × 30sh = $7.50 credit to account (typically posted same-day or
  next business day on paper trading). Stock will open slightly below yesterday's close adjusted
  for the dividend, which is normal — not a thesis break.
- HWM $232.28, stop $209.052 ($15.15 below current — safe).
- No action needed.

### Guardrail check (pre-market June 3)

| Check | Value | Limit | Status |
|-------|-------|-------|--------|
| New positions this week | 1/3 (META June 1) | ≤3 | 2 slots remaining |
| Cash | $51,823.36 (51.1%) | ≥5% | ✓ Ample |
| Any position below −7% from entry? | Worst: AMZN −4.88% | −7% threshold | ✓ Not triggered |
| AVGO — no add before earnings? | Earnings June 3 tonight | DO NOT ADD | ✓ |
| WTI oil | ~$95/bbl | <$100 watch | ✓ Below, but rising ⚠️ |
| 10yr yield | ~4.4–4.5% | <4.75% | ✓ |
| AVGO +15% tighten rule | +17.98% — rule triggered | WAIVED pre-earnings | ✓ Waived |

### New position research

**No new positions today.** Rationale:
1. AVGO earnings tonight — preserve both remaining slots for the post-earnings scale plan
2. WTI oil at $95/bbl and rising; an additional buy before seeing AVGO results adds unnecessary risk
3. Forcing a new entry the same day as the week's most important earnings is poor process

---

### Planned trades for today (Wednesday June 3, 2026)

**No trades planned.**

All 6 positions held with trailing stops. AVGO earnings tonight is the pivotal event of the week.
AMZN watch: close at midday if below $250.29.
NVDA ex-dividend today: USD 7.50 credit.

**Post-AVGO scale plan (June 4 open) — REVISED:**
- ⚠️ Previous plan used ">$5B AI revenue" as the beat threshold — outdated. Company-guided
  Q2 AI semiconductor revenue was $10.7B (provided in Q1 March report, +140% YoY).
- **New scale trigger:** Q2 AI semiconductor revenue BEATS $10.7B guide AND Q3 AI guidance
  raised meaningfully (guide >$11.5B or FY trajectory raised). BOTH conditions must hold.
  If met: ADD 8–10 shares AVGO at limit ~0.3% below opening quote at June 4 open (~$3,900–$5,000
  at ~$490-500 est.). Scales position from ~9.7% to ~12–14% of portfolio. Uses slot 2.
- **If in-line/miss on AI revenue OR guidance flat/lower:** HOLD existing 20sh with trailing stop.
  Do not add. Let stop protect +8%+ gain from entry.

**Slot 3 (remaining):** After AVGO result, evaluate:
- LLY scale-up (+3 shares ~$3,200 → ~10% portfolio weight)
- V (Visa) new name if macro stable
- Defer to June 5 pre-market research.

**Upcoming catalysts:**
- **AVGO earnings TONIGHT June 3** — KEY WEEK EVENT
- NVDA ex-dividend TODAY ($7.50 credit)
- MSFT Build Day 2 ongoing announcements (autonomous agents, Copilot desktop)
- META dividend payable June 25 ($7.875)
- LLY Medicare GLP-1 Bridge July 1
- ADP jobs data, factory orders (today)

---

## 2026-06-02 — Pre-market research (~08:07 ET)

**Today is Tuesday June 2. Week of June 1: 1/3 new positions used (META June 1). 2 slots remaining.**

### Macro

- **S&P 500 futures:** +0.2%; Nasdaq futures +0.3%. SPY pre-market $756.75 (−0.22% from June 1 close
  $758.44). Broad market off slightly overnight. Market closed June 1 at fresh record highs (10th
  consecutive weekly gain confirmed). No defensive signal.
- **10yr Treasury yield:** 4.46% (+0.01% from prior session) — well below 4.75% watch level.
  Constructive for AI multiples. No stop tightening warranted.
- **Iran — REVERSAL:** Iran suspended communications with Washington June 1, citing US "mixed
  signals." WTI crude surged 6–8% to ~$92/bbl on June 1 (up from ~$87.66). Still below our $100
  watch level. Trump later indicated Lebanon/Hezbollah ceasefire agreed and talks continuing, which
  pulled WTI off session highs. Net: Iran deal trajectory now LESS certain. WTI at $92 is fine
  for now, but the direction reversed. Watch if it re-approaches $100.
- **MSFT Build 2026 — Day 1 TODAY:** Microsoft Build conference at Fort Mason Center, San Francisco.
  Satya Nadella keynote at 9:30 AM PT (12:30 PM ET). Key announcements: new in-house AI coding model
  (addresses investor concern MSFT ceded AI coding to Anthropic/OpenAI), GitHub Copilot as autonomous
  agent, Azure AI Foundry enterprise orchestration dashboard, Copilot Runtime for Windows on-device AI.
  Morgan Stanley eyeing 52% Azure upside. MSFT down −2.46% pre-market ($449.19 from $460.52 last
  session) — likely "sell the news" ahead of conference; initial trading range $450–$472 per reports.
- **Market posture:** Risk-on with modest Iran uncertainty. No defensive pivot. AI sentiment remains
  high (NVDA Computex RTX Spark, MSFT Build, AVGO earnings tomorrow). Proceed with all 6 positions.

### Held positions (pre-market June 2, 2026 — live Alpaca data 08:07 ET)

**All 6 trailing stop orders confirmed ACTIVE (verified via Alpaca orders endpoint):**

| Symbol | Order ID | Live HWM | Live Stop | Pre-mkt price | vs Entry |
|--------|----------|----------|-----------|--------------|---------|
| AVGO | a8e344f4 | **$466.05** (ratcheted overnight) | **$419.445** | $486.51 | +16.57% |
| MSFT | a55a3db6 | $466.32 | $419.688 | $449.19 | +6.37% |
| META | 4ea07e91 | $624.81 | $562.329 | $605.49 | −2.44% |
| LLY | d4147484 | $1,149.10 | $1,034.19 | $1,077.07 | +0.39% |
| AMZN | bbcd70fa | $274.75 | $247.275 | $257.35 | −4.38% |
| NVDA | 8c6b9680 | **$224.87** (ratcheted overnight) | **$202.383** | $227.35 | +5.11% |

**AVGO ($486.51 pre-mkt, +5.77% from $459.97 close, +16.57% from entry $417.37):**
- Extraordinary pre-market surge. Earnings TOMORROW June 3 after close (2 PM PT / 5 PM ET).
- Consensus: EPS $2.40 (+51.9% YoY), revenue $22.11B (+47% YoY). Buy-side bar: AI revenue >$5B
  (vs $4.1B in Q1). EPS consensus raised 11% over past 90 days — growing confidence.
- Broker ratcheted HWM overnight from $463.19 → $466.05. At $486.51, broker will ratchet
  HWM → $486.51+ at open → stop → ~$437.86 (10% below HWM).
- **HARD RULE: DO NOT ADD before earnings. Hold with trailing stop. Post-earnings scale plan below.**

**MSFT ($449.19 pre-mkt, −2.46% from $460.52, +6.37% from entry $422.31):**
- Pre-market softness on Build Day 1 open. Classic "sell the news" pattern at conference start.
- Conference runs today and tomorrow June 3 — new AI coding model, GitHub Copilot agent, Azure AI.
  Morgan Stanley raised target citing 52% Azure upside. Thesis very intact.
- Trailing stop HWM $466.32. Stop $419.688. MSFT at $449.19 is $29.73 above stop — safe. Stop
  will NOT ratchet today (MSFT below HWM). This is fine — trend is intact, just a pullback day.
- **Action: HOLD. No concern at this level.**

**META ($605.49 pre-mkt, +0.84% from $600.47, −2.44% from entry $620.64):**
- Recovering. META declared quarterly cash dividend $0.525/sh payable June 25 — modest positive.
- Thesis intact: AI-driven ad moat, +33% revenue, subscription layer, Llama flywheel. Current
  price $605.49 = $43.16 above stop $562.329. Safe. HWM $624.81 (only $19.32 above entry).
- **Action: HOLD. Normal early-position volatility.**

**LLY ($1,077.07 pre-mkt, −0.47% from $1,082.20, +0.39% from entry $1,072.94):**
- Mild softness. Medicare GLP-1 Bridge program starts July 1 (new catalyst) — Medicare beneficiaries
  get discounted LLY obesity medicines through end of 2027. Materially expands access beyond commercial.
- CVS Foundayo coverage live since June 1. All three major PBMs now covering full portfolio.
- Phase 3 Libretto-432 trial (Retevmo) met primary endpoint May 31 — pipeline diversification catalyst.
- Trailing stop HWM $1,149.10, stop $1,034.19. Current $1,077.07 = 4.2% above stop. Safe.
- **Action: HOLD. Thesis is the strongest long-term in the portfolio.**

**AMZN ($257.35 pre-mkt, −1.50% from $261.26, −4.38% from entry $269.13):** ⚠️ WATCH
- Drifting lower. Headwinds: European cloud regulations potentially limiting AWS government contracts,
  AWS outage May 7–8 (resolved), regretted attrition among senior AWS engineers noted.
- Near-term catalyst: Prime Day June 23–26 (moved back to June for first time since 2021).
- Cut threshold: entry $269.13 × 0.93 = $250.19. Current $257.35 = $7.16 above cut.
- Stop $247.275. Current = 4.1% above stop. Thesis (AWS $364B backlog, $100B Anthropic) intact.
  57/60 analysts buy, avg target $312.83.
- **Action: HOLD. Monitor intraday. If AMZN approaches $252–254, re-evaluate thesis.**

**NVDA ($227.35 pre-mkt, +1.33% from $224.36, +5.11% from entry $216.302):**
- Strong. Broker ratcheted HWM overnight $222.694 → $224.87, stop $200.42 → $202.383.
- At $227.35, broker will ratchet HWM → $227.35+ at open → stop → ~$204.62.
- Ex-dividend THURSDAY June 4: $0.25/sh × 30sh = $7.50 credit.
- RTX Spark momentum continues. Pre-market reportedly +6.25% around $229.72 per some sources
  (vs Alpaca's $227.35 at 8:07 AM — pre-market price may have moved after data pull).
- **Action: HOLD. Let trailing stop ratchet.**

### New position research

**No new position candidates for today.** Reasoning:
- AVGO earnings TOMORROW (June 3) — reserve 1 slot for post-earnings scale-up if strong beat.
- Iran oil trend reversal ($92 and rising vs falling): modest added uncertainty, prefer caution.
- 2 slots remaining. Optimal use:
  - Slot 2: AVGO scale-up June 4 open (if beat strongly: AI revenue >$5B, guidance raised)
  - Slot 3: New name research after AVGO print — candidates: LLY scale-up to 10%, V (Visa),
    COST (re-evaluate), or new name with fresh catalyst.
- Forcing a new entry today, before the week's pivotal earnings event, is suboptimal.

### Guardrail check

| Check | Value | Limit | Status |
|-------|-------|-------|--------|
| New positions this week | 1/3 (META June 1) | ≤3 | 2 slots remaining |
| Cash | $51,823.36 (51.0%) | ≥5% | ✓ Ample |
| Any position below −7% from entry? | Max: AMZN −4.38% | −7% threshold | ✓ None triggered |
| AVGO — no add before earnings? | Earnings June 3 | DO NOT ADD | ✓ |
| WTI oil | ~$92/bbl | <$100 watch | ✓ (below watch, but rising trend) |
| 10yr yield | 4.46% | <4.75% | ✓ |

---

### Planned trades for today (Tuesday June 2, 2026)

**No trades planned.**

All 6 positions intact. AVGO earnings tomorrow is the dominant week event — do not add concentration
before the print. Iran oil reversal introduces modest caution. AMZN drifting toward watch territory
but well above −7% cut threshold and stop. All stops confirmed active.

**Post-AVGO plan (June 4 open):**
- **Strong beat** (AI revenue >$5B, guidance raised, hyperscaler commentary positive): Scale AVGO
  toward 12–14%. Currently 20sh × ~$490 = 9.6%. Add 8–10 shares (~$3,900–$4,900) for 10.4–11.4%.
  → Uses 1 position slot (slot 2 of week). Thesis: AI custom silicon monopoly with multi-year
  hyperscaler ASIC demand; earnings confirmation of the investment thesis.
- **In-line or miss:** Hold existing 20sh with trailing stop. Do not add. Let stop protect gains.

**Upcoming catalysts:**
- MSFT Build Day 2 June 3 — continued developer AI announcements.
- **AVGO earnings June 3 (after close)** — KEY WEEK EVENT.
- **NVDA ex-dividend June 4** — $0.25/sh × 30sh = $7.50 credit.
- META dividend payable June 25 ($0.525/sh × 15sh = $7.875).
- LLY Medicare GLP-1 Bridge program July 1.

---

## 2026-06-01 — Pre-market research (~08:07 ET)

**Today is Monday June 1 — first trading day of week of June 1. Weekly new-position count: 0/3 used. 1 slot carried from last week (COST/MRVL both skipped).**

### Macro

- **S&P 500 futures:** +0.2%; Dow futures +227 pts (+0.4%). SPY pre-market ~$758.34 (+0.26% from Friday close $756.34).
  Strong May recap: Nasdaq +8%, S&P 500 +5%, Dow +3% — market at/near ATH heading into June.
  Constructive risk-on open. No defensive signals.
- **NVDA RTX Spark — Computex 2026 keynote TODAY:** NVIDIA CEO Jensen Huang unveiled the RTX Spark superchip
  at Computex in Taipei: Arm-based N1X processor co-developed with Microsoft. Launching in laptops from
  Microsoft, Dell, HP, ASUS, Lenovo, MSI. 1 petaflop AI performance, up to 128GB unified memory. Company
  entering the PC CPU market (challenging Intel, AMD, Qualcomm). "Reinvention of the computer as big as
  the smartphone." Arm Holdings, HPE, ServiceNow, IBM also surging. **NVDA +2.17% pre-market to $215.725.**
- **MSFT Build conference June 2–3 (tomorrow–Wednesday):** MSFT will unveil a new in-house AI coding model —
  addresses investor concern that MSFT ceded AI coding market to Anthropic/others. Snowflake's Q1 results
  ("enterprise AI demand at clear inflection point") vindicated MSFT's $190B AI capex thesis.
  **MSFT +3.89% pre-market to $467.76** — massive move, new equity high. Azure AI secular thesis fully intact.
- **10yr Treasury yield:** ~4.48–4.50% (last week), well below 4.75% watch level. No macro concern.
- **Iran / WTI:** Tentative deal framework progress continues. WTI ~$87/bbl area. Below $100 watch. Constructive.
- **LLY CVS Foundayo coverage: EFFECTIVE TODAY.** CVS Caremark commercial template coverage for Foundayo
  begins June 1. All three largest US PBMs will cover LLY's full obesity medicine portfolio. Eligible
  commercially insured patients may pay as low as $25/month. Major commercial access catalyst — going live today.
- **Goldman Sachs S&P 500 target 8,000** (raised from 7,600 on May 27). Broad market bullish.
- **Market posture:** Decidedly risk-on. AI sentiment high (NVDA Computex, MSFT Build imminent), macro
  constructive (low yields, falling oil, benign PCE), market at ATH starting the month strongly.
  No defensive pivot warranted. Full risk-on posture appropriate.

### Held positions (pre-market June 1, 2026)

**Trailing stop orders — ALL 5 CONFIRMED ACTIVE (verified via Alpaca orders endpoint):**

| Symbol | Order ID | HWM (actual) | Stop | Pre-mkt price | vs Entry |
|--------|----------|-------------|------|--------------|---------|
| AVGO | a8e344f4 | **$448.88** | **$403.99** | $456.83 | +9.46% |
| MSFT | a55a3db6 | **$450.33** | **$405.30** | $467.76 | +10.76% |
| LLY | d4147484 | $1,149.10 | $1,034.19 | $1,098.01 | +2.34% |
| AMZN | bbcd70fa | **$274.75** | **$247.28** | $268.22 | −0.34% |
| NVDA | 8c6b9680 | $218.18 | $196.36 | $215.725 | −0.27% |

_Note: MSFT HWM ratcheted to $450.33 and AMZN to $274.75 by broker at Friday EOD — higher than
portfolio.md had recorded. AVGO HWM ratcheted to $448.88. All stops will ratchet further at open
given strong pre-market: MSFT→~$421, AVGO→~$411._

**AVGO ($456.83 pre-mkt, +2.25%, +9.46% from entry):**
- Strong pre-market momentum ahead of June 3 earnings.
- UBS raised target to $490, consensus "Strong Buy." AI revenue +106% in latest quarter.
- **DO NOT ADD — earnings June 3 (2 trading days). Hold.** Stop ratchets ~$411 at open.

**MSFT ($467.76 pre-mkt, +3.89%, +10.76% from entry):**
- MASSIVE move: Snowflake Q1 "enterprise AI inflection point" vindicated capex; MSFT Build June 2–3
  with new AI coding model announcement; Pershing Square stake; $1B EY partnership.
- New HWM will be ~$467-468+ at open → stop ratchets to ~$421+.
- Azure AI thesis: STRONGEST conviction in the portfolio today. Hold and let broker ratchet stop.

**LLY ($1,098.01 pre-mkt, −0.63%, +2.34% from entry):**
- CVS Foundayo coverage live today — **catalyst is real but stock is mildly soft** (−0.63%).
  Suggests this was largely priced in after the May 28 ATH announcement. Prior HWM: $1,149.10.
  LLY is $51 (4.4%) below its HWM — some mean-reversion underway.
- Thesis still strongest in portfolio long-term. No scale-up today — wait for post-CVS
  momentum to rebuild. Stop at $1,034.19 is safe (current $1,098 = 6.2% above stop).

**AMZN ($268.22 pre-mkt, −0.89%, −0.34% from entry):**
- Mild softness. No negative catalyst. Prime Day moved to June (slight positive for retail).
  Truist raised target $310→$320. AWS $364B backlog thesis intact. Hold.
  HWM $274.75, stop $247.28. Current is 8.5% above stop — safe.

**NVDA ($215.725 pre-mkt, +2.17%, −0.27% from entry):**
- **NEW CATALYST:** RTX Spark chip at Computex 2026 — entering PC CPU market. NVDA +2.17% pre-mkt.
  This is an incremental positive for long-term addressable market expansion.
  Ex-dividend June 4 ($0.25/sh × 30sh = $7.50). HWM $218.18, stop $196.36.
  If NVDA clears $218.18 today, stop ratchets higher — watch.

### New position research: META

**META Platforms — primary candidate for the week of June 1 carried slot**

**Fundamentals:**
- Q1 2026 revenue: $56.3B (+33% YoY) — beat consensus. Ad impressions +19%, pricing +12%.
  AI-driven ad targeting is driving higher advertiser ROI → advertisers bid up prices willingly.
- 2026 capex guidance raised to $125-145B (from $115-135B) — some investor concern but market
  has accepted it; META recovered from any post-Q1 dip to reach $635+ by late May.
- May 27: Global launch of Instagram Plus and Facebook Plus ($3.99/month each) — adds
  recurring subscription revenue layer. META surged 4% on the announcement.
- Llama open-source AI flywheel: drives developer adoption, creates enterprise AI ecosystem
  that funnels back to Meta's advertising and communication platforms.

**Analyst consensus:**
- 64 analysts: "Strong Buy" consensus. Average 12-month target: $826.75 (31% upside vs $632).
- Target range: $825-$880 with bulls reaching $1,086.
- Oppenheimer, UBS, Cantor Fitzgerald all maintaining positive coverage.

**Valuation:**
- At $632, with ~$30 EPS estimate for 2026, forward P/E ≈ 21x — reasonable for 30%+ revenue grower.
- P/E to growth (PEG) ≈ 21x / 33x growth ≈ 0.64 — well below 2.5x threshold. ✓

**Entry signal check (need ≥3 of 5):**
1. Earnings momentum: Q1 +33% revenue beat, subscription launch catalyst ✓
2. Clear catalyst: MSFT Build sentiment lift (enterprise AI demand confirmed); Llama adoption flywheel;
   subscription revenue launch May 27 ✓
3. Valuation: Forward P/E ~21x, PEG 0.64 — reasonable for 30%+ grower ✓
4. Technical: At $632-635, META is trending up from ~$607 area (4% higher in 2 weeks). Above recent
   support. Not overextended (4% rise from prior level). ✓
5. Macro tailwind: AI ad market secular tailwind intact; risk-on environment; NVDA/MSFT both surging ✓
**Result: 5 of 5 criteria met → PROCEED.**

**Sizing:**
- 15 shares × ~$633 = ~$9,495 = 9.3% of portfolio [$101,829] → starter "high conviction" position.
- Within 20% cap. Within 25% daily deployment cap ($9,495 is 9.3% of $101,829; cap = $25,457).
- Cash after fill: $61,132.91 − $9,495 ≈ $51,638 (50.7% of portfolio) — above 5% minimum. ✓
- Sector check: Adding ad-tech (META) alongside AI-infra (AVGO, MSFT, AMZN, NVDA) + healthcare (LLY).
  META is ad-tech/social, not direct AI-semi — adds sector diversification. ✓
- Tech/AI concentration after META: (AVGO 8.97% + MSFT 9.19% + AMZN 7.90% + NVDA 6.35% + META 9.3%)
  = ~41.7% — note this approaches the 35% heuristic. However META is ad-tech, not AI-semi.
  AI-semi specifically (AVGO + NVDA) = 15.3%, which is healthy. Cloud+AI-infra (MSFT + AMZN) = 17.1%.
  The 41.7% is tech-broad but diversified across sub-sectors. OK to proceed at starter sizing.

**Stop:** 10% trailing stop placed immediately after fill. Initial stop ~$569.70 (10% below $633).

**Thesis:** Meta's AI-driven advertising moat (+19% impression growth, +12% pricing) creates compounding
FCF at scale. The subscription launch ($3.99/month across Instagram/Facebook) layers recurring revenue
atop the ad business. Llama open-source creates an enterprise AI ecosystem. 64-analyst "Strong Buy"
consensus with $826.75 target (31% upside) on reasonable valuation (PEG 0.64). The AI capex
overhang ($125-145B) is known and priced — META's ad machine generates enough FCF to fund it.
Invalidation: advertising market deterioration (ad pricing falls >10% YoY, impressions stall);
Llama open-source strategy reversal; META breaks below $570 on volume.

### Guardrail check

| Check | Value | Limit | Status |
|-------|-------|-------|--------|
| New positions this week | 0/3 (resets June 1) | ≤3 | 1 after META |
| Positions ≥ −7% from entry? | Max: AMZN −0.34%, NVDA −0.27% | −7% threshold | ✓ None near |
| Cash after META fill | ~$51,638 (50.7%) | ≥5% | ✓ |
| META position size | 15sh × $633 = $9,495 = 9.3% | ≤20% | ✓ |
| Daily new-buy deployment | $9,495 = 9.3% of portfolio | ≤25% ($25,457) | ✓ |
| Market open today? | Opens 9:30 AM ET June 1 | Must be open | ✓ (confirmed) |
| AVGO buy today? | NO — earnings June 3 | DO NOT ADD | ✓ |

---

### Planned trades for today (Monday June 1, 2026)

**1 new position: BUY META 15 shares** (carried slot from last week)

**BUY META 15 shares** (limit order ~0.3% below opening quote per lessons.md)
*Thesis:* Meta's AI-driven advertising moat is compounding revenue at +33% YoY with ad impressions
+19% and pricing +12%. The May 27 subscription launch (Instagram Plus/Facebook Plus, $3.99/month)
adds a recurring revenue layer. Llama open-source flywheel drives enterprise AI ecosystem adoption.
64 analysts Strong Buy, avg target $826.75 (31% upside), PEG 0.64 on 30%+ growth. Constructive
macro, AI sentiment at cycle highs (NVDA Computex, MSFT Build), enterprise AI demand confirmed by
Snowflake Q1. Starting at 9.3% of portfolio — room to scale.
*Stop:* 10% trailing stop immediately after fill.
*Invalidation:* Break below $570 on volume; advertising market deterioration; META capex ROI concerns escalate.

**No action on:**
- AVGO: DO NOT ADD — earnings June 3 (2 days). Hold stop. Expect strong print; evaluate scale-up post-earnings.
- LLY: HOLD — CVS catalyst live but priced in; stock soft −0.63%. Wait for momentum to rebuild.
- All other positions: HOLD with trailing stops. MSFT and AVGO stops will auto-ratchet at open.

**Upcoming catalysts this week:**
- MSFT Build conference June 2–3 — new AI coding model reveal. Positive for MSFT thesis.
- AVGO earnings June 3 (after close) — KEY EVENT. If strong beat + AI revenue raised → scale AVGO to 12-15%.
- NVDA ex-dividend June 4 — $0.25/sh × 30sh = $7.50 credit.
- LLY: CVS Foundayo coverage effective today. Monitor for any secondary price response.

---

## 2026-07-16 — Pre-market research (~08:07 ET)

Control switch: STATUS ACTIVE, no NOTE, no QUERY. Today is Thursday — fresh-candidate scan runs (step 4).

### Macro
S&P 500 futures modestly higher (~+0.2%, one source flagged −0.1% — mixed signals) on a cooler-than-expected June CPI: headline −0.4% MoM, YoY eased to 3.5%; core held at 2.6%. 10yr yield ~4.57% (below the 4.75% halt trigger). WTI/Brent not re-checked today — no new Hormuz escalation reported. No halt triggers close to tripping. Constructive-but-mixed, no reason for a defensive pivot. [Yahoo Finance, Benzinga — July 16, 2026]

### Held positions — what changed since yesterday

- **CAT** ($888.50 pre-market, −5.952% from entry, −2.822% intraday): Down sharply for a second session. July 15 closed −2.15% day/day at $914.13 — below its 50-day MA ($929.44, −1.63%) but on volume only 0.70x the 20-day average, so the written invalidation ("close below ~$925.64 MA **on volume**") has NOT technically triggered. Cause: fresh commentary on dealer inventory build, margin compression, cooling global industrial cycle, and mining conglomerates deferring capex on volatile commodity prices — layers on top of the already-known ~USD 2.2-2.4B tariff-cost drag and the Michael Burry short thesis (both known since before entry). Aug 4 earnings confirmed (outside 2-day window). **Decision: HOLD, not a confirmed thesis break** — no company disclosure, no guidance cut, and the technical breach lacked volume confirmation; the existing invalidation criteria are deliberately volume-gated to avoid overreacting to noise-level breaks. However CAT is now the closest position to the −7% midday cut rule (−5.952% and falling pre-market) — **flagged HIGH PRIORITY for today's midday routine.** review_by 2026-08-03 renewed, not due.
- **ETN** ($402.95 pre-market, −2.901% from entry, −2.4% intraday): Sympathetic weakness alongside CAT/industrials, not company-specific — no negative ETN news found. July 14 close ($412.86) was still +2.0% above its 50-day MA (~$404.8); invalidation ("close below ~USD 405 MA on volume") not triggered. FranklinWH home-energy partnership and the Dana Mobility-business combination (USD 5.1B) both reported as recent positives; Buy-rated by multiple analysts, avg PT USD 456. July 31 earnings confirmed (outside 2-day window). HOLD, thesis intact. review_by 2026-07-30 not due.
- **LLY** ($1,163.00 pre-market, +6.352% from entry): Constructive — Bernstein PT USD 1,385, UBS USD 1,425, Guggenheim USD 1,273 (all raised mid-July, already known). New since last check: full FDA approval for Retevmo (oncology) and reported acquisition interest in AtaiBeckley — both incremental positives, not thesis-moving. Stock hit its ATH July 7 at USD 1,249.45 (still the HWM). No thesis break. review_by 2026-07-21 not due. Conviction A.
- **V** ($357.25 pre-market, +10.409% from entry): Constructive — AI Financial Assistant launch and the ACE Money Transfer partnership (both already known) continue to be cited positively; consensus target ~USD 401-410, no sell ratings. Touched a 52-week high USD 365.02 July 6, now −2.2% off that peak — normal pullback, not a reversal. Q3 earnings July 28 (12 days away — outside the 2-day window, will need a hold/trim decision as it approaches). No thesis break. review_by 2026-07-28 not due. Conviction B.

### 3b. Thesis contract review
All four review_by dates checked against today (2026-07-16): LLY (07-21), ETN (07-30), V (07-28), CAT (08-03) — none due. No invalidation triggered on any held name (see per-position notes above); CAT's technical breach explicitly failed the volume-confirmation clause, so it does not count as triggered. All four contracts renewed as-is (no new review_by needed since none expired).

### 6b. Daily candidate diligence — JNJ (full pass)

JNJ has sat on the watchlist since 2026-05-22 (8 weeks) with only passive "no new signal" notes and no full diligence pass — the most overdue name in the research queue (ahead of WMT, added same day, and PWR, added 2026-06-12). Picked as today's diligence target.

- **Catalyst — Q2 2026 earnings, reported yesterday July 15:** Sales USD 25.3B (+6.6% reported, +5.6% operational) beat consensus ~USD 25.05B. Adjusted EPS USD 2.90 beat the USD 2.85 consensus (reported EPS USD 2.27). Innovative Medicine segment +7.8% to USD 16.38B; MedTech +4.5% to USD 8.93B. **FY26 guidance raised**: sales to USD 101.1B (+7.3% midpoint) — first time in JNJ's 140-year history crossing USD 100B; adjusted EPS raised USD 0.13 to USD 11.68 midpoint (+8.2%). [JNJ investor relations, BioSpace, Yahoo Finance — July 15-16, 2026]
- **Analyst reaction:** RBC (Shagun Singh Chadha) raised PT to USD 287 from USD 265, Outperform. TD Cowen (Michael Nedelcovych) raised PT to USD 300 from USD 250, Buy — a materially more bullish stance post-print. 19-of-24-analyst consensus is Buy as of early July; consensus PT ~USD 257-261 (will likely move up further as more analysts update post-print).
- **Valuation — FAILS the gate:** Trailing P/E ~27.87x; forward P/E 21.17x vs sector average 18.49x and JNJ's own 5-year historical average 15.65x. No discount to peers or own history; roughly PEG ≈ 21.17/8.2 ≈ 2.58, just over the 2.5 threshold. This is a real valuation stretch, acknowledged and outweighed by the other four signals below.
- **Technical — passes:** 50-day MA (through July 15) = USD 237.59; last close USD 247.02 = **+3.967% above the MA** — clears the 0.5% separation floor and stays well under the 10% extension ceiling. 20-day ATR = 2.293% — under the 3% halving threshold, full starter size is appropriate.
- **Macro/sector tailwind — passes:** Healthcare secular growth is one of the strategy's three named tailwinds; defensive-quality compounder positioning is a good complement to LLY (GLP-1 growth stock) — diversifies the healthcare sleeve by sub-theme rather than doubling down on one name's risk.
- **Entry signal count: 4 of 5 clear** (earnings momentum, catalyst, technical, macro) — valuation is the lone miss. Strategy requires "at least two," so this comfortably qualifies. Buying one session after a confirmed beat+raise with a positive market reaction (not before, avoiding the earnings-gap-risk lesson) is the correct sequencing.
- **Earnings window:** JNJ reported yesterday (July 15) — no upcoming-earnings conflict; next report is ~mid-October 2026.
- **Not promoted — WMT and PWR:** both remain in the "no new signal" holding pattern (unchanged from prior weeks); neither got today's diligence slot. Will rotate to one of them on a future pre-market if no fresher catalyst emerges first.

**Decision: PROMOTE JNJ to a buy candidate for today's market-open.** See "Planned trades for today" below.

### Fresh-candidate scan (Thursday)

Searched for AI-infrastructure/real-economy/healthcare names not already on the watchlist. Most-cited AI-infra names this week (Teradyne, Ouster, Vishay Precision Group per 24/7 Wall St) are chip-test/component plays, not previously diligenced here.

- **Added research-only: TER (Teradyne)** — semiconductor test equipment, a picks-and-shovels play on AI-accelerator production volume (test capacity scales with chip output, distinct exposure from GPU/ASIC makers already implicitly covered via AGGRO's book). Not diligenced today — JNJ took today's diligence slot. Logged to strategy.md watchlist for a future full pass (fundamentals, valuation, technical, ATR).
- Ouster (lidar) and Vishay Precision Group (sensors) considered but skipped — lidar/autonomous-driving exposure is a weaker fit for the strategy's three named tailwinds than direct AI-power/AI-test infrastructure; not added.

### Cash-drag check (step 6)

Cash is 68.995% of portfolio — well above the 25-40% target band for a 4-position book, and has been above band since inception (structural, not new). Tape is constructive-but-mixed (cooling CPI vs. a shaky industrials tape on CAT-specific weakness). Per policy, this qualifies as "cash above band for more than a week + constructive tape" → today's JNJ buy plan (below) is the qualifying entry that addresses the cash-drag check; no separate sentence needed since a trade is planned.

### Guardrail check for the JNJ plan

| Check | Value | Limit | Status |
|-------|-------|-------|--------|
| Position size | 32sh × ~USD 247.02 ≈ USD 7,904.64 = 7.98% of portfolio | ≤20% | ✓ |
| Single-order size | 7.98% | ≤15% | ✓ |
| Daily new-buy deployment | 7.98% of portfolio | ≤25% (~USD 24,765) | ✓ |
| Cash after fill | ~USD 60,455 (61.0%) | ≥5% | ✓ |
| Sector (Healthcare) after fill | LLY 11.740% + JNJ 7.98% ≈ 19.72% | ≤60% | ✓ |
| Earnings window | JNJ reported yesterday (July 15); next ~mid-Oct | No buy within 2 days before | ✓ |
| ATR (20-day) | 2.293% | Halve if >3% | ✓ under threshold, full size |
| Market open today? | Opens 9:30 AM ET July 16 | Must be open | ✓ (confirmed via clock) |

### Planned trades for today

**1 new position: BUY JNJ.** No other trades — CAT/ETN/LLY/V all HOLD (see per-position notes above); no exits or trims warranted (no confirmed thesis breaks, no −7% breach yet — that's midday's call if CAT keeps falling).

```json
{
  "plan_date": "2026-07-16",
  "trades": [
    {"action": "buy", "symbol": "JNJ", "qty": 32, "thesis": "Q2 2026 beat+raise reported July 15 (sales USD 25.3B +6.6%, adj EPS USD 2.90 vs USD 2.85 est, FY26 guidance raised to USD 100B+ revenue milestone); TD Cowen and RBC both raised PT post-print; technical confirmation +3.97% above 50-day MA, ATR 2.293% under the halving threshold; healthcare secular-growth tailwind, diversifies the healthcare sleeve away from pure GLP-1 exposure; valuation is rich (forward P/E 21.17x vs 5-yr avg 15.65x) but 4 of 5 entry signals clear",
     "invalidation": "Close back below the ~USD 237.59 pre-earnings 50-day MA on volume, OR management/analysts walk back the raised FY26 guidance, OR the forward P/E de-rates toward its historical average without a fundamental trigger",
     "review_by": "2026-08-15"}
  ]
}
```

---

